GL 10-Q Quarterly Report Sept. 30, 2024 | Alphaminr

GL 10-Q Quarter ended Sept. 30, 2024

GLOBE LIFE INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
gl-20240930
0000320335 12/31 2024 Q3 FALSE http://fasb.org/us-gaap/2024#RealizedInvestmentGainsLosses http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent http://fasb.org/us-gaap/2024#RealizedInvestmentGainsLosses http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent xbrli:shares iso4217:USD iso4217:USD xbrli:shares gl:segment xbrli:pure gl:Issue gl:issuer gl:loan gl:commercial_mortgage_loan gl:complainant gl:extension_option 0000320335 2024-01-01 2024-09-30 0000320335 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0000320335 gl:JuniorSubordinatedDebenturesMember 2024-01-01 2024-09-30 0000320335 2024-10-31 0000320335 2024-09-30 0000320335 2023-12-31 0000320335 gl:PartnershipInterestFairValueOptionMember 2024-09-30 0000320335 gl:PartnershipInterestFairValueOptionMember 2023-12-31 0000320335 us-gaap:LifeInsuranceSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:LifeInsuranceSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:LifeInsuranceSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:LifeInsuranceSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:HealthInsuranceProductLineMember 2024-07-01 2024-09-30 0000320335 us-gaap:HealthInsuranceProductLineMember 2023-07-01 2023-09-30 0000320335 us-gaap:HealthInsuranceProductLineMember 2024-01-01 2024-09-30 0000320335 us-gaap:HealthInsuranceProductLineMember 2023-01-01 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2024-07-01 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2023-07-01 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2024-01-01 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2023-01-01 2023-09-30 0000320335 2024-07-01 2024-09-30 0000320335 2023-07-01 2023-09-30 0000320335 2023-01-01 2023-09-30 0000320335 us-gaap:PreferredStockMember 2023-12-31 0000320335 us-gaap:CommonStockMember 2023-12-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000320335 us-gaap:RetainedEarningsMember 2023-12-31 0000320335 us-gaap:TreasuryStockCommonMember 2023-12-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000320335 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000320335 2024-01-01 2024-03-31 0000320335 2024-04-01 2024-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000320335 us-gaap:PreferredStockMember 2024-03-31 0000320335 us-gaap:CommonStockMember 2024-03-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000320335 us-gaap:RetainedEarningsMember 2024-03-31 0000320335 us-gaap:TreasuryStockCommonMember 2024-03-31 0000320335 2024-03-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000320335 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000320335 us-gaap:PreferredStockMember 2024-06-30 0000320335 us-gaap:CommonStockMember 2024-06-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000320335 us-gaap:RetainedEarningsMember 2024-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2024-06-30 0000320335 2024-06-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000320335 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000320335 us-gaap:PreferredStockMember 2024-09-30 0000320335 us-gaap:CommonStockMember 2024-09-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000320335 us-gaap:RetainedEarningsMember 2024-09-30 0000320335 us-gaap:TreasuryStockCommonMember 2024-09-30 0000320335 us-gaap:PreferredStockMember 2022-12-31 0000320335 us-gaap:CommonStockMember 2022-12-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000320335 us-gaap:RetainedEarningsMember 2022-12-31 0000320335 us-gaap:TreasuryStockCommonMember 2022-12-31 0000320335 2022-12-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000320335 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000320335 2023-01-01 2023-03-31 0000320335 2023-04-01 2023-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000320335 us-gaap:PreferredStockMember 2023-03-31 0000320335 us-gaap:CommonStockMember 2023-03-31 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000320335 us-gaap:RetainedEarningsMember 2023-03-31 0000320335 us-gaap:TreasuryStockCommonMember 2023-03-31 0000320335 2023-03-31 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000320335 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000320335 us-gaap:PreferredStockMember 2023-06-30 0000320335 us-gaap:CommonStockMember 2023-06-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000320335 us-gaap:RetainedEarningsMember 2023-06-30 0000320335 us-gaap:TreasuryStockCommonMember 2023-06-30 0000320335 2023-06-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000320335 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000320335 us-gaap:PreferredStockMember 2023-09-30 0000320335 us-gaap:CommonStockMember 2023-09-30 0000320335 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000320335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000320335 us-gaap:RetainedEarningsMember 2023-09-30 0000320335 us-gaap:TreasuryStockCommonMember 2023-09-30 0000320335 2023-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-06-30 0000320335 gl:FuturePolicyBenefitsMember 2024-06-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-06-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-07-01 2024-09-30 0000320335 gl:FuturePolicyBenefitsMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-09-30 0000320335 gl:FuturePolicyBenefitsMember 2024-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-06-30 0000320335 gl:FuturePolicyBenefitsMember 2023-06-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-07-01 2023-09-30 0000320335 gl:FuturePolicyBenefitsMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-09-30 0000320335 gl:FuturePolicyBenefitsMember 2023-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0000320335 gl:FuturePolicyBenefitsMember 2023-12-31 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-09-30 0000320335 gl:FuturePolicyBenefitsMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0000320335 gl:FuturePolicyBenefitsMember 2022-12-31 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-09-30 0000320335 gl:FuturePolicyBenefitsMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000320335 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000320335 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000320335 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000320335 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000320335 gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2024-09-30 0000320335 us-gaap:USStatesAndPoliticalSubdivisionsMember 2024-09-30 0000320335 us-gaap:ForeignGovernmentDebtSecuritiesMember 2024-09-30 0000320335 gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2023-12-31 0000320335 us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-12-31 0000320335 us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0000320335 gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 gl:RealEstateInvestmentTrustMember us-gaap:FixedMaturitiesMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:RealEstateInvestmentTrustMember us-gaap:FixedMaturitiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FixedMaturitiesMember 2024-07-01 2024-09-30 0000320335 us-gaap:FixedMaturitiesMember 2023-07-01 2023-09-30 0000320335 us-gaap:FixedMaturitiesMember 2024-01-01 2024-09-30 0000320335 us-gaap:FixedMaturitiesMember 2023-01-01 2023-09-30 0000320335 us-gaap:PolicyLoansMember 2024-07-01 2024-09-30 0000320335 us-gaap:PolicyLoansMember 2023-07-01 2023-09-30 0000320335 us-gaap:PolicyLoansMember 2024-01-01 2024-09-30 0000320335 us-gaap:PolicyLoansMember 2023-01-01 2023-09-30 0000320335 gl:MortgageLoansMember 2024-07-01 2024-09-30 0000320335 gl:MortgageLoansMember 2023-07-01 2023-09-30 0000320335 gl:MortgageLoansMember 2024-01-01 2024-09-30 0000320335 gl:MortgageLoansMember 2023-01-01 2023-09-30 0000320335 us-gaap:OtherLongTermInvestmentsMember 2024-07-01 2024-09-30 0000320335 us-gaap:OtherLongTermInvestmentsMember 2023-07-01 2023-09-30 0000320335 us-gaap:OtherLongTermInvestmentsMember 2024-01-01 2024-09-30 0000320335 us-gaap:OtherLongTermInvestmentsMember 2023-01-01 2023-09-30 0000320335 us-gaap:ShortTermInvestmentsMember 2024-07-01 2024-09-30 0000320335 us-gaap:ShortTermInvestmentsMember 2023-07-01 2023-09-30 0000320335 us-gaap:ShortTermInvestmentsMember 2024-01-01 2024-09-30 0000320335 us-gaap:ShortTermInvestmentsMember 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueOptionOtherEligibleItemsMember 2024-07-01 2024-09-30 0000320335 us-gaap:FairValueOptionOtherEligibleItemsMember 2023-07-01 2023-09-30 0000320335 us-gaap:FairValueOptionOtherEligibleItemsMember 2024-01-01 2024-09-30 0000320335 us-gaap:FairValueOptionOtherEligibleItemsMember 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member gl:IndustrialsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member gl:FinancialMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member gl:UtilitiesMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2024-01-01 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2024-01-01 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2024-01-01 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2022-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000320335 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CollateralizedDebtObligationsMember 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000320335 us-gaap:FairValueInputsLevel3Member 2023-09-30 0000320335 us-gaap:AssetBackedSecuritiesMember 2024-01-01 2024-09-30 0000320335 us-gaap:CollateralizedDebtObligationsMember 2024-01-01 2024-09-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2024-01-01 2024-09-30 0000320335 us-gaap:AssetBackedSecuritiesMember 2023-01-01 2023-09-30 0000320335 us-gaap:CollateralizedDebtObligationsMember 2023-01-01 2023-09-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2023-01-01 2023-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2024-09-30 0000320335 gl:IndustrialsMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:FinancialMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:UtilitiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember 2024-09-30 0000320335 gl:IndustrialsMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:FinancialMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 gl:UtilitiesMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CollateralizedDebtObligationsMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember gl:OtherAssetBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember 2024-09-30 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-12-31 0000320335 gl:IndustrialsMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:FinancialMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:UtilitiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingInvestmentGradeMember 2023-12-31 0000320335 gl:IndustrialsMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:FinancialMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 gl:UtilitiesMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CollateralizedDebtObligationsMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember gl:OtherAssetBackedSecuritiesMember 2023-12-31 0000320335 us-gaap:ExternalCreditRatingNonInvestmentGradeMember 2023-12-31 0000320335 us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0000320335 us-gaap:CorporateDebtSecuritiesMember 2024-07-01 2024-09-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2023-07-01 2023-09-30 0000320335 us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0000320335 srt:MultifamilyMember 2024-09-30 0000320335 srt:MultifamilyMember 2023-12-31 0000320335 srt:IndustrialPropertyMember 2024-09-30 0000320335 srt:IndustrialPropertyMember 2023-12-31 0000320335 gl:RetailPropertyMember 2024-09-30 0000320335 gl:RetailPropertyMember 2023-12-31 0000320335 gl:HospitalityMember 2024-09-30 0000320335 gl:HospitalityMember 2023-12-31 0000320335 gl:MixedUseMember 2024-09-30 0000320335 gl:MixedUseMember 2023-12-31 0000320335 srt:OfficeBuildingMember 2024-09-30 0000320335 srt:OfficeBuildingMember 2023-12-31 0000320335 stpr:TX 2024-09-30 0000320335 stpr:TX 2023-12-31 0000320335 stpr:NJ 2024-09-30 0000320335 stpr:NJ 2023-12-31 0000320335 stpr:FL 2024-09-30 0000320335 stpr:FL 2023-12-31 0000320335 stpr:CA 2024-09-30 0000320335 stpr:CA 2023-12-31 0000320335 stpr:NY 2024-09-30 0000320335 stpr:NY 2023-12-31 0000320335 stpr:AL 2024-09-30 0000320335 stpr:AL 2023-12-31 0000320335 gl:OtherGeographicalLocationMember 2024-09-30 0000320335 gl:OtherGeographicalLocationMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTVLessThan70PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTVLessThan70PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTVLessThan70PercentMember 2024-09-30 0000320335 gl:LTVLessThan70PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTV70PercentTo80PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTV70PercentTo80PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTV70PercentTo80PercentMember 2024-09-30 0000320335 gl:LTV70PercentTo80PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTV81PercentTo90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTV81PercentTo90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTV81PercentTo90PercentMember 2024-09-30 0000320335 gl:LTV81PercentTo90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTVGreaterThan90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTVGreaterThan90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTVGreaterThan90PercentMember 2024-09-30 0000320335 gl:LTVGreaterThan90PercentMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember 2024-09-30 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTVLessThan70PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTVLessThan70PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTVLessThan70PercentMember 2023-12-31 0000320335 gl:LTVLessThan70PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTV70PercentTo80PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTV70PercentTo80PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTV70PercentTo80PercentMember 2023-12-31 0000320335 gl:LTV70PercentTo80PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTV81PercentTo90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTV81PercentTo90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTV81PercentTo90PercentMember 2023-12-31 0000320335 gl:LTV81PercentTo90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember gl:LTVGreaterThan90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember gl:LTVGreaterThan90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember gl:LTVGreaterThan90PercentMember 2023-12-31 0000320335 gl:LTVGreaterThan90PercentMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioLessThan1.00xMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatio1.00x1.20xMember 2023-12-31 0000320335 gl:DebtServiceCoverageRatioGreaterThan1.20xMember 2023-12-31 0000320335 us-gaap:CommercialPortfolioSegmentMember 2024-09-30 0000320335 us-gaap:UnfundedLoanCommitmentMember 2024-09-30 0000320335 gl:CompanyOwnedLifeInsuranceMember 2024-09-30 0000320335 gl:CompanyOwnedLifeInsuranceMember 2023-12-31 0000320335 us-gaap:OtherInvestmentsMember 2024-09-30 0000320335 us-gaap:OtherInvestmentsMember 2023-12-31 0000320335 us-gaap:CommercialMortgageBackedSecuritiesMember 2024-09-30 0000320335 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0000320335 gl:OpportunisticAndPrivateCreditMember 2024-09-30 0000320335 gl:OpportunisticAndPrivateCreditMember 2023-12-31 0000320335 gl:InfrastructureMember 2024-09-30 0000320335 gl:InfrastructureMember 2023-12-31 0000320335 srt:PartnershipInterestMember 2024-09-30 0000320335 srt:PartnershipInterestMember 2023-12-31 0000320335 srt:MinimumMember 2024-01-01 2024-09-30 0000320335 srt:MaximumMember 2024-01-01 2024-09-30 0000320335 srt:PartnershipInterestMember 2024-01-01 2024-09-30 0000320335 us-gaap:LetterOfCreditMember 2024-09-30 0000320335 2024-09-26 2024-09-26 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2022-12-31 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2022-12-31 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2022-12-31 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2022-12-31 0000320335 gl:LifeSegmentMember 2022-12-31 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-09-30 0000320335 gl:LifeSegmentMember 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-12-31 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2023-12-31 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-12-31 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-12-31 0000320335 gl:LifeSegmentMember 2023-12-31 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-09-30 0000320335 gl:LifeSegmentMember 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-06-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2023-06-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-06-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-06-30 0000320335 gl:LifeSegmentMember 2023-06-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-06-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2024-06-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-06-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-06-30 0000320335 gl:LifeSegmentMember 2024-06-30 0000320335 gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DirectToConsumerMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2022-12-31 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2022-12-31 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2022-12-31 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2022-12-31 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2022-12-31 0000320335 gl:HealthSegmentMember 2022-12-31 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2023-09-30 0000320335 gl:HealthSegmentMember 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-12-31 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2023-12-31 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-12-31 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-12-31 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2023-12-31 0000320335 gl:HealthSegmentMember 2023-12-31 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2024-09-30 0000320335 gl:HealthSegmentMember 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-06-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2023-06-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-06-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-06-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2023-06-30 0000320335 gl:HealthSegmentMember 2023-06-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-06-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2024-06-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-06-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-06-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2024-06-30 0000320335 gl:HealthSegmentMember 2024-06-30 0000320335 gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DirectToConsumerMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:ReclassificationOtherMember 2023-12-31 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember us-gaap:OtherInsuranceProductLineMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:FamilyHeritageMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:FamilyHeritageMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:FamilyHeritageMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:FamilyHeritageMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:DirectToConsumerMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromExperienceMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromExperienceMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:UnitedAmericanIndependentMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:FamilyHeritageMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:FamilyHeritageMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:FamilyHeritageMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:FamilyHeritageMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:LibertyNationalExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:AmericanIncomeExclusiveMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:DirectToConsumerMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:GainLossFromUnlockingAssumptionsMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2023-12-31 0000320335 us-gaap:DeferredFixedAnnuityMember 2023-12-31 0000320335 us-gaap:OtherInsuranceProductLineMember 2023-12-31 0000320335 us-gaap:InterestSensitiveLifeMember 2022-12-31 0000320335 us-gaap:DeferredFixedAnnuityMember 2022-12-31 0000320335 us-gaap:OtherInsuranceProductLineMember 2022-12-31 0000320335 us-gaap:InterestSensitiveLifeMember 2024-01-01 2024-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2024-01-01 2024-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2023-01-01 2023-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2023-01-01 2023-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2024-06-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2024-06-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2024-06-30 0000320335 us-gaap:InterestSensitiveLifeMember 2023-06-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2023-06-30 0000320335 us-gaap:OtherInsuranceProductLineMember 2023-06-30 0000320335 us-gaap:InterestSensitiveLifeMember 2024-07-01 2024-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2024-07-01 2024-09-30 0000320335 us-gaap:InterestSensitiveLifeMember 2023-07-01 2023-09-30 0000320335 us-gaap:DeferredFixedAnnuityMember 2023-07-01 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:InterestSensitiveLifeMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:DeferredFixedAnnuityMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:OtherInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MinimumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember srt:MaximumMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member gl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:InterestSensitiveLifeMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:DeferredFixedAnnuityMember 2023-09-30 0000320335 us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member us-gaap:OtherInsuranceProductLineMember 2023-09-30 0000320335 gl:AnnuitySegmentMember 2024-09-30 0000320335 gl:AnnuitySegmentMember 2023-09-30 0000320335 us-gaap:HealthInsuranceProductLineMember 2023-12-31 0000320335 us-gaap:HealthInsuranceProductLineMember 2022-12-31 0000320335 us-gaap:HealthInsuranceProductLineMember 2023-01-01 2023-12-31 0000320335 us-gaap:HealthInsuranceProductLineMember 2024-09-30 0000320335 us-gaap:LifeInsuranceSegmentMember 2024-09-30 0000320335 us-gaap:LifeInsuranceSegmentMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember 2024-09-30 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ExchangeTradedFundsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:EquityExchangeTradedFundMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:OtherBondsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:GuaranteedAnnuityContractMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ShortTermInvestmentsMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember gl:OtherMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:QualifiedPlanMember 2024-09-30 0000320335 us-gaap:PensionPlansDefinedBenefitMember us-gaap:QualifiedPlanMember 2023-12-31 0000320335 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember us-gaap:NonqualifiedPlanMember 2024-09-30 0000320335 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember us-gaap:NonqualifiedPlanMember 2023-12-31 0000320335 gl:A585SeniorNotesDueSeptember152034Member us-gaap:SeniorNotesMember 2024-08-23 0000320335 gl:A585SeniorNotesDueSeptember152034Member us-gaap:SeniorNotesMember 2024-08-23 2024-08-23 0000320335 gl:TermLoanCreditAgreementMember 2024-08-14 0000320335 gl:TermLoanCreditAgreementMember 2024-08-15 0000320335 gl:TermLoanCreditAgreementMember 2024-08-15 2024-08-15 0000320335 gl:SeniorNotesDueSeptember152028Member 2024-09-30 0000320335 gl:SeniorNotesDueSeptember152028Member 2023-12-31 0000320335 gl:SeniorNotesDueAugust152030Member 2024-09-30 0000320335 gl:SeniorNotesDueAugust152030Member 2023-12-31 0000320335 gl:SeniorNotesDueJune152032Member 2024-09-30 0000320335 gl:SeniorNotesDueJune152032Member 2023-12-31 0000320335 gl:A585SeniorNotesDueSeptember152034Member 2024-09-30 0000320335 gl:A585SeniorNotesDueSeptember152034Member 2023-12-31 0000320335 gl:JuniorSubordinatedDebenturesDue2057Member 2024-09-30 0000320335 gl:JuniorSubordinatedDebenturesDue2057Member 2023-12-31 0000320335 gl:JuniorSubordinatedDebenturesDue2061Member 2024-09-30 0000320335 gl:JuniorSubordinatedDebenturesDue2061Member 2023-12-31 0000320335 gl:TermLoanDueNovember112024Member 2024-09-30 0000320335 gl:TermLoanDueNovember112024Member 2023-12-31 0000320335 gl:TermLoanDueNovember112024Member 2024-09-30 0000320335 gl:TermLoanDueNovember112024Member 2023-12-31 0000320335 us-gaap:FederalHomeLoanBankBorrowingsMember 2024-09-30 0000320335 us-gaap:FederalHomeLoanBankBorrowingsMember 2023-12-31 0000320335 us-gaap:CommercialPaperMember 2024-09-30 0000320335 us-gaap:CommercialPaperMember 2023-12-31 0000320335 srt:SubsidiariesMember gl:SeniorNotesDueJune152032Member srt:ConsolidationEliminationsMember 2024-09-30 0000320335 gl:TermLoanDueNovember112024Member 2024-01-01 2024-09-30 0000320335 us-gaap:SeniorNotesMember 2024-01-01 2024-09-30 0000320335 gl:JuniorSubordinatedDebenturesDue2056Member 2024-09-30 0000320335 us-gaap:LineOfCreditMember 2024-03-29 0000320335 us-gaap:LineOfCreditMember 2024-03-29 2024-03-29 0000320335 us-gaap:ShortTermDebtMember 2024-09-30 0000320335 us-gaap:ShortTermDebtMember 2023-12-31 0000320335 us-gaap:ShortTermDebtMember 2023-09-30 0000320335 us-gaap:CommercialPaperMember 2024-01-01 2024-09-30 0000320335 us-gaap:CommercialPaperMember 2023-01-01 2023-09-30 0000320335 us-gaap:FederalHomeLoanBankBorrowingsMember 2024-09-30 0000320335 us-gaap:AssetPledgedAsCollateralMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-09-30 0000320335 us-gaap:FederalHomeLoanBankBorrowingsMember 2023-12-31 0000320335 gl:AmericanIncomeExclusiveMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember 2024-07-01 2024-09-30 0000320335 gl:DirectResponseMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DirectResponseMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DirectResponseMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:DirectResponseMember 2024-07-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember 2024-07-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember 2024-07-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:FamilyHeritageMember 2024-07-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember 2024-07-01 2024-09-30 0000320335 gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember 2023-07-01 2023-09-30 0000320335 gl:DirectResponseMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DirectResponseMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DirectResponseMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:DirectResponseMember 2023-07-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember 2023-07-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember 2023-07-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:FamilyHeritageMember 2023-07-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember 2023-07-01 2023-09-30 0000320335 gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember 2024-01-01 2024-09-30 0000320335 gl:DirectResponseMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DirectResponseMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DirectResponseMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:DirectResponseMember 2024-01-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:LibertyNationalExclusiveMember 2024-01-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:UnitedAmericanIndependentMember 2024-01-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:FamilyHeritageMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:FamilyHeritageMember 2024-01-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:DistributionChannelOtherMember 2024-01-01 2024-09-30 0000320335 gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 gl:AmericanIncomeExclusiveMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:AmericanIncomeExclusiveMember 2023-01-01 2023-09-30 0000320335 gl:DirectResponseMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DirectResponseMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DirectResponseMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:DirectResponseMember 2023-01-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:LibertyNationalExclusiveMember 2023-01-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:UnitedAmericanIndependentMember 2023-01-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:FamilyHeritageMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:FamilyHeritageMember 2023-01-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 gl:DistributionChannelOtherMember 2023-01-01 2023-09-30 0000320335 gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:LifeSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:HealthSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:AnnuitySegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:InvestmentSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:CorporateNonSegmentMember 2024-07-01 2024-09-30 0000320335 us-gaap:MaterialReconcilingItemsMember 2024-07-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:LifeSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:HealthSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:AnnuitySegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:InvestmentSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000320335 us-gaap:MaterialReconcilingItemsMember 2023-07-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:LifeSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:HealthSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:AnnuitySegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:InvestmentSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-09-30 0000320335 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:LifeSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:HealthSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:AnnuitySegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember gl:InvestmentSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0000320335 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-09-30 0000320335 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0000320335 us-gaap:SubsequentEventMember srt:ScenarioForecastMember 2024-12-31 0000320335 us-gaap:SubsequentEventMember srt:ScenarioForecastMember 2024-10-01 2024-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ________
Commission File Number: 001-08052
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 63-0780404
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
3700 South Stonebridge Drive , McKinney , Texas 75070
(Address of principal executive offices) (Zip Code)

( 972 ) 569-4000
(Registrant’s telephone number, including area code)

NONE
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value per share GL New York Stock Exchange
4.250% Junior Subordinated Debentures GL PRD New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class Outstanding at October 31, 2024
Common Stock, $1.00 Par Value 83,945,064
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Table of Contents
Page
PART I . FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
PART I I . OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.



As used in this Form 10-Q, “Globe Life,” the “Company,” “we,” “our” and “us” refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
GL Q3 2024 FORM 10-Q

PART I—FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements

Globe Life Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(Dollar amounts in thousands, except per share data)
September 30,
2024
December 31, 2023
Assets:
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2024—$ 19,084,454 ;
2023—$ 18,924,914 , allowance for credit losses: 2024— $ 7,132 ; 2023— $ 7,115 )
$ 18,334,570 $ 17,870,206
Mortgage loans 381,315 279,199
Policy loans 691,072 657,020
Other long-term investments (includes: 2024—$ 979,397 ; 2023—$ 795,583 under the fair value option)
1,221,888 835,878
Short-term investments 100,501 81,740
Total investments 20,729,346 19,724,043
Cash 134,549 103,156
Accrued investment income 284,952 270,396
Other receivables 651,871 630,223
Deferred acquisition costs 6,386,682 6,009,477
Goodwill 490,446 481,791
Other assets 878,974 832,413
Total assets $ 29,556,820 $ 28,051,499
Liabilities:
Future policy benefits at current discount rates: (at original discount rates: 2024—$ 17,402,917 ; 2023—$ 16,984,615 )
$ 19,814,913 $ 19,460,353
Unearned and advance premium 264,644 254,567
Policy claims and other benefits payable 530,399 514,875
Other policyholders' funds 469,288 236,958
Total policy liabilities 21,079,244 20,466,753
Current and deferred income taxes 619,970 494,639
Short-term debt 437,418 486,113
Long-term debt (estimated fair value: 2024—$ 2,202,644 ; 2023—$ 1,491,229 )
2,323,676 1,629,559
Other liabilities 457,887 487,632
Total liabilities 24,918,195 23,564,696
Commitments and Contingencies (Note 5)
Shareholders' equity:
Preferred stock, par value $ 1 per share— 5,000,000 shares authorized; outstanding: 0 in 2024 and 2023
Common stock, par value $ 1 per share— 320,000,000 shares authorized; outstanding: (2024— 102,218,183 issued; 2023— 102,218,183 issued)
102,218 102,218
Additional paid-in-capital 543,255 532,474
Accumulated other comprehensive income (loss) ( 2,484,743 ) ( 2,772,419 )
Retained earnings 8,225,030 7,478,813
Treasury stock, at cost: (2024— 17,942,902 shares; 2023— 8,426,854 shares)
( 1,747,135 ) ( 854,283 )
Total shareholders' equity 4,638,625 4,486,803
Total liabilities and shareholders' equity $ 29,556,820 $ 28,051,499
See accompanying Notes to Condensed Consolidated Financial Statements.
1
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollar amounts in thousands, except per share data)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Revenue:
Life premium $ 818,638 $ 788,099 $ 2,438,385 $ 2,342,429
Health premium 353,955 331,236 1,046,617 982,916
Other premium
Total premium 1,172,593 1,119,335 3,485,002 3,325,345
Net investment income 284,964 266,926 853,178 785,275
Realized gains (losses) ( 2,192 ) ( 2,193 ) ( 26,580 ) ( 78,963 )
Other income 42 50 192 185
Total revenue 1,455,407 1,384,118 4,311,792 4,031,842
Benefits and expenses:
Life policyholder benefits (1)
454,502 515,676 1,493,165 1,536,317
Health policyholder benefits (2)
221,926 193,790 629,676 580,676
Other policyholder benefits 11,756 9,578 32,830 27,488
Total policyholder benefits 688,184 719,044 2,155,671 2,144,481
Amortization of deferred acquisition costs 104,310 95,757 305,703 282,159
Commissions, premium taxes, and non-deferred acquisition costs 149,693 138,677 447,605 414,933
Other operating expense 104,874 85,870 297,196 256,074
Interest expense 31,388 25,955 91,413 76,640
Total benefits and expenses 1,078,449 1,065,303 3,297,588 3,174,287
Income before income taxes 376,958 318,815 1,014,204 857,555
Income tax benefit (expense) ( 73,964 ) ( 61,732 ) ( 198,638 ) ( 161,602 )
Net income
$ 302,994 $ 257,083 $ 815,566 $ 695,953
Basic net income per common share
$ 3.45 $ 2.72 $ 8.96 $ 7.29
Diluted net income per common share
$ 3.44 $ 2.68 $ 8.93 $ 7.20

(1) Net of total remeasurement including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in a gain of $ 70.6 million for the three months ended September 30, 2024, and a total remeasurement gain of $ 11.3 million for the same period in 2023. Net of a total remeasurement gain of $ 87.8 million for the nine months ended September 30, 2024, and a total remeasurement gain of $ 16.5 million for the same period in 2023.
(2) Net of total remeasurement including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in a loss of $ 9.6 million for the three months ended September 30, 2024 and a total remeasurement gain of $ 7.8 million for the same period in 2023. Net of a total remeasurement loss of $ 3.1 million for the nine months ended September 30, 2024, and a total remeasurement gain of $ 8.3 million for the same period in 2023.





See accompanying Notes to Condensed Consolidated Financial Statements.
2
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Net income
$ 302,994 $ 257,083 $ 815,566 $ 695,953
Other comprehensive income (loss):
Investments:
Unrealized gains (losses) on fixed maturities:
Unrealized holding gains (losses) arising during period 869,743 ( 1,068,091 ) 301,715 ( 932,301 )
Other reclassification adjustments included in net income ( 2,408 ) 851 2,580 82,866
Foreign exchange adjustment on fixed maturities recorded at fair value ( 954 ) 1,603 546 603
Total unrealized investment gains (losses) 866,381 ( 1,065,637 ) 304,841 ( 848,832 )
Less applicable tax (expense) benefit ( 181,941 ) 223,782 ( 64,018 ) 178,250
Unrealized gains (losses) on investments, net of tax 684,440 ( 841,855 ) 240,823 ( 670,582 )
Future Policy Benefits:
Change in discount rate on future policy benefits ( 1,247,366 ) 1,687,310 63,614 1,272,631
Less applicable tax (expense) benefit 261,946 ( 354,334 ) ( 13,360 ) ( 267,252 )
Future policy benefit adjustments, net of tax ( 985,420 ) 1,332,976 50,254 1,005,379
Foreign exchange translation:
Foreign exchange translation adjustments, other than securities 7,296 ( 7,881 ) ( 4,660 ) ( 4,039 )
Less applicable tax (expense) benefit ( 1,532 ) 1,655 979 847
Foreign exchange translation adjustments, other than securities, net of tax 5,764 ( 6,226 ) ( 3,681 ) ( 3,192 )
Pension:
Pension adjustments 118 35 354 ( 336 )
Less applicable tax (expense) benefit ( 25 ) ( 7 ) ( 74 ) 70
Pension adjustments, net of tax 93 28 280 ( 266 )
Other comprehensive income (loss) ( 295,123 ) 484,923 287,676 331,339
Comprehensive income (loss)
$ 7,871 $ 742,006 $ 1,103,242 $ 1,027,292











See accompanying Notes to Condensed Consolidated Financial Statements.
3
GL Q3 2024 FORM 10-Q


Globe Life Inc.
Condensed Consolidated Statements of Shareholders' Equity
(Unaudited)
(Dollar amounts in thousands, except per share data)



Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2023
$ $ 102,218 $ 532,474 $ ( 2,772,419 ) $ 7,478,813 $ ( 854,283 ) $ 4,486,803
Comprehensive income (loss) 305,183 254,217 559,400
Common dividends declared
($ 0.2400 per share)
( 22,603 ) ( 22,603 )
Acquisition of treasury stock ( 23,469 ) ( 23,469 )
Stock-based compensation ( 5,612 ) ( 438 ) 15,317 9,267
Exercise of stock options ( 3,334 ) 33,097 29,763
Balance at March 31, 2024
102,218 526,862 ( 2,467,236 ) 7,706,655 ( 829,338 ) 5,039,161
Comprehensive income (loss) 277,616 258,355 535,971
Common dividends declared
($ 0.2400 per share)
( 21,595 ) ( 21,595 )
Acquisition of treasury stock ( 335,873 ) ( 335,873 )
Stock-based compensation 7,166 2,924 10,090
Exercise of stock options
Balance at June 30, 2024
102,218 534,028 ( 2,189,620 ) 7,943,415 ( 1,162,287 ) 5,227,754
Comprehensive income (loss) ( 295,123 ) 302,994 7,871
Common dividends declared
($ 0.2400 per share)
( 20,215 ) ( 20,215 )
Acquisition of treasury stock ( 591,106 ) ( 591,106 )
Stock-based compensation 9,227 6 9,233
Exercise of stock options ( 1,164 ) 6,252 5,088
Balance at September 30, 2024 $ $ 102,218 $ 543,255 $ ( 2,484,743 ) $ 8,225,030 $ ( 1,747,135 ) $ 4,638,625
















See accompanying Notes to Condensed Consolidated Financial Statements.


4
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Condensed Consolidated Statements of Shareholders' Equity (Continued)
(Unaudited)
(Dollar amounts in thousands, except per share data)



Preferred Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Treasury Stock Total Shareholders' Equity
Balance at December 31, 2022
$ $ 105,218 $ 529,661 $ ( 2,790,313 ) $ 6,894,535 $ ( 789,524 ) $ 3,949,577
Comprehensive income (loss) ( 170,780 ) 223,610 52,830
Common dividends declared
($ 0.2250 per share)
( 21,542 ) ( 21,542 )
Acquisition of treasury stock ( 179,276 ) ( 179,276 )
Stock-based compensation ( 1,022 ) 8,700 7,678
Exercise of stock options ( 4,059 ) 41,083 37,024
Balance at March 31, 2023
105,218 528,639 ( 2,961,093 ) 7,092,544 ( 919,017 ) 3,846,291
Comprehensive income (loss) 17,196 215,260 232,456
Common dividends declared
($ 0.2250 per share)
( 21,330 ) ( 21,330 )
Acquisition of treasury stock ( 89,755 ) ( 89,755 )
Stock-based compensation 7,487 7,487
Exercise of stock options ( 665 ) 5,822 5,157
Balance at June 30, 2023
105,218 536,126 ( 2,943,897 ) 7,285,809 ( 1,002,950 ) 3,980,306
Comprehensive income (loss) 484,923 257,083 742,006
Common dividends declared
($ 0.2250 per share)
( 21,181 ) ( 21,181 )
Acquisition of treasury stock ( 96,898 ) ( 96,898 )
Stock-based compensation 7,567 7,567
Exercise of stock options ( 1,818 ) 13,149 11,331
Balance at September 30, 2023
$ $ 105,218 $ 543,693 $ ( 2,458,974 ) $ 7,519,893 $ ( 1,086,699 ) $ 4,623,131























See accompanying Notes to Condensed Consolidated Financial Statements.
5
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollar amounts in thousands)
Nine Months Ended
September 30,
2024 2023
Cash provided from (used for) operating activities
$ 1,065,513 $ 1,091,028
Cash provided from (used for) investing activities:
Investments sold or matured:
Fixed maturities available for sale—sold 674,125 192,007
Fixed maturities available for sale—matured or other redemptions 161,275 212,936
Mortgage loans 29,433 32,164
Other long-term investments 29,995 100,999
Total investments sold or matured 894,828 538,106
Acquisition of investments:
Fixed maturities—available for sale ( 1,000,665 ) ( 1,076,699 )
Mortgage loans ( 134,667 ) ( 95,995 )
Other long-term investments ( 445,776 ) ( 103,098 )
Total investments acquired ( 1,581,108 ) ( 1,275,792 )
Net (increase) decrease in policy loans ( 34,052 ) ( 29,687 )
Net (increase) decrease in short-term investments ( 18,761 ) 30,187
Additions to property and equipment ( 56,047 ) ( 36,449 )
Other investing activities 96
Investments in low-income housing interests ( 27,840 ) ( 54,337 )
Cash provided from (used for) investing activities
( 822,884 ) ( 827,972 )
Cash provided from (used for) financing activities:
Issuance of common stock 34,851 61,079
Cash dividends paid to shareholders ( 65,292 ) ( 62,945 )
Repayment of debt ( 165,612 )
Proceeds from issuance of debt 530,000 170,000
Payment for debt issuance costs ( 7,138 ) ( 757 )
Net borrowing from Federal Home Loan Bank (FHLB)
17,000 198,000
Net borrowing (repayment) of commercial paper 31,443 ( 34,066 )
Proceeds from commercial paper with original maturities greater than 90 days 387,247
Repayment of commercial paper with original maturities greater than 90 days ( 314,836 )
Acquisition of treasury stock ( 950,448 ) ( 365,929 )
Net receipts (payments) from deposit-type products 122,291 ( 69,526 )
Cash provided from (used for) financing activities
( 214,882 ) ( 269,756 )
Effect of foreign exchange rate changes on cash 3,646 ( 313 )
Net increase (decrease) in cash 31,393 ( 7,013 )
Cash at beginning of year 103,156 92,559
Cash at end of period $ 134,549 $ 85,546


See accompanying Notes to Condensed Consolidated Financial Statements.
6
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Note 1—Significant Accounting Policies

Business : (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (Parent Company).

Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments.

Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (DTC).

Basis of Presentation : The accompanying condensed consolidated financial statements of Globe Life have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all of the disclosures required by accounting principles generally accepted in the United States of America (GAAP) for annual financial statements. However, in the opinion of management, these statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial position at September 30, 2024, and the condensed consolidated results of operations, comprehensive income, and cash flows for the periods ended September 30, 2024 and 2023. The interim period condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements that are included in the Form 10-K filed with the Securities Exchange Commission (SEC) on February 28, 2024.

Use of Estimates : The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.





7
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 2—New Accounting Standards

Accounting Pronouncements Adopted in the Current Year
Standard Description Effective Date Effect on the Condensed Consolidated Financial Statements
ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions
ASU 2022-03 adds disclosure requirements specific to equity securities subject to contractual sale restrictions. The disclosures clarify the nature of the contractual sale as well as the duration of the restriction and the circumstances that could cause a lapse in the restriction. This standard is effective for the Company for fiscal years beginning on January 1, 2024 and interim periods within those fiscal years. The adoption of this standard did not have a material impact on the Condensed Consolidated Financial Statements.


Accounting Pronouncements Yet to be Adopted
Standard Description Effective Date Effect on the Condensed Consolidated Financial Statements
ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
ASU 2023-07 adds disclosure requirements to segment expenses, improving the financial reporting of the entity’s overall performance and assessment of future cash flows. The disclosures will require more detailed information related to the entity’s reportable segments.
This standard is effective for the Company for annual periods beginning on January 1, 2024 and for interim periods beginning on January 1, 2025, and will be implemented on a retrospective basis.
The Company is evaluating the standard, but does not expect the standard will have a material impact on the Condensed Consolidated Financial Statements.
ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
ASU 2023-09 adds disclosure requirements to disaggregated information related to the effective tax rate reconciliation and information on income taxes paid. The disclosures will enhance the assessment of the entity’s operations and related tax risks.
This standard is effective for the Company for annual periods beginning on January 1, 2025, and will be implemented on a prospective basis. The Company does not expect the standard will have a material impact on the Condensed Consolidated Financial Statements.
8
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income

Components of Accumulated Other Comprehensive Income : An analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for the three and nine month periods ended September 30, 2024 and 2023:
Three Months Ended September 30, 2024
Available
for Sale
Assets
Future Policy Benefits Foreign
Exchange
Pension
Adjustments
Total
Balance at July 1, 2024
$ ( 1,271,213 ) $ ( 911,717 ) $ ( 4,726 ) $ ( 1,964 ) $ ( 2,189,620 )
Other comprehensive income (loss) before reclassifications, net of tax 686,343 ( 985,420 ) 5,764 ( 293,313 )
Reclassifications, net of tax ( 1,903 ) 93 ( 1,810 )
Other comprehensive income (loss) 684,440 ( 985,420 ) 5,764 93 ( 295,123 )
Balance at September 30, 2024
$ ( 586,773 ) $ ( 1,897,137 ) $ 1,038 $ ( 1,871 ) $ ( 2,484,743 )

Three Months Ended September 30, 2023
Available
for Sale
Assets
Future Policy Benefits Foreign
Exchange
Pension
Adjustments
Total
Balance at July 1, 2023
$ ( 1,249,399 ) $ ( 1,696,801 ) $ 1,353 $ 950 $ ( 2,943,897 )
Other comprehensive income (loss) before reclassifications, net of tax ( 842,527 ) 1,332,976 ( 6,226 ) 484,223
Reclassifications, net of tax 672 28 700
Other comprehensive income (loss) ( 841,855 ) 1,332,976 ( 6,226 ) 28 484,923
Balance at September 30, 2023
$ ( 2,091,254 ) $ ( 363,825 ) $ ( 4,873 ) $ 978 $ ( 2,458,974 )

Nine Months Ended September 30, 2024
Available
for Sale
Assets
Future Policy Benefits Foreign
Exchange
Pension
Adjustments
Total
Balance at January 1, 2024
$ ( 827,596 ) $ ( 1,947,391 ) $ 4,719 $ ( 2,151 ) $ ( 2,772,419 )
Other comprehensive income (loss) before reclassifications, net of tax 238,785 50,254 ( 3,681 ) 285,358
Reclassifications, net of tax 2,038 280 2,318
Other comprehensive income (loss) 240,823 50,254 ( 3,681 ) 280 287,676
Balance at September 30, 2024
$ ( 586,773 ) $ ( 1,897,137 ) $ 1,038 $ ( 1,871 ) $ ( 2,484,743 )

Nine Months Ended September 30, 2023
Available
for Sale
Assets
Future Policy Benefits Foreign
Exchange
Pension
Adjustments
Total
Balance at January 1, 2023
$ ( 1,420,672 ) $ ( 1,369,204 ) $ ( 1,681 ) $ 1,244 $ ( 2,790,313 )
Other comprehensive income (loss) before reclassifications, net of tax ( 736,046 ) 1,005,379 ( 3,192 ) 266,141
Reclassifications, net of tax 65,464 ( 266 ) 65,198
Other comprehensive income (loss) ( 670,582 ) 1,005,379 ( 3,192 ) ( 266 ) 331,339
Balance at September 30, 2023
$ ( 2,091,254 ) $ ( 363,825 ) $ ( 4,873 ) $ 978 $ ( 2,458,974 )

9
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Reclassification Adjustments : Reclassification adjustments out of Accumulated Other Comprehensive Income are presented below for the three and nine month periods ended September 30, 2024 and 2023.
Three Months Ended
September 30,
Nine Months Ended September 30, Affected line items in the Statements of Operations
Component Line Item 2024 2023 2024 2023
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses $ ( 257 ) $ 1,759 $ 9,732 $ 85,230 Realized (gains) losses
Amortization of (discount) premium ( 2,151 ) ( 908 ) ( 7,152 ) ( 2,364 ) Net investment income
Total before tax ( 2,408 ) 851 2,580 82,866
Tax 505 ( 179 ) ( 542 ) ( 17,402 ) Income taxes
Total after-tax ( 1,903 ) 672 2,038 65,464
Pension adjustments:
Amortization of prior service cost 265 269 803 807 Other operating expense
Amortization of actuarial (gain) loss ( 147 ) ( 234 ) ( 449 ) ( 1,143 ) Other operating expense
Total before tax 118 35 354 ( 336 )
Tax ( 25 ) ( 7 ) ( 74 ) 70 Income taxes
Total after-tax 93 28 280 ( 266 )
Total reclassification (after-tax)
$ ( 1,810 ) $ 700 $ 2,318 $ 65,198
10
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 4—Investments

Portfolio Composition : Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at September 30, 2024 and December 31, 2023, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector."
At September 30, 2024

Amortized
Cost
Allowance for Credit Losses Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value (1)
% of Total
Fixed
Maturities (2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 397,969 $ $ 38 $ ( 21,026 ) $ 376,981 2
States, municipalities, and political subdivisions 3,253,819 49,409 ( 424,989 ) 2,878,239 16
Foreign governments 41,794 17 ( 9,885 ) 31,926
Corporates, by sector:
Industrials 8,115,835 ( 7,132 ) 258,165 ( 508,089 ) 7,858,779 43
Financial 5,014,169 171,762 ( 299,903 ) 4,886,028 26
Utilities 2,140,610 109,998 ( 72,371 ) 2,178,237 12
Total corporates 15,270,614 ( 7,132 ) 539,925 ( 880,363 ) 14,923,044 81
Collateralized debt obligations 36,685 5,798 42,483
Other asset-backed securities 83,573 1 ( 1,677 ) 81,897 1
Total fixed maturities
$ 19,084,454 $ ( 7,132 ) $ 595,188 $ ( 1,337,940 ) $ 18,334,570 100
(1) Amount reported in the balance sheet.
(2) At fair value.
At December 31, 2023
Amortized
Cost
Allowance for Credit Losses Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value (1)
% of Total
Fixed
Maturities (2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ 398,450 $ $ 7 $ ( 32,306 ) $ 366,151 2
States, municipalities, and political subdivisions 3,296,305 47,346 ( 403,329 ) 2,940,322 16
Foreign governments 44,453 1 ( 10,348 ) 34,106
Corporates, by sector:
Industrials
8,016,126 ( 7,115 ) 213,078 ( 566,847 ) 7,655,242 43
Financial 5,028,151 112,368 ( 388,340 ) 4,752,179 27
Utilities 2,017,967 73,925 ( 94,130 ) 1,997,762 11
Total corporates 15,062,244 ( 7,115 ) 399,371 ( 1,049,317 ) 14,405,183 81
Collateralized debt obligations 37,110 5,036 42,146
Other asset-backed securities 86,352 3 ( 4,057 ) 82,298 1
Total fixed maturities
$ 18,924,914 $ ( 7,115 ) $ 451,764 $ ( 1,499,357 ) $ 17,870,206 100
(1) Amount reported in the balance sheet.
(2) At fair value.
11
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 429 million ( 2 % of the total fixed maturity portfolio) and $ 425 million ( 2 % of the total fixed maturity portfolio) at September 30, 2024 and December 31, 2023, respectively.

A schedule of fixed maturities available for sale by contractual maturity date at September 30, 2024, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions.
At September 30, 2024
Amortized
Cost, net
Fair
Value
Fixed maturities available for sale:
Due in one year or less $ 111,956 $ 111,456
Due after one year through five years 748,300 771,458
Due after five years through ten years 1,841,477 1,912,103
Due after ten years through twenty years 8,954,048 8,827,993
Due after twenty years 7,301,254 6,587,150
Mortgage-backed and asset-backed securities 120,287 124,410
$ 19,077,322 $ 18,334,570

Analysis of Investment Operations: "Net investment income" for the three and nine month periods ended September 30, 2024 and 2023 is summarized as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 % Change 2024 2023 % Change
Fixed maturities available for sale $ 245,313 $ 237,609 3 $ 738,626 $ 704,095 5
Policy loans 13,296 12,446 7 39,196 36,435 8
Mortgage loans 7,668 5,363 43 21,337 13,919 53
Other long-term investments (1)
19,992 14,630 37 58,608 38,753 51
Short-term investments 3,083 1,396 8,396 4,811
289,352 271,444 7 866,163 798,013 9
Less investment expense ( 4,388 ) ( 4,518 ) ( 3 ) ( 12,985 ) ( 12,738 ) 2
Net investment income
$ 284,964 $ 266,926 7 $ 853,178 $ 785,275 9
(1) For the three months ended September 30, 2024 and 2023, the investment funds, accounted for under the fair value option method, recorded $ 19.1 million and $ 14.0 million, respectively, in net investment income. For the nine months ended September 30, 2024 and 2023, the investment funds, accounted for under the fair value option method, recorded $ 56.1 million and $ 37.2 million, respectively, in net investment income. Refer to Other Long-Term Investments below for further discussion on the investment funds.

Selected information about sales of fixed maturities available for sale is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Fixed maturities available for sale:
Proceeds from sales (1)
$ 163,221 $ 46,210 $ 674,125 $ 192,034
Gross realized gains 2,042 261 6,086 308
Gross realized losses ( 1,856 ) ( 67,018 ) ( 15,824 ) ( 77,879 )
(1) As of September 30, 2024 and 2023, the Company had $ 0 and $ 27 thousand of unsettled trades, respectively.

12
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
An analysis of "Realized gains (losses)" is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Realized investment gains (losses):
Fixed maturities available for sale:
Sales and other (1)
$ 257 $ ( 66,767 ) $ ( 9,716 ) $ ( 77,730 )
Provision for credit losses 65,008 ( 16 ) ( 7,500 )
Fair value option—change in fair value ( 3,683 ) 868 ( 22,777 ) 7,954
Mortgage loans
( 1,376 ) ( 59 ) ( 3,530 ) ( 4,918 )
Other investments ( 16 ) 880 1,135 502
Realized gains (losses) from investments
( 4,818 ) ( 70 ) ( 34,904 ) ( 81,692 )
Other gains (losses) 2,626 ( 2,123 ) 8,324 2,729
Total realized gains (losses)
( 2,192 ) ( 2,193 ) ( 26,580 ) ( 78,963 )
Applicable tax 460 461 5,582 16,583
Realized gains (losses), net of tax
$ ( 1,732 ) $ ( 1,732 ) $ ( 20,998 ) $ ( 62,380 )
(1) During the three months ended September 30, 2024 and 2023, the Company recorded $ 3.4 million and $ 21.1 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in no realized gains (losses) in either period. During the nine months ended September 30, 2024 and 2023, the Company recorded $ 82.2 million and $ 39.0 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in no realized gains (losses) in either period.

13
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fair Value Measurements: The following tables represent the fair value of fixed maturities measured on a recurring basis at September 30, 2024 and December 31, 2023:
Fair Value Measurement at September 30, 2024:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ $ 376,981 $ $ 376,981
States, municipalities, and political subdivisions 2,878,239 2,878,239
Foreign governments 31,926 31,926
Corporates, by sector:
Industrials
7,659,257 199,522 7,858,779
Financial 4,754,596 131,432 4,886,028
Utilities
2,063,380 114,857 2,178,237
Total corporates 14,477,233 445,811 14,923,044
Collateralized debt obligations 42,483 42,483
Other asset-backed securities 74,021 7,876 81,897
Total fixed maturities
$ $ 17,838,400 $ 496,170 $ 18,334,570
Percentage of total % 97 % 3 % 100 %

Fair Value Measurement at December 31, 2023:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises $ $ 366,151 $ $ 366,151
States, municipalities, and political subdivisions 2,940,322 2,940,322
Foreign governments 34,106 34,106
Corporates, by sector:
Industrials
7,440,493 214,749 7,655,242
Financial 4,621,160 131,019 4,752,179
Utilities 1,888,797 108,965 1,997,762
Total corporates 13,950,450 454,733 14,405,183
Collateralized debt obligations 42,146 42,146
Other asset-backed securities 82,298 82,298
Total fixed maturities
$ $ 17,373,327 $ 496,879 $ 17,870,206
Percentage of total % 97 % 3 % 100 %

14
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
Collateralized
Debt
Obligations
Corporates Total
Balance at January 1, 2024
$ $ 42,146 $ 454,733 $ 496,879
Included in realized gains / losses
Included in other comprehensive income 762 5,448 6,210
Acquisitions 7,876 14,800 22,676
Sales
Amortization 3,414 ( 38 ) 3,376
Other (1)
( 3,839 ) ( 29,132 ) ( 32,971 )
Transfers into Level 3 (2)
Transfers out of Level 3 (2)
Balance at September 30, 2024
$ 7,876 $ 42,483 $ 445,811 $ 496,170
Percent of total fixed maturities % % 3 % 3 %
(1) Includes capitalized interest, foreign exchange adjustments, and principal repayments.
(2) Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
Collateralized
Debt
Obligations
Corporates Total
Balance at January 1, 2023
$ $ 50,364 $ 478,083 $ 528,447
Included in realized gains / losses
Included in other comprehensive income ( 8,424 ) ( 15,968 ) ( 24,392 )
Acquisitions
Sales
Amortization 3,429 5 3,434
Other (1)
( 3,684 ) ( 26,669 ) ( 30,353 )
Transfers into Level 3 (2)
Transfers out of Level 3 (2)
Balance at September 30, 2023
$ $ 41,685 $ 435,451 $ 477,136
Percent of total fixed maturities % % 3 % 3 %
(1) Includes capitalized interest, foreign exchange adjustments, and principal repayments.
(2) Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

15
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents changes in unrealized gains and losses for the period included in accumulated other comprehensive income for assets held at the end of the reporting period for Level 3 classification:
Changes in Unrealized Gains (Losses) included in Accumulated Other Comprehensive Income for Assets Held at the End of the Period
Asset-
backed Securities
Collateralized
Debt
Obligations
Corporates Total
At September 30, 2024
$ $ 762 $ 5,448 $ 6,210
At September 30, 2023
( 8,424 ) ( 15,968 ) ( 24,392 )
Unrealized Loss Analysis : The following table discloses information about fixed maturities available for sale in an unrealized loss position.
Less than Twelve Months Twelve Months or Longer Total
Number of issues (CUSIPs) held:
As of September 30, 2024 87 1,553 1,640
As of December 31, 2023 151 1,614 1,765
Globe Life's entire fixed maturity portfolio consisted of 2,532 issues by 975 different issuers at September 30, 2024 and 2,473 issues by 980 different issuers at December 31, 2023. The weighted-average quality rating of all unrealized loss positions at amortized cost was A- as of September 30, 2024 and December 31, 2023.

16
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at September 30, 2024 and December 31, 2023.

Analysis of Gross Unrealized Investment Losses
At September 30, 2024
Less than Twelve Months Twelve Months or Longer Total
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ $ $ 374,361 $ ( 21,026 ) $ 374,361 $ ( 21,026 )
States, municipalities, and political subdivisions 201,640 ( 4,821 ) 1,636,467 ( 420,168 ) 1,838,107 ( 424,989 )
Foreign governments 28,493 ( 9,885 ) 28,493 ( 9,885 )
Corporates, by sector:
Industrials
124,717 ( 11,134 ) 4,071,839 ( 464,628 ) 4,196,556 ( 475,762 )
Financial 19,176 ( 303 ) 2,005,383 ( 261,465 ) 2,024,559 ( 261,768 )
Utilities
7,012 ( 92 ) 667,192 ( 71,489 ) 674,204 ( 71,581 )
Total corporates 150,905 ( 11,529 ) 6,744,414 ( 797,582 ) 6,895,319 ( 809,111 )
Collateralized debt obligations
Other asset-backed securities 68,549 ( 1,607 ) 68,549 ( 1,607 )
Total investment grade securities 352,545 ( 16,350 ) 8,852,284 ( 1,250,268 ) 9,204,829 ( 1,266,618 )
Below investment grade securities:
Corporates, by sector:
Industrials 2,670 ( 169 ) 143,088 ( 32,158 ) 145,758 ( 32,327 )
Financial 4,199 ( 13 ) 178,887 ( 38,122 ) 183,086 ( 38,135 )
Utilities 11,945 ( 790 ) 11,945 ( 790 )
Total corporates 6,869 ( 182 ) 333,920 ( 71,070 ) 340,789 ( 71,252 )
Collateralized debt obligations
Other asset-backed securities 5,432 ( 70 ) 5,432 ( 70 )
Total below investment grade securities 6,869 ( 182 ) 339,352 ( 71,140 ) 346,221 ( 71,322 )
Total fixed maturities
$ 359,414 $ ( 16,532 ) $ 9,191,636 $ ( 1,321,408 ) $ 9,551,050 $ ( 1,337,940 )

Gross unrealized losses may fluctuate quarter over quarter due to factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is unlikely that the Company will be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations.

17
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Analysis of Gross Unrealized Investment Losses
At December 31, 2023
Less than Twelve Months Twelve Months or Longer Total
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises $ $ $ 364,006 $ ( 32,306 ) $ 364,006 $ ( 32,306 )
States, municipalities, and political subdivisions 252,800 ( 3,520 ) 1,610,163 ( 399,809 ) 1,862,963 ( 403,329 )
Foreign governments 32,591 ( 10,348 ) 32,591 ( 10,348 )
Corporates, by sector:
Industrials 191,573 ( 3,881 ) 4,317,827 ( 530,011 ) 4,509,400 ( 533,892 )
Financial 242,099 ( 6,584 ) 2,341,424 ( 339,628 ) 2,583,523 ( 346,212 )
Utilities 81,194 ( 648 ) 686,043 ( 91,959 ) 767,237 ( 92,607 )
Total corporates 514,866 ( 11,113 ) 7,345,294 ( 961,598 ) 7,860,160 ( 972,711 )
Collateralized debt obligations
Other asset-backed securities 70,956 ( 3,648 ) 70,956 ( 3,648 )
Total investment grade securities 767,666 ( 14,633 ) 9,423,010 ( 1,407,709 ) 10,190,676 ( 1,422,342 )
Below investment grade securities:
Corporates, by sector:
Industrials 10,745 ( 199 ) 145,697 ( 32,756 ) 156,442 ( 32,955 )
Financial 25,563 ( 2,602 ) 151,190 ( 39,526 ) 176,753 ( 42,128 )
Utilities 19,654 ( 1,523 ) 19,654 ( 1,523 )
Total corporates 36,308 ( 2,801 ) 316,541 ( 73,805 ) 352,849 ( 76,606 )
Collateralized debt obligations
Other asset-backed securities 11,288 ( 409 ) 11,288 ( 409 )
Total below investment grade securities 36,308 ( 2,801 ) 327,829 ( 74,214 ) 364,137 ( 77,015 )
Total fixed maturities
$ 803,974 $ ( 17,434 ) $ 9,750,839 $ ( 1,481,923 ) $ 10,554,813 $ ( 1,499,357 )

18
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fixed Maturities, Allowance for Credit Losses : A summary of the activity in the allowance for credit losses is as follows.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Allowance for credit losses beginning balance
$ 7,132 $ 72,508 $ 7,115 $
Additions to allowance for which credit losses were not previously recorded 72,508
Additions (reductions) to allowance for fixed maturities that previously had an allowance ( 65,008 ) 17 ( 65,008 )
Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period
Allowance for credit losses ending balance
$ 7,132 $ 7,500 $ 7,132 $ 7,500

As of September 30, 2024 and December 31, 2023, the Company did not have any fixed maturities in non-accrual status.

Mortgage Loans (commercial mortgage loans) : Summaries of commercial mortgage loans by property type and geographical location at September 30, 2024 and December 31, 2023 are as follows:
September 30, 2024 December 31, 2023
Carrying Value % of Total Carrying Value % of Total
Property type:
Multi-family $ 127,155 33 $ 116,299 42
Industrial 102,402 27 57,267 20
Retail 73,252 19 23,925 9
Hospitality 43,435 11 43,897 16
Mixed use 35,886 10 34,749 12
Office 6,387 2 6,734 2
Total recorded investment 388,517 102 282,871 101
Less allowance for credit losses ( 7,202 ) ( 2 ) ( 3,672 ) ( 1 )
Carrying value, net of allowance for credit losses
$ 381,315 100 $ 279,199 100

September 30, 2024 December 31, 2023
Carrying Value % of Total Carrying Value % of Total
Geographic location:
Texas $ 75,002 20 $ 45,111 16
New Jersey 51,454 14 44,574 16
Florida 46,506 12 48,233 17
California 40,715 11 54,721 20
New York 35,865 9 20,284 7
Alabama 35,838 9 11,003 4
Other 103,137 27 58,945 21
Total recorded investment 388,517 102 282,871 101
Less allowance for credit losses ( 7,202 ) ( 2 ) ( 3,672 ) ( 1 )
Carrying value, net of allowance for credit losses
$ 381,315 100 $ 279,199 100
19
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value (LTV) ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. LTV's that exceed 80% are generally as a result of decreases in the valuation of the underlying property. Generally, a higher LTV ratio and a lower debt service coverage ratio equates to higher risk of loss.
September 30, 2024
Recorded Investment
Debt Service Coverage Ratios (1)
<1.00x 1.00x—1.20x >1.20x Total % of Gross Total
Loan-to-value ratio (2) :
Less than 70% $ 22,841 $ 138,034 $ 203,226 $ 364,101 94
70% to 80% 1,058 1,058
81% to 90% 8,569 8,569 2
Greater than 90% 14,789 14,789 4
Total $ 47,257 $ 138,034 $ 203,226 388,517 100
Less allowance for credit losses ( 7,202 )
Total, net of allowance for credit losses
$ 381,315
(1) Annual net operating income divided by annual mortgage debt service (principal and interest).
(2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.
December 31, 2023
Recorded Investment
Debt Service Coverage Ratios (1)
<1.00x 1.00x—1.20x >1.20x Total % of Gross Total
Loan-to-value ratio (2) :
Less than 70% $ 27,091 $ 180,761 $ 58,364 $ 266,216 94
70% to 80%
81% to 90% 8,468 1,153 9,621 3
Greater than 90% 7,034 7,034 3
Total $ 42,593 $ 180,761 $ 59,517 282,871 100
Less allowance for credit losses ( 3,672 )
Total, net of allowance for credit losses
$ 279,199
(1) Annual net operating income divided by annual mortgage debt service (principal and interest).
(2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.

As of September 30, 2024, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 36 loans in the portfolio. For the nine months ended September 30, 2024, the allowance for credit losses increased by $ 3.5 million to $ 7.2 million. The provision for credit losses is included in "Realized gains (losses)" in the Condensed Consolidated Statements of Operations .
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Allowance for credit losses beginning balance
$ 5,826 $ 2,928 $ 3,672 $ 1,789
Provision (reversal) for credit losses 1,376 60 3,530 1,199
Allowance for credit losses ending balance
$ 7,202 $ 2,988 $ 7,202 $ 2,988
20
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
There was one delinquent commercial mortgage loan, with an outstanding par value of $ 36.0 million and outstanding interest due of $ 1.9 million, as of September 30, 2024. The underlying collateral for this loan is in the process of being sold and the Company expects to recover all interest and principal due as of September 30, 2024. There were no delinquent commercial mortgage loans as of December 31, 2023. As of September 30, 2024, the Company had three commercial mortgage loans in non-accrual status with a principal balance of $ 8.8 million. As of December 31, 2023, the Company had no commercial mortgage loans in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $ 31 million as of September 30, 2024.

Other Long-Term Investments : Other long-term investments consist of the following assets:
September 30,
2024
December 31, 2023
Investment funds $ 979,397 $ 795,583
Company-owned life insurance
200,114
Other 42,377 40,295
Total
$ 1,221,888 $ 835,878

During the current quarter ended September 30, 2024, the Company acquired other investments in company-owned life insurance (COLI) in the amount of $ 200 million. COLI is reported at cash surrender value.

The following table presents additional information about the Company's investment funds as of September 30, 2024 and December 31, 2023 at fair value:
Fair Value Unfunded Commitments
Investment Category September 30,
2024
December 31, 2023 September 30,
2024
Redemption Term/Notice (1)
Commercial mortgage loans $ 567,425 $ 411,315 $ 378,892 Fully redeemable and non-redeemable with varying terms.
Opportunistic and private credit
195,957 181,410 166,514 Fully redeemable and non-redeemable with varying terms.
Infrastructure 174,971 165,887 16,318 Fully redeemable and non-redeemable with varying terms.
Other 41,044 36,971 50,757 Non-redeemable with varying terms
Total investment funds $ 979,397 $ 795,583 $ 612,481
(1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners.

The Company had $ 226 million of capital called during the period from existing investment funds. The Company's unfunded commitments were $ 612 million as of September 30, 2024.


Note 5—Commitments and Contingencies

Guarantees : The Parent Company has guaranteed letters of credit in connection with its credit facility with a group of banks. The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers . The credit facility was amended on March 29, 2024 and now expires in 2029. The maximum amount of letters of credit available is $ 250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount of letters of credit outstanding at September 30, 2024 was $ 115 million.

21
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Litigation : Globe Life Inc. and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including: putative class action litigation; alleged breaches of contract; torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries; alleged employment discrimination; alleged worker misclassification; and miscellaneous other causes of action. Based upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life's financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts.

On July 22, 2022, putative class and collective action litigation was filed against Arias Agencies and American Income Life Insurance Company (“American Income”) (collectively, “Defendants”) in United States District Court for the Western District of Pennsylvania ( David Burkes v. Arias Agencies and American Income Life Insurance Company , Case No. 2:22-cv-1054). The complaint alleges that insurance agent trainees should have been classified as employees, and after contracting should have been classified as employees instead of independent contractors. Plaintiff David Burkes is a former Pennsylvania independent sales agent and asserts claims under Pennsylvania law on behalf of a putative class of all individuals who trained to become and/or worked as sales agents for American Income in the three years prior to July 22, 2022 through case conclusion. Burkes makes claims (a) under the Pennsylvania Minimum Wage Act and the Pennsylvania Wage Payment and Collection Law for the alleged failure to pay minimum wage, alleged failure to pay for time spent in training, alleged failure to pay for missed meals and rest breaks, allegedly requiring putative class members to pay for work-related expenses, and allegedly subjecting putative class members to “chargebacks”; (b) for unjust enrichment for allegedly benefiting from the uncompensated labor of putative class members; and (c) for the rescission of putative class members’ agent contracts. Burkes also asserts a collective action on behalf of the same group of individuals for minimum wage, overtime, liquidated damages, and attorney’s fees and costs under the Fair Labor Standards Act for the three years prior to July 22, 2022 through case conclusion, as well as a claim that American Income allegedly did not keep accurate records of hours worked by sales agents. On January 26, 2023, the court entered an order compelling Burkes to arbitrate his claims on an individual basis and staying the case pending completion of arbitration. Burkes’ individual claims, as well as the individual claims of other current and former agents who are members of the putative class, are currently pending in arbitration.

On April 4, 2023, putative class action litigation was filed against National Income Life Insurance Company (“National Income”) in New York Supreme Court by plaintiffs Melissa K. Goppert, Sarah Valente, James O’Neill, Jennifer Abe, and Emily Herendeen (“Plaintiffs”) ( Goppert, et al. v. National Income Life Insurance Company , Index No. 153096/2023). Plaintiffs are former National Income independent sales agents who allege they should have been classified as employees and assert claims under New York state law on behalf of a putative class of former independent sales agents and individuals who trained to become independent sale agents since March 2017. Plaintiffs make claims under New York’s Minimum Wage Law (NYLL § 633 and 12 NYCRR § 142-2.1); Overtime Compensation Law (NYLL § 633 and 12 NYCRR § 142-2.2); and “Spread of Hours” Law (12 NYCRR § 142-2.4) for the alleged failure to pay minimum wages and overtime pay, including for time spent in training, and attorney’s fees and costs. National Income filed a motion to compel arbitration of each Plaintiff’s claims on an individual basis, which the Court granted in full on January 11, 2024, and on February 7, 2024, Plaintiffs filed a notice of appeal of the Court’s order.

On September 1, 2023, plaintiff Miné Caglar Cost (“Plaintiff”) filed a complaint against American Income Life Insurance Company (“American Income”) in the Superior Court of the State of California for the County of Los Angeles, asserting a single claim for violation of the Private Attorneys General Act (“PAGA”) ( Cost v. American Income Life Insurance Company , et al. , Case No. 23SMCV04113). Plaintiff is a former California independent insurance sales agent who alleges one cause of action for civil penalties under PAGA arising out of alleged violations of the wage-and-hour provisions of the California Labor Code stemming from American Income’s alleged misclassification of Plaintiff and other California-based sales agents as independent contractors. American Income filed a motion to compel arbitration on an individual basis and stay the representative component of Plaintiff’s
22
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
claims, to which Plaintiff stipulated. On December 12, 2023, the Court approved the parties’ stipulation to compel the matter to individual arbitration and stayed the case pending the completion of the individual arbitration.

On November 30, 2023, Globe Life Inc. and its subsidiary, American Income Life Insurance Company (“American Income”), received subpoenas from the U.S. Attorney’s Office for the Western District of Pennsylvania, seeking documents relating to sales practices by certain of our independent sales agents contracted to sell American Income policies. Globe Life Inc. and American Income continue to fully cooperate in responding to the Department of Justice’s requests. The Department of Justice has not asserted any claims or made allegations against Globe Life Inc. and American Income, and Globe Life Inc. currently is not aware that any legal proceedings are contemplated by governmental authorities. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss.

In April 2024, Globe Life Inc. received an inquiry from the SEC's Fort Worth Regional Office requesting information related to recent short seller reports making allegations about Globe Life Inc. Globe Life Inc. has provided information in response to the SEC’s requests and continues to cooperate fully with the SEC. At this time, the SEC has not asserted any claims against Globe Life Inc. or indicated that it intends to do so. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss.

On April 30, 2024, a putative securities class action was filed against Globe Life Inc. and six of its current/former executives and directors in the United States District Court for the Eastern District of Texas ( City of Miami Gen. Emp. & Sanitation Emp. Ret. Trust, et al. v. Globe Life Inc. , et al., Case No. 4:24-cv-00376). On July 24, 2024, the Court appointed Lead Plaintiffs and Lead Counsel for the putative class of shareholders. The Lead Plaintiffs filed a Consolidated Complaint on October 4, 2024 that asserts claims under §§ 10(b), 20(a), and 20(A) of the Securities Exchange Act of 1934 and SEC Rules 10b-5(a), 10b-5(b), and 10b-5(c) promulgated thereunder, on behalf of a putative class of purchasers of Globe Life Inc.'s securities from May 8, 2019 through April 10, 2024. The Consolidated Complaint adds four additional executives as defendants and alleges that certain of Globe Life Inc.'s disclosures about financial performance and certain other public statements during the putative class period were materially false or misleading. Defendants’ response to the Consolidated Complaint is due December 3, 2024. Globe Life Inc. plans to vigorously defend against the lawsuit. Pursuant to Globe Life Inc.'s Restated Certificate of Incorporation and indemnification agreements with the named defendants, Globe Life Inc. has agreed to indemnify those defendants for all expenses and losses related to the litigation, subject to the terms of those indemnification agreements. The outcome of litigation of this type is inherently uncertain, and there is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc. and the individual defendants. However, the amount of any such loss in that outcome cannot be reasonably estimated at this time. Further, management cannot reasonably estimate whether an outcome on the putative class action will be resolved in the near term.

On September 26, 2024, Globe Life Inc. and its subsidiary, American Income Life Insurance Company (“American Income”), were notified by the Equal Employment Opportunity Commission (“EEOC”) that the EEOC conducted an investigation of charges filed against Globe Life Inc. and/or American Income by five former sales agents and one current sales agent. The EEOC asserts that there is reasonable cause to believe the six complainants were employees, not independent contractors, of Globe Life Inc. and/or American Income and were discriminated against on the basis of sex, and that one complainant was also discriminated against on the basis of race. In addition, the EEOC asserts that there is reasonable cause to believe that a class of female workers were employees, not independent contractors, and were subject to unlawful conduct which also constitutes a pattern-or-practice of discrimination. The EEOC’s investigative findings are not binding on Globe Life Inc. The EEOC’s procedures provide for a conciliation process that has recently concluded without achieving a resolution. The EEOC may elect to file a lawsuit in federal court on behalf of the workers based on the alleged statutory violations. The EEOC has not filed any legal proceedings at this time. In the event the EEOC elects to pursue any claims in court, Globe Life Inc. intends to defend against any such lawsuit vigorously. The outcome of litigation of this type would be inherently uncertain and cannot be reasonably estimated or determined at this time. There is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc.

Note 6—Policy Liabilities
23
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

The liability for future policy benefits is determined based on the net level premium method, which requires the liability be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts for the three and nine month periods ended September 30, 2024 and 2023:
Life
Present value of expected future net premiums
American Income DTC Liberty National Other Total
Balance at January 1, 2023
$ 4,273,156 $ 5,910,224 $ 1,094,407 $ 470,741 $ 11,748,528
Beginning balance at original discount rates 4,246,723 5,680,864 1,066,123 449,209 11,442,919
Effect of changes in assumptions on future cash flows
14,265 36,170 5,178 8,419 64,032
Effect of actual variances from expected experience ( 103,922 ) ( 219,723 ) ( 26,533 ) ( 13,882 ) ( 364,060 )
Adjusted balance at January 1, 2023
4,157,066 5,497,311 1,044,768 443,746 11,142,891
Issuances (1)
557,844 450,361 92,894 21,756 1,122,855
Interest accrual (2)
147,968 214,988 40,362 17,071 420,389
Net premiums collected (3)
( 388,288 ) ( 461,367 ) ( 100,093 ) ( 34,542 ) ( 984,290 )
Effect of changes in the foreign exchange rate ( 631 ) ( 631 )
Ending balance at original discount rates 4,473,959 5,701,293 1,077,931 448,031 11,701,214
Effect of change from original to current discount rates ( 155,254 ) ( 31,118 ) ( 18,702 ) ( 1,499 ) ( 206,573 )
Balance at September 30, 2023
$ 4,318,705 $ 5,670,175 $ 1,059,229 $ 446,532 $ 11,494,641
Balance at January 1, 2024
$ 4,681,888 $ 6,052,651 $ 1,129,716 $ 478,052 $ 12,342,307
Beginning balance at original discount rates 4,523,329 5,664,259 1,077,831 443,949 11,709,368
Effect of changes in assumptions on future cash flows
( 82,348 ) ( 28,366 ) ( 29,292 ) ( 982 ) ( 140,988 )
Effect of actual variances from expected experience ( 173,180 ) ( 226,062 ) ( 29,381 ) ( 9,292 ) ( 437,915 )
Adjusted balance at January 1, 2024
4,267,801 5,409,831 1,019,158 433,675 11,130,465
Issuances (1)
616,527 398,034 90,517 18,126 1,123,204
Interest accrual (2)
164,917 220,485 41,610 17,213 444,225
Net premiums collected (3)
( 412,717 ) ( 455,625 ) ( 101,687 ) ( 33,960 ) ( 1,003,989 )
Effect of changes in the foreign exchange rate ( 4,101 ) ( 4,101 )
Ending balance at original discount rates 4,632,427 5,572,725 1,049,598 435,054 11,689,804
Effect of change from original to current discount rates 204,567 421,888 54,498 35,513 716,466
Balance at September 30, 2024
$ 4,836,994 $ 5,994,613 $ 1,104,096 $ 470,567 $ 12,406,270
(1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business.

24
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future net premiums
American Income DTC Liberty National Other Total
Balance at July 1, 2023
$ 4,472,847 $ 5,988,577 $ 1,110,017 $ 471,279 $ 12,042,720
Beginning balance at original discount rates 4,399,053 5,700,354 1,071,561 445,475 11,616,443
Effect of changes in assumptions on future cash flows
14,265 36,170 5,178 8,419 64,032
Effect of actual variances from expected experience ( 34,571 ) ( 91,120 ) ( 10,938 ) ( 7,232 ) ( 143,861 )
Adjusted balance at July 1, 2023
4,378,747 5,645,404 1,065,801 446,662 11,536,614
Issuances (1)
181,823 136,611 32,045 7,143 357,622
Interest accrual (2)
51,119 72,515 13,707 5,741 143,082
Net premiums collected (3)
( 131,329 ) ( 153,237 ) ( 33,622 ) ( 11,515 ) ( 329,703 )
Effect of changes in the foreign exchange rate ( 6,401 ) ( 6,401 )
Ending balance at original discount rates 4,473,959 5,701,293 1,077,931 448,031 11,701,214
Effect of change from original to current discount rates ( 155,254 ) ( 31,118 ) ( 18,702 ) ( 1,499 ) ( 206,573 )
Balance at September 30, 2023
$ 4,318,705 $ 5,670,175 $ 1,059,229 $ 446,532 $ 11,494,641
Balance at July 1, 2024
$ 4,635,903 $ 5,810,518 $ 1,085,233 $ 449,883 $ 11,981,537
Beginning balance at original discount rates 4,648,111 5,670,288 1,080,642 437,551 11,836,592
Effect of changes in assumptions on future cash flows
( 82,348 ) ( 28,366 ) ( 29,292 ) ( 982 ) ( 140,988 )
Effect of actual variances from expected experience ( 59,483 ) ( 103,089 ) ( 12,113 ) ( 1,970 ) ( 176,655 )
Adjusted balance at July 1, 2024
4,506,280 5,538,833 1,039,237 434,599 11,518,949
Issuances (1)
203,828 110,993 30,298 5,969 351,088
Interest accrual (2)
55,750 73,134 13,836 5,709 148,429
Net premiums collected (3)
( 138,552 ) ( 150,235 ) ( 33,773 ) ( 11,223 ) ( 333,783 )
Effect of changes in the foreign exchange rate 5,121 5,121
Ending balance at original discount rates 4,632,427 5,572,725 1,049,598 435,054 11,689,804
Effect of change from original to current discount rates 204,567 421,888 54,498 35,513 716,466
Balance at September 30, 2024
$ 4,836,994 $ 5,994,613 $ 1,104,096 $ 470,567 $ 12,406,270
(1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business.
25
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American Income DTC Liberty National Other Total
Balance at January 1, 2023
$ 9,119,104 $ 9,225,451 $ 3,429,256 $ 3,976,150 $ 25,749,961
Beginning balance at original discount rates 8,409,761 8,477,892 3,272,980 3,403,704 23,564,337
Effect of changes in assumptions on future cash flows 13,344 34,407 6,156 11,661 65,568
Effect of actual variances from expected experience ( 109,386 ) ( 227,639 ) ( 27,482 ) ( 17,962 ) ( 382,469 )
Adjusted balance at January 1, 2023
8,313,719 8,284,660 3,251,654 3,397,403 23,247,436
Issuances (1)
557,844 450,362 92,894 21,756 1,122,856
Interest accrual (2)
335,349 342,208 130,712 152,378 960,647
Benefit payments (3)
( 296,133 ) ( 432,393 ) ( 153,294 ) ( 86,008 ) ( 967,828 )
Effect of changes in the foreign exchange rate ( 819 ) ( 819 )
Ending balance at original discount rates 8,909,960 8,644,837 3,321,966 3,485,529 24,362,292
Effect of change from original to current discount rates 80,477 228,607 ( 46,234 ) 282,118 544,968
Balance at September 30, 2023
$ 8,990,437 $ 8,873,444 $ 3,275,732 $ 3,767,647 $ 24,907,260
Balance at January 1, 2024
$ 10,163,627 $ 9,714,516 $ 3,605,392 $ 4,239,623 $ 27,723,158
Beginning balance at original discount rates 9,061,833 8,656,752 3,338,252 3,506,859 24,563,696
Effect of changes in assumptions on future cash flows ( 104,498 ) ( 50,106 ) ( 41,836 ) ( 2,027 ) ( 198,467 )
Effect of actual variances from expected experience ( 187,711 ) ( 241,231 ) ( 34,722 ) ( 12,841 ) ( 476,505 )
Adjusted balance at January 1, 2024
8,769,624 8,365,415 3,261,694 3,491,991 23,888,724
Issuances (1)
611,802 398,032 90,518 18,127 1,118,479
Interest accrual (2)
367,403 355,850 134,020 157,318 1,014,591
Benefit payments (3)
( 326,318 ) ( 439,992 ) ( 159,219 ) ( 103,998 ) ( 1,029,527 )
Effect of changes in the foreign exchange rate ( 8,768 ) ( 8,768 )
Ending balance at original discount rates 9,413,743 8,679,305 3,327,013 3,563,438 24,983,499
Effect of change from original to current discount rates 1,091,042 1,082,717 275,358 717,751 3,166,868
Balance at September 30, 2024
$ 10,504,785 $ 9,762,022 $ 3,602,371 $ 4,281,189 $ 28,150,367
(1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the revised expected assumptions.


26
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American Income DTC Liberty National Other Total
Balance at July 1, 2023
$ 9,668,207 $ 9,487,233 $ 3,507,845 $ 4,109,706 $ 26,772,991
Beginning balance at original discount rates 8,753,526 8,592,897 3,297,781 3,448,491 24,092,695
Effect of changes in assumptions on future cash flows 13,344 34,407 6,156 11,661 65,568
Effect of actual variances from expected experience ( 36,998 ) ( 97,632 ) ( 14,364 ) ( 9,595 ) ( 158,589 )
Adjusted balance at July 1, 2023
8,729,872 8,529,672 3,289,573 3,450,557 23,999,674
Issuances (1)
181,822 136,612 32,046 7,145 357,625
Interest accrual (2)
114,683 115,547 43,991 51,249 325,470
Benefit payments (3)
( 101,161 ) ( 136,994 ) ( 43,644 ) ( 23,422 ) ( 305,221 )
Effect of changes in the foreign exchange rate ( 15,256 ) ( 15,256 )
Ending balance at original discount rates 8,909,960 8,644,837 3,321,966 3,485,529 24,362,292
Effect of change from original to current discount rates 80,477 228,607 ( 46,234 ) 282,118 544,968
Balance at September 30, 2023
$ 8,990,437 $ 8,873,444 $ 3,275,732 $ 3,767,647 $ 24,907,260
Balance at July 1, 2024
$ 9,811,407 $ 9,289,834 $ 3,424,768 $ 3,981,898 $ 26,507,907
Beginning balance at original discount rates 9,353,526 8,748,900 3,356,531 3,545,323 25,004,280
Effect of changes in assumptions on future cash flows ( 104,498 ) ( 50,106 ) ( 41,836 ) ( 2,027 ) ( 198,467 )
Effect of actual variances from expected experience ( 65,766 ) ( 111,255 ) ( 15,385 ) ( 2,629 ) ( 195,035 )
Adjusted balance at July 1, 2024
9,183,262 8,587,539 3,299,310 3,540,667 24,610,778
Issuances (1)
199,097 110,991 30,298 5,970 346,356
Interest accrual (2)
124,308 118,873 44,743 52,747 340,671
Benefit payments (3)
( 105,757 ) ( 138,098 ) ( 47,338 ) ( 35,946 ) ( 327,139 )
Effect of changes in the foreign exchange rate 12,833 12,833
Ending balance at original discount rates 9,413,743 8,679,305 3,327,013 3,563,438 24,983,499
Effect of change from original to current discount rates 1,091,042 1,082,717 275,358 717,751 3,166,868
Balance at September 30, 2024
$ 10,504,785 $ 9,762,022 $ 3,602,371 $ 4,281,189 $ 28,150,367
(1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the revised expected assumptions.



27
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life (2)
Net liability for future policy benefits as of September 30, 2023
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 4,436,001 $ 2,943,544 $ 2,244,035 $ 3,037,498 $ 12,661,078
Effect of changes in discount rate assumptions 235,731 259,725 ( 27,532 ) 283,617 751,541
Other adjustments (1)
508 3,982 6,272 466 11,228
Net liability for future policy benefits, after other adjustments, at current discount rates
4,672,240 3,207,251 2,222,775 3,321,581 13,423,847
Reinsurance recoverable
( 141 ) ( 7,661 ) ( 32,947 ) ( 40,749 )
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 4,672,099 $ 3,207,251 $ 2,215,114 $ 3,288,634 $ 13,383,098
(1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).
(2) Includes the immaterial error correction noted below.


Life
Net liability for future policy benefits as of September 30, 2024
American Income DTC Liberty National Other Total
Net liability for future policy benefits at original discount rates
$ 4,781,316 $ 3,106,580 $ 2,277,415 $ 3,128,384 $ 13,293,695
Effect of changes in discount rate assumptions 886,475 660,829 220,860 682,238 2,450,402
Other adjustments (1)
150 37 187
Net liability for future policy benefits, after other adjustments, at current discount rates
5,667,941 3,767,409 2,498,275 3,810,659 15,744,284
Reinsurance recoverable
( 170 ) ( 7,885 ) ( 38,506 ) ( 46,561 )
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 5,667,771 $ 3,767,409 $ 2,490,390 $ 3,772,153 $ 15,697,723
(1) Other adjustments include the Company's effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



28
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts for the three and nine month periods ended September 30, 2024 and 2023:
Health
Present value of expected future net premiums
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2023
$ 2,908,501 $ 1,594,992 $ 423,490 $ 190,296 $ 90,143 $ 5,207,422
Beginning balance at original discount rates 2,941,261 1,729,219 415,442 192,631 87,751 5,366,304
Effect of changes in assumptions on future cash flows
466,883 ( 30,255 ) ( 56,964 ) ( 6,061 ) 16,553 390,156
Effect of actual variances from expected experience ( 6,240 ) ( 50,052 ) ( 30,526 ) ( 7,643 ) ( 1,666 ) ( 96,127 )
Adjusted balance at January 1, 2023
3,401,904 1,648,912 327,952 178,927 102,638 5,660,333
Issuances (1)
226,363 202,561 43,373 30,667 6,532 509,496
Interest accrual (2)
99,390 50,091 14,047 6,304 3,278 173,110
Net premiums collected (3)
( 202,669 ) ( 134,009 ) ( 38,322 ) ( 16,611 ) ( 8,028 ) ( 399,639 )
Effect of changes in the foreign exchange rate ( 165 ) ( 165 )
Ending balance at original discount rates 3,524,988 1,767,555 347,050 199,122 104,420 5,943,135
Effect of change from original to current discount rates ( 183,608 ) ( 192,981 ) ( 8,372 ) ( 9,976 ) ( 1,254 ) ( 396,191 )
Balance at September 30, 2023
$ 3,341,380 $ 1,574,574 $ 338,678 $ 189,146 $ 103,166 $ 5,546,944
Balance at January 1, 2024
$ 3,697,771 $ 1,711,741 $ 358,472 $ 206,381 $ 115,363 $ 6,089,728
Beginning balance at original discount rates 3,625,803 1,783,173 348,570 201,869 109,880 6,069,295
Effect of changes in assumptions on future cash flows
9,892 ( 8,117 ) ( 3,463 ) 12,207 4,449 14,968
Effect of actual variances from expected experience ( 18,894 ) ( 43,359 ) ( 26,123 ) ( 11,168 ) ( 1,818 ) ( 101,362 )
Adjusted balance at January 1, 2024
3,616,801 1,731,697 318,984 202,908 112,511 5,982,901
Issuances (1)
287,072 200,220 43,367 34,121 12,325 577,105
Interest accrual (2)
128,533 55,733 12,450 7,135 4,221 208,072
Net premiums collected (3)
( 220,380 ) ( 141,735 ) ( 39,223 ) ( 18,171 ) ( 8,338 ) ( 427,847 )
Effect of changes in the foreign exchange rate ( 377 ) ( 377 )
Ending balance at original discount rates 3,812,026 1,845,915 335,578 225,616 120,719 6,339,854
Effect of change from original to current discount rates 130,218 ( 44,372 ) 11,529 8,173 7,153 112,701
Balance at September 30, 2024
$ 3,942,244 $ 1,801,543 $ 347,107 $ 233,789 $ 127,872 $ 6,452,555
(1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business.
29
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future net premiums
United American Family Heritage Liberty National American Income DTC Total
Balance at July 1, 2023
$ 2,984,554 $ 1,661,020 $ 409,551 $ 201,844 $ 89,674 $ 5,346,643
Beginning balance at original discount rates 2,985,660 1,771,206 400,180 201,709 86,840 5,445,595
Effect of changes in assumptions on future cash flows
466,883 ( 30,255 ) ( 56,964 ) ( 6,061 ) 16,553 390,156
Effect of actual variances from expected experience 22,683 ( 15,658 ) ( 2,692 ) ( 2,394 ) 229 2,168
Adjusted balance at July 1, 2023
3,475,226 1,725,293 340,524 193,254 103,622 5,837,919
Issuances (1)
82,647 70,216 15,183 9,880 2,317 180,243
Interest accrual (2)
35,536 17,272 4,380 2,170 1,160 60,518
Net premiums collected (3)
( 68,421 ) ( 45,226 ) ( 13,037 ) ( 5,630 ) ( 2,679 ) ( 134,993 )
Effect of changes in the foreign exchange rate ( 552 ) ( 552 )
Ending balance at original discount rates 3,524,988 1,767,555 347,050 199,122 104,420 5,943,135
Effect of change from original to current discount rates ( 183,608 ) ( 192,981 ) ( 8,372 ) ( 9,976 ) ( 1,254 ) ( 396,191 )
Balance at September 30, 2023
$ 3,341,380 $ 1,574,574 $ 338,678 $ 189,146 $ 103,166 $ 5,546,944
Balance at July 1, 2024
$ 3,658,491 $ 1,690,797 $ 337,741 $ 205,889 $ 114,876 $ 6,007,794
Beginning balance at original discount rates 3,720,108 1,823,728 338,934 208,867 113,247 6,204,884
Effect of changes in assumptions on future cash flows
9,892 ( 8,117 ) ( 3,463 ) 12,207 4,449 14,968
Effect of actual variances from expected experience 18,179 ( 12,068 ) ( 4,959 ) ( 4,110 ) 644 ( 2,314 )
Adjusted balance at July 1, 2024
3,748,179 1,803,543 330,512 216,964 118,340 6,217,538
Issuances (1)
95,279 71,345 14,352 11,997 3,823 196,796
Interest accrual (2)
43,903 19,016 4,104 2,493 1,460 70,976
Net premiums collected (3)
( 75,335 ) ( 47,989 ) ( 13,390 ) ( 6,300 ) ( 2,904 ) ( 145,918 )
Effect of changes in the foreign exchange rate 462 462
Ending balance at original discount rates 3,812,026 1,845,915 335,578 225,616 120,719 6,339,854
Effect of change from original to current discount rates 130,218 ( 44,372 ) 11,529 8,173 7,153 112,701
Balance at September 30, 2024
$ 3,942,244 $ 1,801,543 $ 347,107 $ 233,789 $ 127,872 $ 6,452,555
(1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business.





30
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2023
$ 3,046,829 $ 3,005,664 $ 941,574 $ 312,750 $ 87,532 $ 7,394,349
Beginning balance at original discount rates 3,080,633 3,336,344 904,865 303,713 85,212 7,710,767
Effect of changes in assumptions on future cash flows 464,652 ( 32,428 ) ( 60,437 ) ( 6,407 ) 15,930 381,310
Effect of actual variances from expected experience ( 5,530 ) ( 53,292 ) ( 29,581 ) ( 8,680 ) ( 1,925 ) ( 99,008 )
Adjusted balance at January 1, 2023
3,539,755 3,250,624 814,847 288,626 99,217 7,993,069
Issuances (1)
225,915 202,561 42,863 30,667 6,518 508,524
Interest accrual (2)
104,932 99,344 34,699 11,199 3,278 253,452
Benefit payments (3)
( 221,753 ) ( 92,973 ) ( 73,614 ) ( 18,633 ) ( 9,502 ) ( 416,475 )
Effect of changes in the foreign exchange rate ( 217 ) ( 217 )
Ending balance at original discount rates 3,648,849 3,459,556 818,795 311,642 99,511 8,338,353
Effect of change from original to current discount rates ( 191,041 ) ( 498,312 ) ( 4,792 ) ( 5,601 ) ( 1,111 ) ( 700,857 )
Balance at September 30, 2023
$ 3,457,808 $ 2,961,244 $ 814,003 $ 306,041 $ 98,400 $ 7,637,496
Balance at January 1, 2024
$ 3,814,328 $ 3,315,880 $ 865,808 $ 335,504 $ 109,482 $ 8,441,002
Beginning balance at original discount rates 3,741,530 3,506,689 816,819 315,431 104,501 8,484,970
Effect of changes in assumptions on future cash flows 10,680 ( 5,054 ) ( 2,775 ) 20,293 7,733 30,877
Effect of actual variances from expected experience ( 15,162 ) ( 48,407 ) ( 26,421 ) ( 12,611 ) ( 1,509 ) ( 104,110 )
Adjusted balance at January 1, 2024
3,737,048 3,453,228 787,623 323,113 110,725 8,411,737
Issuances (1)
286,358 200,219 42,780 34,123 12,296 575,776
Interest accrual (2)
133,143 109,479 32,202 12,145 4,220 291,189
Benefit payments (3)
( 248,769 ) ( 103,070 ) ( 69,649 ) ( 19,574 ) ( 9,655 ) ( 450,717 )
Effect of changes in the foreign exchange rate ( 646 ) ( 646 )
Ending balance at original discount rates 3,907,780 3,659,856 792,956 349,161 117,586 8,827,339
Effect of change from original to current discount rates 131,531 ( 144,821 ) 52,819 24,383 6,871 70,783
Balance at September 30, 2024
$ 4,039,311 $ 3,515,035 $ 845,775 $ 373,544 $ 124,457 $ 8,898,122
(1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the revised expected assumptions.
31
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United American Family Heritage Liberty National American Income DTC Total
Balance at July 1, 2023
$ 3,116,389 $ 3,167,461 $ 923,148 $ 328,579 $ 85,856 $ 7,621,433
Beginning balance at original discount rates 3,116,768 3,436,167 880,879 315,087 83,188 7,832,089
Effect of changes in assumptions on future cash flows 464,652 ( 32,428 ) ( 60,437 ) ( 6,407 ) 15,930 381,310
Effect of actual variances from expected experience 22,410 ( 17,000 ) ( 2,563 ) ( 2,662 ) ( 95 ) 90
Adjusted balance at July 1, 2023
3,603,830 3,386,739 817,879 306,018 99,023 8,213,489
Issuances (1)
82,511 70,215 14,963 9,880 2,310 179,879
Interest accrual (2)
37,340 34,024 11,173 3,810 1,160 87,507
Benefit payments (3)
( 74,832 ) ( 31,422 ) ( 25,220 ) ( 6,973 ) ( 2,982 ) ( 141,429 )
Effect of changes in the foreign exchange rate ( 1,093 ) ( 1,093 )
Ending balance at original discount rates 3,648,849 3,459,556 818,795 311,642 99,511 8,338,353
Effect of change from original to current discount rates ( 191,041 ) ( 498,312 ) ( 4,792 ) ( 5,601 ) ( 1,111 ) ( 700,857 )
Balance at September 30, 2023
$ 3,457,808 $ 2,961,244 $ 814,003 $ 306,041 $ 98,400 $ 7,637,496
Balance at July 1, 2024
$ 3,758,487 $ 3,249,466 $ 815,778 $ 328,436 $ 108,617 $ 8,260,784
Beginning balance at original discount rates 3,823,510 3,605,315 799,316 322,706 107,143 8,657,990
Effect of changes in assumptions on future cash flows 10,680 ( 5,054 ) ( 2,775 ) 20,293 7,733 30,877
Effect of actual variances from expected experience 21,522 ( 13,407 ) ( 4,998 ) ( 4,432 ) 817 ( 498 )
Adjusted balance at July 1, 2024
3,855,712 3,586,854 791,543 338,567 115,693 8,688,369
Issuances (1)
95,126 71,345 14,177 11,997 3,811 196,456
Interest accrual (2)
45,365 37,299 10,653 4,189 1,460 98,966
Benefit payments (3)
( 88,423 ) ( 35,642 ) ( 23,417 ) ( 6,502 ) ( 3,378 ) ( 157,362 )
Effect of changes in the foreign exchange rate 910 910
Ending balance at original discount rates 3,907,780 3,659,856 792,956 349,161 117,586 8,827,339
Effect of change from original to current discount rates 131,531 ( 144,821 ) 52,819 24,383 6,871 70,783
Balance at September 30, 2024
$ 4,039,311 $ 3,515,035 $ 845,775 $ 373,544 $ 124,457 $ 8,898,122
(1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the based on the revised expected assumptions.

32
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health (2)
Net liability for future policy benefits as of September 30, 2023
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
$ 123,861 $ 1,692,001 $ 471,745 $ 112,520 $ ( 4,909 ) $ 2,395,218
Effect of changes in discount rate assumptions ( 7,433 ) ( 305,331 ) 3,580 4,375 143 ( 304,666 )
Other adjustments (1)
7,729 4,347 8,379 993 5,530 26,978
Net liability for future policy benefits, after other adjustments, at current discount rates
124,157 1,391,017 483,704 117,888 764 2,117,530
Reinsurance recoverable
( 3,355 ) ( 9,064 ) ( 1,336 ) ( 13,755 )
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 120,802 $ 1,381,953 $ 482,368 $ 117,888 $ 764 $ 2,103,775
(1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).
(2) Includes the immaterial error correction noted below.
Health
Net liability for future policy benefits as of September 30, 2024
United American Family Heritage Liberty National American Income Direct to Consumer Total
Net liability for future policy benefits at original discount rates
95,754 1,813,941 457,378 123,545 ( 3,133 ) 2,487,485
Effect of changes in discount rate assumptions 1,313 ( 100,449 ) 41,290 16,210 ( 282 ) ( 41,918 )
Other adjustments (1)
17,014 38 9,964 926 4,326 32,268
Net liability for future policy benefits, after other adjustments, at current discount rates
114,081 1,713,530 508,632 140,681 911 2,477,835
Reinsurance recoverable
( 2,868 ) ( 11,613 ) ( 1,096 ) ( 15,577 )
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$ 111,213 $ 1,701,917 $ 507,536 $ 140,681 $ 911 $ 2,462,258
(1) Other adjustments include the effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).

Immaterial Correction of Previously Issued Financial Statements —The Company previously presented reinsurance recoverable on a net basis as a component of future policy benefits. In the fourth quarter of 2023, the Company corrected its presentation of reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 55 million of reinsurance recoverable at current discount rates from liabilities to assets ($ 50 million at original discount rates) as of September 30, 2023, with no change to equity, and the related tables in the footnote have been adjusted to reflect such changes.

Remeasurement Gain or Loss In accordance with the accounting guidance, the Company reviews, and updates as necessary, its assumptions utilized in the calculation of the liability for future benefits annually in the third quarter and recalculates the net premium ratio. The revised net premium ratio is used to update the liability for future policy benefits as of the beginning of the current reporting period, and is compared to the liability using the prior cash flow assumptions. The difference is recorded as a component of the remeasurement gain or loss for the current period, along with the effect of the difference between actual and expected experience for the period. The total remeasurement gain or loss is included in the Condensed Consolidated Statements of Operations .

33
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables include the total remeasurement gain or loss, bifurcated between the gain or loss due to differences between actual and expected experience and the amount due to assumption updates, for the three and nine month periods ended September 30, 2024 and 2023:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Life Remeasurement Gain (Loss)—Experience:
American Income $ 4,771 $ 2,388 $ 12,619 $ 5,276
Direct to Consumer 6,913 6,293 13,640 7,594
Liberty National 1,537 2,578 2,187 2,115
Other 508 2,082 2,533 3,487
Total Life Remeasurement Gain (Loss)—Experience
13,729 13,341 30,979 18,472
Life Remeasurement Gain (Loss)—Assumption Updates:
American Income 21,974 308 21,974 308
Direct to Consumer 21,744 1,763 21,744 1,763
Liberty National 12,224 ( 1,248 ) 12,224 ( 1,248 )
Other 904 ( 2,836 ) 904 ( 2,836 )
Total Life Remeasurement Gain (Loss)—Assumption Updates
56,846 ( 2,013 ) 56,846 ( 2,013 )
Total Life Remeasurement Gain (Loss)
70,575 11,328 87,825 16,459
Health Remeasurement Gain (Loss)—Experience:
United American ( 2,100 ) 239 ( 1,423 ) ( 651 )
Family Heritage 1,420 1,212 4,972 3,009
Liberty National 874 634 2,015 ( 284 )
American Income 729 457 1,769 1,025
Direct to Consumer 28 35 74 10
Total Health Remeasurement Gain (Loss)—Experience
951 2,577 7,407 3,109
Health Remeasurement Gain (Loss)—Assumption Updates:
United American 1,205 762 1,205 762
Family Heritage ( 3,063 ) 2,173 ( 3,063 ) 2,173
Liberty National ( 234 ) 2,171 ( 234 ) 2,171
American Income ( 8,036 ) 119 ( 8,036 ) 119
Direct to Consumer ( 373 ) 8 ( 373 ) 8
Health Remeasurement Gain (Loss)—Assumption Updates
( 10,501 ) 5,233 ( 10,501 ) 5,233
Total Health Remeasurement Gain (Loss)
$ ( 9,550 ) $ 7,810 $ ( 3,094 ) $ 8,342

The Company performs an annual review of its assumptions during the third quarter. This review process resulted in favorable changes to its mortality and lapse assumptions on life and unfavorable changes to morbidity assumptions on health. Generally, in our life segment mortality assumptions were decreased across most channels in line with recent experience consistent with decreasing levels of excess deaths. Also, for the life segment lapse rate assumptions were slightly increased across all channels. For the health segment, morbidity assumptions were increased, causing higher future policy benefit reserves. The assumption review process of the life and health segments resulted in a $ 46.3 million net remeasurement gain as compared to a $ 3.2 million net remeasurement gain in the year-ago quarter.

Excluding the impact of assumption changes, the Company's results for actual variances from expected experience for both life and health produced a $ 14.7 million net remeasurement gain and a $ 15.9 million net remeasurement gain for the three months ended September 30, 2024 and 2023, respectively. During the nine months ended September 30, 2024 and 2023, the Company's results for actual variances from expected experience for both life and health produced a $ 38.4 million net remeasurement gain and a $ 21.6 million net remeasurement gain, respectively.
34
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

The following table reconciles the liability for future policy benefits to the Condensed Consolidated Balance Sheets as of September 30, 2024 and 2023:

At Original Discount Rates At Current Discount Rates
As of September 30, As of September 30,
2024
2023 (2)
2024
2023 (2)
Life (1) :
American Income $ 4,781,464 $ 4,436,042 $ 5,667,941 $ 4,672,240
Direct to Consumer 3,106,582 2,943,544 3,767,409 3,207,251
Liberty National 2,277,415 2,244,035 2,498,275 2,222,775
Other 3,128,419 3,037,595 3,810,659 3,321,581
Net liability for future policy benefits—long duration life 13,293,880 12,661,216 15,744,284 13,423,847
Health (1) :
United American 110,384 129,410 114,081 124,157
Family Heritage 1,813,971 1,692,080 1,713,530 1,391,017
Liberty National 466,474 479,394 508,632 483,704
American Income 124,534 113,340 140,681 117,888
Direct to Consumer 877 752 911 764
Net liability for future policy benefits—long duration health 2,516,240 2,414,976 2,477,835 2,117,530
Deferred profit liability 177,108 173,520 177,108 173,520
Deferred annuity 680,849 813,276 680,849 813,276
Interest sensitive life 725,857 735,025 725,857 735,025
Other 8,983 9,901 8,980 9,904
Total future policy benefits
$ 17,402,917 $ 16,807,914 $ 19,814,913 $ 17,273,102
(1) Balances are presented net of the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).
(2) Includes the immaterial error correction for reinsurance as noted above.


35
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities as of September 30, 2024 and 2023:
As of September 30,
2024 2023
Original discount rate Current discount rate Original discount rate Current discount rate
Life
American Income 5.7 % 5.0 % 5.7 % 5.6 %
Direct to Consumer 6.0 % 5.0 % 6.0 % 5.6 %
Liberty National 5.6 % 5.0 % 5.6 % 5.7 %
Other 6.2 % 5.0 % 6.2 % 5.7 %
Health
United American 5.1 % 4.8 % 5.2 % 5.5 %
Family Heritage 4.2 % 4.9 % 4.3 % 5.7 %
Liberty National 5.8 % 4.8 % 5.8 % 5.7 %
American Income 5.8 % 4.8 % 5.9 % 5.6 %
Direct to Consumer 5.1 % 4.8 % 5.2 % 5.5 %

The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities as of September 30, 2024 and 2023:
As of September 30,
2024 2023
At original discount rates At current discount rates At original discount rates At current discount rates
Life
American Income 22.81 23.03 23.08 23.29
Direct to Consumer 19.42 20.81 19.73 21.00
Liberty National 15.31 15.80 15.12 15.20
Other 16.07 17.48 16.34 17.42
Health
United American 11.73 10.93 11.40 10.34
Family Heritage 15.34 14.60 14.90 13.81
Liberty National 9.26 9.48 9.11 8.97
American Income 12.50 12.89 12.14 12.20
Direct to Consumer 11.73 10.93 11.40 10.34
36
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize the amount of gross premiums and interest related to long duration life and health contracts that are recognized in the Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2024 and 2023:
Life
Nine Months Ended
September 30, 2024
Nine Months Ended
September 30, 2023
Gross
Premiums
Interest
expense
Gross
Premiums
Interest
expense
American Income $ 1,264,474 $ 202,486 $ 1,181,247 $ 187,381
Direct to Consumer 734,860 135,249 735,374 127,040
Liberty National 273,746 91,890 256,641 89,765
Other 152,065 138,724 154,836 133,991
Total $ 2,425,145 $ 568,349 $ 2,328,098 $ 538,177
Life
Three Months Ended
September 30, 2024
Three Months Ended
September 30, 2023
Gross
Premiums
Interest
expense
Gross
Premiums
Interest
expense
American Income $ 427,543 $ 68,558 $ 399,794 $ 63,565
Direct to Consumer 243,625 45,708 244,931 42,978
Liberty National 92,636 30,737 87,071 30,095
Other 50,413 46,573 51,493 45,065
Total $ 814,217 $ 191,576 $ 783,289 $ 181,703
Health
Nine Months Ended
September 30, 2024
Nine Months Ended
September 30, 2023
Gross
Premiums
Interest
expense
Gross
Premiums
Interest
expense
United American $ 325,415 $ 4,449 $ 298,964 $ 5,345
Family Heritage 317,065 53,357 294,047 48,904
Liberty National 142,051 19,679 139,875 20,567
American Income 88,017 5,010 84,863 4,896
Direct to Consumer 11,196 10,680
Total $ 883,744 $ 82,495 $ 828,429 $ 79,712
Health
Three Months Ended
September 30, 2024
Three Months Ended
September 30, 2023
Gross
Premiums
Interest
expense
Gross
Premiums
Interest
expense
United American $ 110,565 $ 1,408 $ 100,285 $ 1,741
Family Heritage 107,819 18,150 99,828 16,632
Liberty National 47,099 6,524 46,441 6,766
American Income 29,628 1,696 28,528 1,640
Direct to Consumer 3,806 3,583
Total $ 298,917 $ 27,778 $ 278,665 $ 26,779
Gross premiums are included within life and health premium on the Condensed Consolidated Statements of Operations , while the related interest expense is included in life and health policyholder benefits.
37
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums, and expected future policy benefits, at both original and current discount rates, for life and health contracts as of September 30, 2024 and 2023:
Life
As of September 30, 2024 As of September 30, 2023
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
American Income
PV of expected future gross premiums $ 25,300,910 $ 14,305,914 $ 15,028,140 $ 23,974,963 $ 13,530,015 $ 13,147,003
PV of expected future net premiums 8,185,825 4,632,427 4,836,994 7,912,903 4,473,959 4,318,705
PV of expected future policy benefits 31,554,905 9,413,743 10,504,785 30,182,319 8,909,960 8,990,437
DTC
PV of expected future gross premiums $ 17,506,090 $ 9,144,676 $ 9,825,694 $ 17,575,618 $ 9,182,146 $ 9,112,202
PV of expected future net premiums 10,614,237 5,572,725 5,994,613 10,850,664 5,701,293 5,670,175
PV of expected future policy benefits 25,907,169 8,679,305 9,762,022 25,711,499 8,644,837 8,873,444
Liberty National
PV of expected future gross premiums $ 4,797,146 $ 2,792,129 $ 2,886,943 $ 4,601,176 $ 2,681,034 $ 2,577,877
PV of expected future net premiums 1,855,536 1,049,598 1,104,096 1,901,039 1,077,931 1,059,229
PV of expected future policy benefits 9,028,196 3,327,013 3,602,371 8,852,345 3,321,966 3,275,732
Other
PV of expected future gross premiums $ 3,657,885 $ 1,857,769 $ 2,063,274 $ 3,753,093 $ 1,901,531 $ 1,953,533
PV of expected future net premiums 894,843 435,054 470,567 919,200 448,031 446,532
PV of expected future policy benefits 12,471,336 3,563,438 4,281,189 12,427,646 3,485,529 3,767,647
Total
PV of expected future gross premiums $ 51,262,031 $ 28,100,488 $ 29,804,051 $ 49,904,850 $ 27,294,726 $ 26,790,615
PV of expected future net premiums 21,550,441 11,689,804 12,406,270 21,583,806 11,701,214 11,494,641
PV of expected future policy benefits 78,961,606 24,983,499 28,150,367 77,173,809 24,362,292 24,907,260

As of September 30, 2024, for the life segment using current discount rates, the Company anticipates $ 29.8 billion of expected future gross premiums and $ 12.4 billion of expected future net premiums. As of September 30, 2023, using current discount rates, the Company anticipated $ 26.8 billion of expected future gross premiums and $ 11.5 billion in expected future net premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums of $ 17.4 billion and $ 15.3 billion for September 30, 2024 and 2023, respectively, is not.

38
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
As of September 30, 2024 As of September 30, 2023
Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates
United American
PV of expected future gross premiums $ 9,068,701 $ 5,556,347 $ 5,742,668 $ 8,442,713 $ 5,141,771 $ 4,871,878
PV of expected future net premiums 6,229,763 3,812,026 3,942,244 5,799,017 3,524,988 3,341,380
PV of expected future policy benefits 6,390,307 3,907,780 4,039,311 5,998,770 3,648,849 3,457,808
Family Heritage
PV of expected future gross premiums $ 7,107,124 $ 4,155,037 $ 4,074,915 $ 6,637,472 $ 3,932,327 $ 3,523,258
PV of expected future net premiums 3,139,624 1,845,915 1,801,543 2,962,973 1,767,555 1,574,574
PV of expected future policy benefits 7,043,880 3,659,856 3,515,035 6,549,339 3,459,556 2,961,244
Liberty National
PV of expected future gross premiums $ 2,037,319 $ 1,297,318 $ 1,370,521 $ 2,084,428 $ 1,321,438 $ 1,308,898
PV of expected future net premiums 495,616 335,578 347,107 515,612 347,050 338,678
PV of expected future policy benefits 1,375,759 792,956 845,775 1,414,512 818,795 814,003
American Income
PV of expected future gross premiums $ 1,781,677 $ 999,161 $ 1,063,740 $ 1,755,682 $ 984,122 $ 969,090
PV of expected future net premiums 400,683 225,616 233,789 354,120 199,122 189,146
PV of expected future policy benefits 710,352 349,161 373,544 632,349 311,642 306,041
Direct to Consumer
PV of expected future gross premiums $ 232,805 $ 147,193 $ 156,142 $ 224,522 $ 141,374 $ 139,748
PV of expected future net premiums 191,566 120,719 127,872 166,099 104,420 103,166
PV of expected future policy benefits 187,260 117,586 124,457 154,931 99,511 98,400
Total
PV of expected future gross premiums $ 20,227,626 $ 12,155,056 $ 12,407,986 $ 19,144,817 $ 11,521,032 $ 10,812,872
PV of expected future net premiums 10,457,252 6,339,854 6,452,555 9,797,821 5,943,135 5,546,944
PV of expected future policy benefits 15,707,558 8,827,339 8,898,122 14,749,901 8,338,353 7,637,496

As of September 30, 2024, for the health segment using current discount rates, the Company anticipates $ 12.4 billion of expected future gross premiums and $ 6.5 billion of expected future net premiums. As of September 30, 2023, using current discount rates, the Company anticipated $ 10.8 billion of expected future gross premiums and $ 5.5 billion in expected future net premiums. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums of $ 5.9 billion and $ 5.3 billion for September 30, 2024 and 2023, respectively, is not.


39
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table summarizes the balances of, and changes in, policyholders’ account balances as of September 30, 2024 and 2023:
Policyholders' Account Balances
2024 2023
Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds
Balance at January 1,
$ 732,948 $ 773,039 $ 236,958 $ 739,105 $ 954,318 $ 123,234
Issuances 495 602
Premiums received 16,187 8,857 239,114 17,062 10,543 100,113
Policy charges ( 9,253 ) ( 9,729 )
Surrenders and withdrawals ( 17,326 ) ( 84,893 ) ( 10,615 ) ( 16,204 ) ( 125,176 ) ( 9,106 )
Benefit payments ( 23,357 ) ( 34,159 ) ( 22,753 ) ( 48,459 )
Interest credited 20,890 17,990 15,210 21,274 21,608 6,164
Other 5,768 ( 480 ) ( 11,379 ) 6,270 ( 161 ) ( 2,195 )
Balance at September 30,
$ 725,857 $ 680,849 $ 469,288 $ 735,025 $ 813,275 $ 218,210

Policyholders' Account Balances
2024 2023
Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds
Balance at July 1,
$ 728,097 $ 706,022 $ 400,625 $ 736,920 $ 853,064 $ 187,873
Issuances 137 231
Premiums received 5,077 2,448 70,644 5,398 2,439 31,704
Policy charges ( 3,081 ) ( 3,213 )
Surrenders and withdrawals ( 5,850 ) ( 22,331 ) ( 3,264 ) ( 5,582 ) ( 37,905 ) ( 2,782 )
Benefit payments ( 6,617 ) ( 10,022 ) ( 7,258 ) ( 11,047 )
Interest credited 6,922 5,777 6,106 7,083 6,863 2,825
Other 1,309 ( 1,182 ) ( 4,823 ) 1,677 ( 370 ) ( 1,410 )
Balance at September 30,
$ 725,857 $ 680,849 $ 469,288 $ 735,025 $ 813,275 $ 218,210

Weighted-average credit rate 3.86 % 3.37 % 5.73 % 3.91 % 3.34 % 5.68 %
Net amount at risk $ 1,687,182 N/A N/A $ 1,793,787 N/A N/A
Cash surrender value $ 678,556 $ 680,849 $ 469,288 $ 673,814 $ 813,276 $ 218,210

The following tables present the policyholders' account balances by range of guaranteed minimum crediting rates and the related range of difference, if any, in basis points between rates being credited to policy holders and the respective guaranteed minimums as of September 30, 2024 and 2023:
40
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At September 30, 2024
Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds
At guaranteed minimum
Less than 3.00 %
$ $ 1,866 $ 373,729
3.00 %- 3.99 %
29,170 494,585 3,046
4.00 %- 4.99 %
606,425 184,398 6,548
Greater than 5.00 %
90,262 36,541
Total
725,857 680,849 419,864
1 - 50 basis points above
Less than 3.00 %
3.00 %- 3.99 %
4.00 %- 4.99 %
1,678
Greater than 5.00 %
Total
1,678
51 - 150 basis points above
Less than 3.00 %
3.00 %- 3.99 %
4.00 %- 4.99 %
47,746
Greater than 5.00 %
Total
47,746
Grand Total
$ 725,857 $ 680,849 $ 469,288


41
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At September 30, 2023
Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds
At guaranteed minimum
Less than 3.00 %
$ $ 2,011 $ 118,565
3.00 %- 3.99 %
29,018 610,785 4,002
4.00 %- 4.99 %
615,835 199,724 6,851
Greater than 5.00 %
90,172 755 38,788
Total
735,025 813,275 168,206
1 - 50 basis points above
Less than 3.00 %
3.00 %- 3.99 %
4.00 %- 4.99 %
Greater than 5.00 %
Total
51 - 150 basis points above
Less than 3.00 %
3.00 %- 3.99 %
4.00 %- 4.99 %
50,004
Greater than 5.00 %
Total
50,004
Grand Total
$ 735,025 $ 813,275 $ 218,210

42
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 7—Deferred Acquisition Costs

The following tables roll forward the deferred policy acquisition costs for the three and nine month periods ended September 30, 2024 and 2023:
Life
American Income DTC Liberty National Other Total
Balance at January 1, 2023
$ 2,258,291 $ 1,676,931 $ 610,723 $ 298,346 $ 4,844,291
Capitalizations 351,933 123,774 78,599 9,970 564,276
Amortization expense ( 118,207 ) ( 74,496 ) ( 38,192 ) ( 12,390 ) ( 243,285 )
Foreign exchange adjustment ( 1,297 ) ( 1,297 )
Balance at September 30, 2023
$ 2,490,720 $ 1,726,209 $ 651,130 $ 295,926 $ 5,163,985
Balance at January 1, 2024
$ 2,573,370 $ 1,737,117 $ 666,419 $ 294,869 $ 5,271,775
Capitalizations 391,707 112,198 88,355 9,304 601,564
Amortization expense ( 133,410 ) ( 75,898 ) ( 42,041 ) ( 12,404 ) ( 263,753 )
Foreign exchange adjustment ( 1,857 ) ( 1,857 )
Balance at September 30, 2024
$ 2,829,810 $ 1,773,417 $ 712,733 $ 291,769 $ 5,607,729

Life
American Income DTC Liberty National Other Total
Balance at July 1, 2023
$ 2,417,480 $ 1,714,715 $ 636,209 $ 296,861 $ 5,065,265
Capitalizations 117,761 36,385 27,950 3,203 185,299
Amortization expense ( 40,465 ) ( 24,891 ) ( 13,029 ) ( 4,138 ) ( 82,523 )
Foreign exchange adjustment ( 4,056 ) ( 4,056 )
Balance at September 30, 2023
$ 2,490,720 $ 1,726,209 $ 651,130 $ 295,926 $ 5,163,985
Balance at July 1, 2024
$ 2,740,138 $ 1,765,673 $ 696,905 $ 292,877 $ 5,495,593
Capitalizations 131,851 33,222 30,255 3,024 198,352
Amortization expense ( 46,033 ) ( 25,478 ) ( 14,427 ) ( 4,132 ) ( 90,070 )
Foreign exchange adjustment 3,854 3,854
Balance at September 30, 2024
$ 2,829,810 $ 1,773,417 $ 712,733 $ 291,769 $ 5,607,729

43
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
United American Family Heritage Liberty National American Income DTC Total
Balance at January 1, 2023
$ 77,394 $ 416,608 $ 133,096 $ 57,811 $ 1,854 $ 686,763
Capitalizations 1,491 46,977 14,854 9,579 72,901
Amortization expense ( 4,504 ) ( 20,071 ) ( 9,977 ) ( 2,919 ) ( 137 ) ( 37,608 )
Foreign exchange adjustment ( 125 ) ( 125 )
Balance at September 30, 2023
$ 74,381 $ 443,514 $ 137,973 $ 64,346 $ 1,717 $ 721,931
Balance at January 1, 2024
$ 73,489 $ 452,843 $ 139,941 $ 66,783 $ 1,679 $ 734,735
Capitalizations 2,069 52,055 18,033 11,097 2 83,256
Amortization expense ( 4,197 ) ( 22,038 ) ( 11,003 ) ( 3,426 ) ( 110 ) ( 40,774 )
Foreign exchange adjustment ( 55 ) ( 55 )
Balance at September 30, 2024
$ 71,361 $ 482,860 $ 146,971 $ 74,399 $ 1,571 $ 777,162

Health
United American Family Heritage Liberty National American Income DTC Total
Balance at July 1, 2023
$ 75,349 $ 433,999 $ 136,276 $ 62,285 $ 1,760 $ 709,669
Capitalizations 495 16,386 5,120 3,259 25,260
Amortization expense ( 1,463 ) ( 6,871 ) ( 3,423 ) ( 1,016 ) ( 43 ) ( 12,816 )
Foreign exchange adjustment ( 182 ) ( 182 )
Balance at September 30, 2023
$ 74,381 $ 443,514 $ 137,973 $ 64,346 $ 1,717 $ 721,931
Balance at July 1, 2024
$ 71,975 $ 472,254 $ 145,097 $ 71,589 $ 1,608 $ 762,523
Capitalizations 780 18,123 5,589 3,817 28,309
Amortization expense ( 1,394 ) ( 7,517 ) ( 3,715 ) ( 1,189 ) ( 37 ) ( 13,852 )
Foreign exchange adjustment 182 182
Balance at September 30, 2024
$ 71,361 $ 482,860 $ 146,971 $ 74,399 $ 1,571 $ 777,162
44
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents a reconciliation of deferred policy acquisition costs to the Condensed Consolidated Balance Sheets as of September 30, 2024:
September 30,
2024 2023
Life
American Income $ 2,829,810 $ 2,490,720
Direct to Consumer 1,773,417 1,726,209
Liberty National 712,733 651,130
Other 291,769 295,926
Total DAC—Life
5,607,729 5,163,985
Health
United American 71,361 74,381
Family Heritage 482,860 443,514
Liberty National 146,971 137,973
American Income 74,399 64,346
Direct to Consumer 1,571 1,717
Total DAC—Health
777,162 721,931
Annuity
1,791 3,377
Tota l
$ 6,386,682 $ 5,889,293
45
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 8—Liability for Unpaid Claims

Activity in the liability for unpaid health claims is summarized as follows:
September 30,
2024
December 31,
2023
Balance at beginning of period
$ 194,809 $ 184,286
Less reinsurance recoverables
( 2,157 ) ( 2,084 )
Net balance at beginning of period
192,652 182,202
Incurred related to:
Current year 560,548 697,521
Prior years ( 7,914 ) ( 4,853 )
Total incurred 552,634 692,668
Paid related to:
Current year 399,412 535,971
Prior years 142,020 146,247
Total paid 541,432 682,218
Net balance at end of period
203,854 192,652
Plus reinsurance recoverables
1,623 2,157
Balance at end of period
$ 205,477 $ 194,809

Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Condensed Consolidated Balance Sheets .
September 30,
2024
December 31,
2023
Policy claims and other benefits payable:
Life insurance $ 324,922 $ 320,066
Health insurance 205,477 194,809
Total $ 530,399 $ 514,875

46
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 9—Postretirement Benefits

Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP.

Pension Assets: The following table presents the assets of the Company's Pension Plans at September 30, 2024 and December 31, 2023.

Pension Assets by Component at September 30, 2024

Fair Value Determined by:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
% of
Total
Exchange traded fund (4)
$ 38,544 $ $ $ 38,544 6
Equity exchange traded fund (1)
318,809 318,809 49
U.S. Government and Agency 204,990 204,990 32
Other bonds 4 4
Guaranteed annuity contract (2)
43,881 43,881 7
Short-term investments 5,122 5,122 1
Other 1,858 1,858
$ 364,333 $ 248,875 $ 613,208 95
Other long-term investments (3)
30,356 5
Total pension assets
$ 643,564 100
(1) A fund including marketable securities that mirror the S&P 500 index.
(2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of September 30, 2024, the Globe Life Inc. Pension Plan owned less than 1 % of two long-term investment funds.
(4) A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.

47
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Assets by Component at December 31, 2023
Fair Value Determined by:

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
% of
Total
Exchange traded fund (4)
$ 18,715 $ $ $ 18,715 3
Equity exchange traded fund (1)
315,886 315,886 55
U.S. Government and Agency 167,450 167,450 30
Other bonds 5 5
Guaranteed annuity contract (2)
43,428 43,428 8
Short-term investments 6,506 6,506 1
Other 463 463
$ 341,570 $ 210,883 $ 552,453 97
Other long-term investments (3)
18,314 3
Total pension assets
$ 570,767 100
(1) A fund including marketable securities that mirror the S&P 500 index.
(2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2023, the Globe Life Inc. Pension Plan owned less than 1 % of two long-term investment funds.
(4) A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.

SERP : The following tables include premiums paid for COLI at September 30, 2024 and 2023 and investments of the Rabbi Trust at September 30, 2024 and December 31, 2023.
Nine Months Ended
September 30,
2024 2023
Premiums paid for insurance coverage $ 443 $ 443
September 30,
2024
December 31,
2023
Total investments:
COLI
$ 56,757 $ 55,185
Exchange traded funds 97,132 86,156
$ 153,889 $ 141,341

Pension Plans and SERP Liabilities : The following table presents liabilities for the defined benefit pension plans and SERP at September 30, 2024 and December 31, 2023.
September 30,
2024
December 31,
2023
Pension Plans $ 615,595 $ 554,957
SERP 72,654 72,603
Benefit obligation
$ 688,249 $ 627,560

48
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Net Periodic Benefit Cost: The following table presents the net periodic benefit costs for the defined benefit pension plans and SERP by expense components for the three and nine month periods ended September 30, 2024 and 2023.
Components of Net Periodic Benefit Cost
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Service cost—benefits earned during the period $ 6,224 $ 5,392 $ 18,673 $ 16,174
Interest cost on projected benefit obligation 8,287 7,834 24,862 23,502
Expected return on assets ( 10,645 ) ( 9,656 ) ( 31,938 ) ( 28,968 )
Amortization:
Prior service cost 265 269 803 807
Actuarial (gain) loss 6 ( 48 ) 18 ( 152 )
Net periodic benefit cost
$ 4,137 $ 3,791 $ 12,418 $ 11,363


Note 10—Earnings Per Share

Earnings per Share : A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Basic weighted average shares outstanding 87,874,488 94,636,867 91,048,853 95,445,416
Weighted average dilutive options outstanding 212,553 1,180,770 273,666 1,211,974
Diluted weighted average shares outstanding 88,087,041 95,817,637 91,322,519 96,657,390
Antidilutive shares 4,234,326 492,970 3,090,848 399,071

Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out of the money employee and Director stock options.
49
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 11—Debt

On August 23, 2024, Globe Life completed the issuance of $ 450 million principal amount of 5.85 % Senior notes due September 15, 2034. Total proceeds received by the Parent from the issuance, net of the underwriters’ discount, were $ 445 million. The proceeds were used for general corporate purposes, which included open market purchases of shares of its common stock under its share repurchase program. On August 15, 2024, Globe Life amended its term loan agreement increasing the principal amount from $ 170 million to $ 250 million, an increase of $ 80 million. The amendment extends the maturity date from November 11, 2024 to August 15, 2027.

The following table presents information about the terms and outstanding balances of Globe Life's debt.
Selected Information about Debt Issues
As of
September 30,
2024
December 31,
2023
Instrument Issue Date Maturity Date Coupon Rate Par
Value
Unamortized Discount & Issuance Costs Book
Value
Fair
Value
Book
Value
Senior notes 09/27/2018 09/15/2028 4.550 % $ 550,000 $ ( 3,180 ) $ 546,820 $ 550,088 $ 546,283
Senior notes 08/21/2020 08/15/2030 2.150 % 400,000 ( 2,983 ) 397,017 344,796 396,670
Senior notes (1)
05/19/2022 06/15/2032 4.800 % 250,000 ( 3,828 ) 246,172 248,443 245,873
Senior notes
08/23/2024 09/15/2034 5.850 % 450,000 ( 5,188 ) 444,812 464,881
Junior subordinated debentures 11/17/2017 11/17/2057 5.275 % 125,000 ( 1,561 ) 123,439 109,657 123,427
Junior subordinated debentures 06/14/2021 06/15/2061 4.250 % 325,000 ( 7,633 ) 317,367 236,730 317,306
Term loan (2)
05/11/2023 08/15/2027 6.593 % 250,000 ( 1,951 ) 248,049 248,049
Total long-term debt
2,350,000 ( 26,324 ) 2,323,676 2,202,644 1,629,559
Term loan (2)
169,549
FHLB borrowings 17,000 17,000 17,000
Commercial paper 426,908 ( 6,490 ) 420,418 420,418 316,564
Total short-term debt
443,908 ( 6,490 ) 437,418 437,418 486,113
Total debt
$ 2,793,908 $ ( 32,814 ) $ 2,761,094 $ 2,640,062 $ 2,115,672
(1) An additional $ 150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2) Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points.

The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25 % junior subordinated debentures and the term loan are payable quarterly while all other long-term debt is payable semi-annually.

Credit facility : On March 29, 2024, Globe Life amended the credit agreement dated September 30, 2021, which provides for a $ 1 billion revolving credit facility that may be increased to $ 1.25 billion. The amended credit facility matures March 29, 2029 and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date.
50
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $ 1 billion, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization. As of September 30, 2024, the Company was in full compliance with these covenants.

The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper

As of
September 30,
2024
December 31, 2023 September 30,
2023
Balance of commercial paper at end of period (par value) $ 426,908 $ 319,000 $ 251,000
Annualized interest rate 5.56 % 5.71 % 5.65 %
Letters of credit outstanding $ 115,000 $ 115,000 $ 115,000
Remaining amount available under credit line 458,092 316,000 384,000



Credit Facility—Commercial Paper Activity

Nine Months Ended September 30,
2024 2023
Average balance of commercial paper outstanding during period (par value) $ 375,851 $ 296,816
Daily-weighted average interest rate (annualized) 5.80 % 5.33 %
Maximum daily amount outstanding during period (par value) $ 633,425 $ 477,700
Commercial paper issued during period (par value)
1,482,556 1,480,000
Commercial paper matured during period (par value) ( 1,374,648 ) ( 1,514,000 )
Net commercial paper issued (matured) during period (par value)
107,908 ( 34,000 )

Federal Home Loan Bank : FHLB membership provides certain of our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1 % of outstanding borrowings.

Globe Life owned $ 32.4 million in FHLB common stock as of September 30, 2024 and $ 22.3 million as of December 31, 2023. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments " in the Condensed Consolidated Balance Sheets. Borrowings with the FHLB are subject to the availability of pledged assets at the insurance subsidiaries of Globe Life. As of September 30, 2024, Globe Life's insurance subsidiaries maximum borrowing capacity under the FHLB facility was approximately $ 781 million, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.4 billion. As of September 30, 2024, $ 372 million in funding agreements were outstanding with the FHLB, compared to $ 138 million as of December 31, 2023. This amount is included in "Other policyholders' funds" in the Condensed Consolidated Balance Sheets . In addition, the Company had $ 17 million in short-term borrowings from the FHLB as of September 30, 2024, compared to $ 0 as of December 31, 2023, this amount is recorded in "Short-term debt".


51
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 12—Business Segments

Globe Life is organized into four segments: life insurance, supplemental health insurance, annuities, and investments. In addition, other expenses not included in these segments are reported in "Corporate & Other."

Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance, supplemental health insurance, and annuities. These major product lines are set out as reportable segments because of the common characteristics of products within these categories, comparability of margins, and the similarity in regulatory environment and management techniques. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments and the corporate function. The Company's chief operating decision makers evaluate the overall performance of the operations of the Company in accordance with these segments.

Life insurance products marketed by Globe Life include traditional whole life and term life insurance. Health insurance products are generally guaranteed renewable and include Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. Annuities include fixed-benefit contracts.

The following tables present segment premium revenue by each of Globe Life's distribution channels.


Premium Income by Distribution Channel
Three Months Ended September 30, 2024
Life Health Annuity Total
Distribution Channel Amount % of
Total
Amount % of
Total
Amount % of
Total
Amount % of
Total
American Income $ 427,839 52 $ 31,277 9 $ $ 459,116 39
Direct to Consumer 246,425 30 18,072 5 264,497 23
Liberty National 93,625 12 47,277 13 140,902 12
United American 1,608 149,510 42 151,118 13
Family Heritage 1,684 107,819 31 109,503 9
Other 47,457 6 47,457 4
$ 818,638 100 $ 353,955 100 $ $ 1,172,593 100

Three Months Ended September 30, 2023
Life Health Annuity Total
Distribution Channel Amount
% of
Total
Amount
% of
Total
Amount
% of
Total
Amount
% of
Total
American Income $ 400,214 51 $ 30,535 9 $ $ 430,749 39
Direct to Consumer 247,858 32 17,153 5 265,011 24
Liberty National 88,199 11 46,643 14 134,842 12
United American 1,802 137,077 42 138,879 12
Family Heritage 1,561 99,828 30 101,389 9
Other 48,465 6 48,465 4
$ 788,099 100 $ 331,236 100 $ $ 1,119,335 100


52
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Nine Months Ended September 30, 2024
Life Health Annuity Total
Distribution Channel Amount % of
Total
Amount % of
Total
Amount % of
Total
Amount % of
Total
American Income $ 1,265,417 52 $ 92,495 9 $ $ 1,357,912 39
Direct to Consumer 743,304 31 54,070 5 797,374 23
Liberty National 276,599 11 142,612 14 419,211 12
United American 5,009 440,375 42 445,384 13
Family Heritage 4,945 317,065 30 322,010 9
Other 143,111 6 143,111 4
$ 2,438,385 100 $ 1,046,617 100 $ $ 3,485,002 100
Nine Months Ended September 30, 2023
Life Health Annuity Total
Distribution Channel Amount
% of
Total
Amount
% of
Total
Amount
% of
Total
Amount
% of
Total
American Income $ 1,182,346 50 $ 89,656 9 $ $ 1,272,002 38
Direct to Consumer 744,132 32 51,576 5 795,708 24
Liberty National 260,036 11 140,518 14 400,554 12
United American 5,533 407,137 42 412,670 13
Family Heritage 4,554 294,029 30 298,583 9
Other 145,828 7 145,828 4
$ 2,342,429 100 $ 982,916 100 $ $ 3,325,345 100

Due to the nature of the life insurance industry, Globe Life has no individual or group that would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States.
The measure of profitability established by the chief operating decision makers for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance and annuity segments) in order to match this cost with the investment income earned on the assets supporting the policy liabilities.
The measure of profitability for the Investment segment is excess investment income, representing the income earned on the investment portfolio in excess of policy requirements. Other than the required interest on the insurance segments, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense and interest on debt, are also included in the “Corporate & Other” segment category.
Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative, and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which are reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses
53
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations.

Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business. All of these items are included in “Other operating expense” in the Condensed Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables.

The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
Three Months Ended September 30, 2024
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 818,638 $ 353,955 $ $ $ $ $ 1,172,593
Net investment income 284,964 284,964
Other income 42 42
Total revenue 818,638 353,955 284,964 42 1,457,599
Expenses:
Policy benefits 454,502 221,926 5,716 6,040 688,184
Required interest on reserves ( 203,875 ) ( 27,717 ) ( 7,829 ) 239,421
Amortization of acquisition costs 90,070 13,852 388 104,310
Commissions, premium taxes, and non-deferred acquisition costs 90,758 58,931 4 149,693
Insurance administrative expense (1)
88,465 730 (3) 89,195
Parent expense 3,210 3,236 (2,3) 6,446
Stock-based compensation expense 9,233 9,233
Interest expense 31,388 31,388
Total expenses 431,455 266,992 ( 1,721 ) 245,461 132,296 3,966 1,078,449
Subtotal 387,183 86,963 1,721 39,503 ( 132,254 ) ( 3,966 ) 379,150
Non-operating items 3,966 (2,3) 3,966
Measure of segment profitability (pretax)
$ 387,183 $ 86,963 $ 1,721 $ 39,503 $ ( 132,254 ) $ 383,116
Realized gains (losses) ( 2,192 )
Legal costs and proceedings ( 3,329 )
Non-operating expenses ( 637 )
$ 376,958
(1) Administrative expense is not allocated to insurance segments.
(2) Non-operating expenses.
(3) Legal costs and proceedings.





54
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Three Months Ended September 30, 2023
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 788,099 $ 331,236 $ $ $ $ $ 1,119,335
Net investment income 266,926 266,926
Other income 50 50
Total revenue 788,099 331,236 266,926 50 1,386,311
Expenses:
Policy obligations 515,676 193,790 6,854 2,724 719,044
Required interest on reserves ( 194,199 ) ( 26,732 ) ( 9,353 ) 230,284
Amortization of acquisition costs 82,523 12,816 418 95,757
Commissions, premium taxes, and non-deferred acquisition costs 84,011 54,662 4 138,677
Insurance administrative expense (1)
74,585 74,585
Parent expense 2,581 1,137 (2) 3,718
Stock-based compensation expense 7,567 7,567
Interest expense 25,955 25,955
Total expenses 488,011 234,536 ( 2,077 ) 233,008 110,688 1,137 1,065,303
Subtotal 300,088 96,700 2,077 33,918 ( 110,638 ) ( 1,137 ) 321,008
Non-operating items 1,137 (2) 1,137
Measure of segment profitability (pretax)
$ 300,088 $ 96,700 $ 2,077 $ 33,918 $ ( 110,638 ) $ 322,145
Realized gains (losses) ( 2,193 )
Non-operating expenses ( 1,137 )
$ 318,815
(1) Administrative expense is not allocated to insurance segments.
(2) Non-operating expenses.



55
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Nine Months Ended September 30, 2024
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 2,438,385 $ 1,046,617 $ $ $ $ $ 3,485,002
Net investment income 853,178 853,178
Other income 192 192
Total revenue 2,438,385 1,046,617 853,178 192 4,338,372
Expenses:
Policy obligations 1,493,165 629,676 17,786 15,044 2,155,671
Required interest on reserves ( 605,397 ) ( 82,300 ) ( 24,358 ) 712,055
Amortization of acquisition costs 263,753 40,774 1,176 305,703
Commissions, premium taxes, and non-deferred acquisition costs 270,347 177,246 12 447,605
Insurance administrative expense (1)
251,072 1,646 (3) 252,718
Parent expense 9,166 6,722 (2,3) 15,888
Stock-based compensation expense 28,590 28,590
Interest expense 91,413 91,413
Total expenses 1,421,868 765,396 ( 5,384 ) 727,099 380,241 8,368 3,297,588
Subtotal 1,016,517 281,221 5,384 126,079 ( 380,049 ) ( 8,368 ) 1,040,784
Non-operating items 8,368 (2,3) 8,368
Measure of segment profitability (pretax)
$ 1,016,517 $ 281,221 $ 5,384 $ 126,079 $ ( 380,049 ) $ 1,049,152
Realized gains (losses) ( 26,580 )
Legal costs and proceedings ( 5,764 )
Non-operating expenses ( 2,604 )
$ 1,014,204
(1) Administrative expense is not allocated to insurance segments.
(2) Non-operating expenses.
(3) Legal costs and proceedings.





56
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Nine Months Ended September 30, 2023
Life Health Annuity Investment Corporate & Other Adjustments Consolidated
Revenue:
Premium $ 2,342,429 $ 982,916 $ $ $ $ $ 3,325,345
Net investment income 785,275 785,275
Other income 185 185
Total revenue 2,342,429 982,916 785,275 185 4,110,805
Expenses:
Policy obligations 1,536,317 580,676 21,502 5,986 2,144,481
Required interest on reserves ( 575,801 ) ( 79,603 ) ( 29,327 ) 684,731
Amortization of acquisition costs 243,285 37,608 1,266 282,159
Commissions, premium taxes, and non-deferred acquisition costs 251,136 163,784 13 414,933
Insurance administrative expense (1)
223,951 223,951
Parent expense 8,254 1,137 (2) 9,391
Stock-based compensation expense 22,732 22,732
Interest expense 76,640 76,640
Total expenses 1,454,937 702,465 ( 6,546 ) 690,717 331,577 1,137 3,174,287
Subtotal 887,492 280,451 6,546 94,558 ( 331,392 ) ( 1,137 ) 936,518
Non-operating items 1,137 (2) 1,137
Measure of segment profitability (pretax)
$ 887,492 $ 280,451 $ 6,546 $ 94,558 $ ( 331,392 ) $ 937,655
Realized gains (losses) ( 78,963 )
Non-operating expenses ( 1,137 )
$ 857,555
(1) Administrative expense is not allocated to insurance segments.
(2) Non-operating expenses.




Note 13—Subsequent Events

In the fourth quarter of 2024, the Company entered into a coinsurance agreement to cede a majority of its annuity business to a third-party insurer. The annuity reserves ceded totaled approximately $ 460 million subject to final settlement. The pre-tax ceding commission under the agreement was approximately $ 50 million and will be recognized into income over the remaining life of the ceded contracts. Under the terms of the agreement, the reinsurer will be required to maintain assets in trust at 105 % of reserves. The Company's annuity business comprises less than 1% of revenue and is not core to the Company's business. We anticipate that we will adjust our segment reporting to reflect the remaining annuity business within the Corporate and Other category of our segment reporting.

57
GL Q3 2024 FORM 10-Q

CAUTIONARY STATEMENTS
We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.
Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control, including uncertainties related to the impact of the recent pandemic and associated direct and indirect effects on our business operations, financial results, and financial condition. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1. Economic and other conditions, including the continued impact of inflation, geopolitical events, and the recent pandemic on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;
2. Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3. Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
4. Interest rate changes that affect product sales, financing costs, and/or investment yields;
5. General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6. Changes in the competitiveness of the Company's products and pricing;
7. Litigation results or regulatory actions against the Company;
8. Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);
9. The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10. The customer response to new products and marketing initiatives;
11. Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12. Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13. The impact of reputational damage on the Company including the impact on the Company's ability to attract and retain agents;
14. The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity, level of claims, and demand for our products; and
15. Globe Life's ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission.
58
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.

"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.

Results of Operations

icons2.jpg
How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life, supplemental health, and annuities, and the investment segment that supports the product lines. Segments are aligned based on their common characteristics, comparability of the profit margins, and management techniques used to operate each segment.
icons.jpg
Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further segmented by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:

Premium revenue
(Policy obligations)
(Policy acquisition costs and commissions)
Underwriting margin

icons3.jpg
Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
Net investment income
(Required interest on policy liabilities)
Excess investment income


59
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
Current Highlights.
Net income as a return on equity (ROE) for the nine months ended September 30, 2024 was 22.4% and net operating income as an ROE, excluding accumulated other comprehensive income (1) was 15.3%.
Total premium increased 5% over the same period in the prior year. Life premium increased 4% for the period from $2.34 billion in 2023 to $2.44 billion in 2024.
Net investment income increased 9% over the same period in the prior year.
Total net sales increased 9% over the same period in the prior year from $568 million in 2023 to $622 million in 2024. The average producing agent count across all of the exclusive agencies increased 12% over the prior year.
Book value per share increased 13% over the same period in the prior year from $48.51 to $54.65. Book value per share, excluding accumulated other comprehensive income (1) , increased 13% over the prior year from $74.31 in 2023 to $83.92 in 2024.
The following graphs represent net income and net operating income for the nine month periods ended September 30, 2024 and 2023.
830 832
(1) As shown in the charts above, net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding accumulated other comprehensive income (AOCI), is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(2.48) billion and $(2.46) billion for the nine months ended September 30, 2024 and 2023, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(29.27) and $(25.80) for the nine months ended September 30, 2024 and 2023, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
60
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations. Net income increased 17% to $816 million during the nine months ended September 30, 2024, compared with $696 million in the same period in 2023. On a diluted per common share basis, net income per common share for the nine months ended September 30, 2024 increased 24% from $7.20 to $8.93.

Net operating income increased 11% to $843 million for the nine months ended September 30, 2024, compared with $759 million for the same period in 2023, due to a 33% increase in excess investment income as well as a 15% increase in life underwriting margin. On a diluted per common share basis, net operating income per common share for the nine months ended September 30, 2024 increased from $7.85 to $9.23, an 18% increase. Net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income was affected by certain non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.

Net operating income is primarily comprised of insurance underwriting margin plus excess investment income, offset by operating expenses. As previously noted, a component of insurance underwriting margin is policy obligations, which includes for each reporting period the change in the liability for future policy benefits (LFPB). The LFPB is determined each reporting period based on the net level premium method. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date, and expected future experience based on future cash-flow assumptions. See Note 6—Policy Liabilities for additional information. The policy liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience in the form of remeasurement gains and losses during the period. If actual mortality, morbidity, and lapse experience equals our expected assumptions used in the development of our liability for future policy benefits, there would be no impact to our financial results. Actual experience can have a material impact on financial results to the extent it significantly deviates from the expected assumptions which are used to develop our estimates of the liability for future policy benefits and amortization of the deferred acquisition cost asset (DAC). For example, deviations in actual versus expected lapses in the early policy years tend to have a larger impact on DAC amortization than LFPB change in reserves. Conversely, deviations in actual versus expected lapses in the later policy years typically have a larger impact on LFPB change in reserves than DAC amortization. This is due to the release of DAC and LFPB where DAC capitalization in earlier years is amortizing over time and the LFPB is increasing over time as the policy stays inforce. Disaggregated rollforwards of our present value of expected future net premiums and our expected future policy benefits are presented within Note 6—Policy Liabilities , which include disclosure of remeasurement gain (loss) for the effect of actual variances from expected experience and the changes in assumptions (mortality, morbidity, and lapses) on future cash flows.

During the third quarter of 2024, the Company performed its annual assumptions review and updated both its life and health assumptions of lapses, mortality, and morbidity resulting in a $46.3 million net remeasurement gain as compared to a $3.2 million net remeasurement gain in the year-ago quarter.

Excluding the impact of assumption changes, the Company's results for actual variances from expected experience for both life and health produced a $14.7 million net remeasurement gain and a $15.9 million net remeasurement gain for the three months ended September 30, 2024 and 2023, respectively. During the nine months ended September 30, 2024 and 2023, the Company's results for actual variances from expected experience for both life and health produced a $38.4 million net remeasurement gain and a $21.6 million net remeasurement gain, respectively.

61
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
Excluding our Direct to Consumer Division, we sell our policies primarily through independently contracted agents (“agents”) who earn commissions in accordance with contracts they have with the respective insurance subsidiary of the Company. These contract arrangements with agents cover commission structures and rates, contract periods, credit terms for settlement of agent advance accounts, vesting rights in future renewal commissions upon termination of contracts and responsibility for premium collections. Contract terms with agents vary, but generally commissions are earned over the life of the policy as premiums are paid. Commissions are calculated on a policy-by-policy basis and vary by product type and policy year. Commission rates are higher for the first-year premium when a policy is issued and are generally reduced for policies that remain in effect for renewal periods (e.g., commission rates may reduce in years 2-10 and again in year 11 and after). After a certain period (typically 10 years), commission rates become constant over the remaining life of the policy and are considered level commissions.

Generally, commissions are paid to an agent when due over the life of a policy as premiums are paid. However, some agents may qualify to have their commissions (primarily first-year commissions) paid in advance of when the commissions are earned. To the extent an advance is made, we will generally advance up to 65% of first year commissions. This creates an agent debit balance which is classified within “Other receivables” in the consolidated financial statements. If an agent has an agent debit balance with the Company, commissions earned by that agent are generally first applied to reduce the amounts owed the company. Any excess will be paid to the agent in cash.

Commissions are earned by the agent over the contract period as long as premium is paid by the policyholder and the policy stays in force. As the commissions are earned by the agent and commission expense is incurred by the Company the agent debit balance is reduced. The portion of commission expense incurred related to non-level commissions is deferred and recorded as “Deferred acquisition cost.” The portion of level commission is recognized as an expense within “Commissions, premium taxes, and non-deferred acquisition costs.”

The Company continues to see positive signs in its core operations, including sales and premium growth, and a consistent operating ROE, excluding accumulated other comprehensive income, generally in the mid-teens.
62
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Analysis of Profitability by Segment
(Dollar amounts in thousands)
Nine Months Ended September 30,
2024 2023 Change %
Life insurance underwriting margin $ 1,016,517 $ 887,492 $ 129,025 15
Health insurance underwriting margin 281,221 280,451 770
Annuity underwriting margin 5,384 6,546 (1,162) (18)
Excess investment income 126,079 94,558 31,521 33
Other insurance:
Other income 192 185 7 4
Administrative expense (251,072) (223,951) (27,121) 12
Corporate and other (129,169) (107,626) (21,543) 20
Pre-tax total 1,049,152 937,655 111,497 12
Applicable taxes (205,977) (178,424) (27,553) 15
Net operating income
843,175 759,231 83,944 11
Reconciling items, net of tax:
Realized gains (losses) (20,998) (62,380) 41,382
Non-operating expenses (2,057) (898) (1,159)
Legal costs and proceedings (4,554) (4,554)
Net income
$ 815,566 $ 695,953 $ 119,613 17

The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $129 million compared with the prior period, primarily a result of increased premiums and favorable policy obligations as a percent of premium due most notably to a remeasurement gain related to the updating of assumptions in the third quarter. Excess investment income increased $32 million compared with the prior period, resulting from growth in our invested assets and increased yields due to higher interest rates. The health segment increased slightly with $281 million of underwriting margin in the first nine months of 2024 compared with $280 million in the first nine months of 2023.
63
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
In 2024, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division (American Income). The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the nine months ended September 30, 2024.
325 326

Total premium income rose 5% for the nine months ended September 30, 2024 to $3.49 billion. Total net sales increased 9% to $622 million, when compared with 2023. Total first-year collected premium (defined in the following section) increased 13% to $507 million for 2024 compared to $449 million in 2023.

Life insurance premium income increased 4% to $2.44 billion over the prior-year total of $2.34 billion. Life net sales rose 9% to $450 million for the first nine months of 2024. First-year collected life premium increased 9% to $342 million. Life underwriting margin, as a percent of premium, increased to 42% for 2024 from 38% in 2023. Underwriting margin increased to $1.02 billion in 2024, compared to $887 million for the same period in 2023.

Health insurance premium income increased 6% to $1.05 billion over the prior-year total of $983 million. Health net sales rose 11% to $171 million for the first nine months of 2024. First-year collected health premium rose 21% to $165 million. Health underwriting margin, as a percent of premium, was 27% for 2024 and 29% for 2023. Health underwriting margin increased slightly to $281 million for the first nine months of 2024, compared to the same period in 2023.

Excess investment income, the measure of profitability of our investment segment, increased 33% during the first nine months of 2024 to $126 million from $95 million in the same period in 2023. Excess investment income per common share, reflecting the impact of our share repurchase program and increased net investment income, increased 41% to $1.38 from $0.98 when compared with the same period in 2023.

Insurance administrative expenses increased 12% in 2024 when compared with the prior-year period. These expenses were 7.2% as a percent of premium during 2024 compared to 6.7% in 2023.

For the nine months ended September 30, 2024, the Company repurchased 9.7 million Globe Life Inc. shares at a total cost of $910 million for an average share price of $93.36.

64
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
The discussions of our segments are presented in the manner we view our operations, as described in Note 12—Business Segments .

We use three measures as indicators of premium growth and sales over the near term: “annualized premium in force,” “net sales,” and “first-year collected premium.”
Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the twelve-month period.
Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued excludes cancellations, and cancellations do not contribute to premium income.
First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future. First-year collected premiums are lower than net sales over the prior 12 months because premiums are not collected on lapsed policies after the date of lapse.

Cancellations are not included in lapses.

Approximately 90% of our premiums are collected monthly; however, other premium payment options such as quarterly and annual are offered by the Company and may be elected by the policyholder. The majority of premiums are paid by way of automatic draft or electronic payment from our policyholders and to a lesser extent from other payment methods such as check, credit card, and worksite payroll deduction.

See further discussion of the distribution channels below for Life and Health .

65
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis
LIFE INSURANCE

Life insurance is the Company's predominant segment. During 2024, life premium represented 70% of total premium and life underwriting margin represented 78% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of excess investment income attributable to the investment segment.
The following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.

Life Insurance
Summary of Results
(Dollar amounts in thousands)
Nine Months Ended September 30, Change
2024 2023
Amount % of Premium Amount % of Premium Amount %
Premium and policy charges $ 2,438,385 100 $ 2,342,429 100 $ 95,956 4
Policy obligations 1,493,165 61 1,536,317 66 (43,152) (3)
Required interest on reserves (605,397) (25) (575,801) (25) (29,596) 5
Net policy obligations 887,768 36 960,516 41 (72,748) (8)
Commissions, premium taxes, and non-deferred acquisition expenses 270,347 11 251,136 11 19,211 8
Amortization of acquisition costs 263,753 11 243,285 10 20,468 8
Total expense 1,421,868 58 1,454,937 62 (33,069) (2)
Insurance underwriting margin
$ 1,016,517 42 $ 887,492 38 $ 129,025 15

Net policy obligations amounted to 36% of premium for the nine months ended September 30, 2024 compared to 41% in the year-ago period. This improvement was primarily due to the assumptions review of lapses, mortality, and morbidity resulting in a remeasurement gain of $56.8 million compared to a remeasurement loss of $2.0 million for the nine months ended September 30, 2024 and 2023, respectively. Refer to Note 6—Policy Liabilities for further discussion of the Company's annual assumptions review.

66
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis
The table below summarizes life underwriting margin by distribution channel.
Life Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)

Nine Months Ended September 30,
2024 2023
Change
Amount % of Premium Amount % of Premium Amount
%
American Income $ 600,976 47 $ 536,202 45 $ 64,774 12
Direct to Consumer 210,712 28 175,652 24 35,060 20
Liberty National 106,486 38 83,502 32 22,984 28
Other 98,343 64 92,136 59 6,207 7
Total
$ 1,016,517 42 $ 887,492 38 $ 129,025 15




The following table presents Globe Life's life insurance premium by distribution channel.

Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Change
2024 2023
Amount % of Total Amount % of Total Amount %
American Income $ 1,265,417 52 $ 1,182,346 50 $ 83,071 7
Direct to Consumer 743,304 31 744,132 32 (828)
Liberty National 276,599 11 260,036 11 16,563 6
Other 153,065 6 155,915 7 (2,850) (2)
Total
$ 2,438,385 100 $ 2,342,429 100 $ 95,956 4

Annualized life premium in force was $3.29 billion at September 30, 2024, an increase of 4% over $3.17 billion a year earlier.

67
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

An analysis of life net sales, an indicator of new business production, by distribution channel is presented below.

Life Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Change
2024 2023
Amount % of Total Amount % of Total Amount %
American Income $ 288,602 64 $ 246,335 59 $ 42,267 17
Direct to Consumer 83,251 18 90,593 22 (7,342) (8)
Liberty National 71,846 16 69,413 17 2,433 4
Other 6,725 2 7,513 2 (788) (10)
Total
$ 450,424 100 $ 413,854 100 $ 36,570 9


First-year collected life premium by distribution channel is presented in the table below.

Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Change
2024 2023
Amount % of Total Amount % of Total Amount %
American Income $ 227,817 67 $ 197,224 63 $ 30,593 16
Direct to Consumer 52,080 15 59,735 19 (7,655) (13)
Liberty National 56,043 16 49,810 16 6,233 13
Other 5,850 2 6,513 2 (663) (10)
Total
$ 341,790 100 $ 313,282 100 $ 28,508 9

68
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

A discussion of life operations by distribution channel follows.

The American Income Life Division markets to members of labor unions and other affinity groups and continues to diversify its lead sources, utilizing third-party internet vendor leads and obtaining referrals to facilitate sustainable growth. This Division is Globe Life's largest contributor of life premium of any distribution channel at 52% of the Company's September 30, 2024 total life premium. For the nine months ended September 30, 2024, the average monthly life premium issued per policy was $56 as compared to $53 for the same period in the prior year. Net sales were $289 million for the nine months ended September 30, 2024, up from $246 million in the year-ago period. The underwriting margin, as a percent of premium, was 47% for the nine months ended September 30, 2024 up from 45% in the year ago period.

Below is the average producing agent count for the nine months ended September 30, 2024 for the American Income Life Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year. The average producing agent count increased 12% over the year-ago period, and over 65% of the Division's net sales are driven by agents that have been producing for the Division for 6 months or more. The increase in average producing agent count was driven by an increase in new agent recruiting along with continued improvement in new agent retention. Sales growth in this Division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.
At September 30,
Change
2024 2023 Amount %
American Income
11,680 10,395 1,285 12

American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency office openings. In addition to offering financial incentives and training opportunities, the Division has made considerable investments in information technology, including a customer relationship management (CRM) tool for the agency force. This tool is designed to drive productivity in lead distribution, conservation of business, manager dashboards and new agent recruiting. Additionally, this Division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training, and sales activity. The agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of sustainability for our agency force.

The Direct to Consumer Division (DTC) offers adult and juvenile life insurance through a variety of marketing approaches, including direct mailings, insert media, and electronic media. In recent years, production from electronic media, which is comprised of sales through both the internet and inbound phone calls to our call center, continue to be the customer preference when compared to direct mail. The proportion of sales from the internet and inbound phone calls continue to outpace the activity from the direct mailings, but all three channels continue to work in an omnichannel approach. The different media channels support and complement one another in the Division's efforts to reach the consumer. Additionally, this channel provides critical support to our agency business through brand impressions and the generation of sales leads. DTC's long-term growth has been fueled by constant innovation and name recognition. We continually introduce new initiatives in this Division in an attempt to increase response rates and create a seamless customer experience.

The juvenile market is an important source of sales, it is also a vehicle to reach the parents and grandparents of juvenile policyholders, who are more likely to respond favorably to a DTC solicitation for life coverage on themselves in comparison to the general adult population. Also, future offerings to juvenile policyholders and their parents are sources of lower acquisition-cost life insurance sales in the future.

DTC net sales declined 8% to $83 million for the nine months ended September 30, 2024 compared with $91 million for the same period in the prior year. This decline is due primarily to the management of direct mail and mailing insert marketing activity resulting from the impact of inflation on postage, paper and online advertising costs. While total sales have declined, the focus has been on improving profitability and improving the underwriting margin. DTC’s underwriting margin, as a percent of premium, was 28% for the nine months ended September 30, 2024 compared with 24% for the same period in 2023.

69
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the agency are expected to help continue this growth. The underwriting margin as a percent of premium was 38% for the nine months ended September 30, 2024, up from 32% during the same period a year ago. The increase is primarily attributable to increased premiums and lower policy obligations as a percent of premium during the first nine months of 2024 as compared to same period in 2023 . For the nine months ended September 30, 2024, the average monthly life premium per policy issued was $43 down slightly from the prior year period.

Net sales rose 4% in the nine months ended September 30, 2024 over the same period in 2023 due primarily to increased agent count.

Below is the average producing agent count for the nine months ended September 30, 2024 and 2023 for the Liberty National Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year.
At September 30,
Change
2024 2023 Amount %
Liberty National
3,638 3,177 461 15

The Liberty National Division average producing agent count increased significantly compared with the prior-year comparable period. We continue to execute our long-term plan to grow this agency through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers. Continued expansion of this agency's presence into more heavily populated, less-penetrated areas will help create long-term agency growth. In addition to the aforementioned geographic expansion, we have also started a campaign of market expansion to increase our agency presence in cities where we currently have offices, but not enough to properly serve the community, region, area and city. These tend to be larger geographic cities which will help create long-term sustainable agency growth. Additionally, the agency continues to help improve the ability of agents to develop new worksite marketing business. Systems that have been put in place, including the addition of a CRM platform and enhanced analytical capabilities, have helped the agents develop additional worksite marketing opportunities as well as improve the productivity of agents selling in the individual life market. As the Division continues to gain momentum in its sales and recruiting initiatives, as well as advances in its technology and CRM platform, the agency anticipates continued growth i n r ecruiting activity and average producing agent count and projects sales growth for the full year.

The Other agency distribution channels primarily include non-exclusive independent agencies selling primarily life insurance. The other distribution channels contributed $153 million of life premium income, or 6% of Globe Life's total life premium income in the nine months ended September 30, 2024, and contributed 2% of net sales for the period.

HEALTH INSURANCE

Health insurance sold by the Company primarily includes Medicare Supplement insurance including Retiree Health Insurance business, accident coverage, and other limited-benefit supplemental health products including accident, cancer, critical illness, heart, and intensive care products.

Health premium accounted for 30% of our total premium in 2024, while the health underwriting margin accounted for 22% of total underwriting margin. Health underwriting margin increased slightly to $281 million compared to $280 million in the prior year. While the Company continues to emphasize life insurance sales relative to health due to life’s superior long-term profitability and its greater contribution to excess investment income, the health business provides a significant contribution to return on equity as it does not require a substantial amount of up-front capital.

70
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

The following table presents underwriting margin data for health insurance.

Health Insurance
Summary of Results
(Dollar amounts in thousands)
Nine Months Ended September 30, Change
2024 2023
Amount % of
Premium
Amount % of
Premium
Amount %
Premium $ 1,046,617 100 $ 982,916 100 $ 63,701 6
Policy obligations 629,676 60 580,676 59 49,000 8
Required interest on reserves (82,300) (8) (79,603) (8) (2,697) 3
Net policy obligations 547,376 52 501,073 51 46,303 9
Commissions, premium taxes, and non-deferred acquisition expenses 177,246 17 163,784 16 13,462 8
Amortization of acquisition costs 40,774 4 37,608 4 3,166 8
Total expense 765,396 73 702,465 71 62,931 9
Insurance underwriting margin
$ 281,221 27 $ 280,451 29 $ 770

Net policy obligations amounted to 52% of premium for the nine months ended September 30, 2024 compared to 51% in the year ago period. This increase was primarily due to the assumptions review of lapses and morbidity resulting in a remeasurement loss of $10.5 million compared to a remeasurement gain of $5.2 million for the nine months ended September 30, 2024 and 2023, respectively. Refer to Note 6—Policy Liabilities for further discussion of the Company's annual assumptions review.

The table below summarizes health underwriting margin by distribution channel.
Health Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)

Nine Months Ended September 30,
2024 2023
Change
Amount % of Premium Amount % of Premium Amount
%
United American $ 42,500 10 $ 43,164 11 $ (664) (2)
Family Heritage 106,481 34 100,058 34 6,423 6
Liberty National 79,181 56 78,160 56 1,021 1
American Income 49,124 53 55,588 62 (6,464) (12)
Direct to Consumer 3,935 7 3,481 7 454 13
Total
$ 281,221 27 $ 280,451 29 $ 770

71
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Globe Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel.

Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Increase
(Decrease)
2024 2023
Amount % of Total Amount % of Total Amount %
United American $ 440,375 42 $ 407,137 42 $ 33,238 8
Family Heritage 317,065 30 294,029 30 23,036 8
Liberty National 142,612 14 140,518 14 2,094 1
American Income 92,495 9 89,656 9 2,839 3
Direct to Consumer 54,070 5 51,576 5 2,494 5
Total
$ 1,046,617 100 $ 982,916 100 $ 63,701 6

Premium related to limited-benefit supplemental health products comprise $586 million, or 56%, of the total health premiums for the nine months ended September 30, 2024, compared with $553 million, or 56%, in the same period in the prior year. Premium from Medicare Supplement products comprises the remaining $461 million, or 44%, for the nine months ended September 30, 2024, compared with $430 million, or 44%, in the same period in the prior year.

Annualized health premium in force was $1.45 billion at September 30, 2024, an increase of 7% over $1.36 billion a year earlier.

Presented below is a table of health net sales by distribution channel.
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Increase
(Decrease)
2024 2023
Amount % of Total Amount % of Total Amount %
United American $ 50,180 29 $ 44,053 29 $ 6,127 14
Family Heritage 78,862 46 70,865 46 7,997 11
Liberty National 24,091 14 23,806 15 285 1
American Income 15,952 9 13,889 9 2,063 15
Direct to Consumer 2,306 2 1,773 1 533 30
Total
$ 171,391 100 $ 154,386 100 $ 17,005 11

Health net sales related to limited-benefit supplemental health products comprise $130 million, or 76%, of the total health net sales for the nine months ended September 30, 2024, compared with $121 million, or 79%, in the same period in the prior year. Medicare Supplement sales make up the remaining $41 million, or 24%, for 2024 compared with $33 million, or 21%, in the same period in the prior year.

72
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

The following table presents health insurance first-year collected premium by distribution channel.

Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Nine Months Ended September 30, Increase
(Decrease)
2024 2023
Amount % of Total Amount % of Total Amount %
United American $ 66,944 40 $ 47,819 35 $ 19,125 40
Family Heritage 58,878 36 53,456 39 5,422 10
Liberty National 21,272 13 18,877 14 2,395 13
American Income 14,740 9 12,857 10 1,883 15
Direct to Consumer 2,891 2 2,638 2 253 10
Total
$ 164,725 100 $ 135,647 100 $ 29,078 21
First-year collected premium related to limited-benefit supplemental health products is $119 million, or 72%, of total first-year collected premium for the nine months ended September 30, 2024 compared with $98 million, or 72%, in the same period in the prior year. First-year collected premium from Medicare Supplement policies make up the remaining $46 million, or 28%, for the nine months ended September 30, 2024 compared with $38 million, or 28%, in the same period in the prior year.

A discussion of health operations by distribution channel follows.
The United American Division consists of non-exclusive independent agencies who may also sell for other companies. The United American Division was Globe Life's largest health agency in terms of health premium income, with net sales up 14% from the same period in the prior year.
This Division includes three different units:

UA General Agency, which primarily sells individual Medicare Supplement insurance through independent agents;
Special Markets, which markets retiree health insurance to employer and union groups through brokers; and
Globe Life Group Benefits, which offers group worksite supplemental health insurance through brokers.

The majority of the premium revenue comes from Medicare Supplement. Underwriting margin as a percent of premium for the Division was 10% for the nine months ended September 30, 2024 and 11% for the same period in 2023.

The Family Heritage Division primarily markets limited-benefit supplemental health insurance in non-urban areas. Most of its policies include a cash-back feature, such as a return of premium, where any excess of premiums over claims paid is returned to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium was 34% for the nine months ended September 30, 2024 and 2023.
The Division experienced a 11% rise in health net sales as compared with the nine-month period a year ago, primarily due to improved agent productivity and training. The Division will continue to implement incentive and retention programs to further these increases in the number of producing agents.
73
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Below is the average producing agent count at the end of the period for the Family Heritage Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year. The average producing agent count was slightly higher than compared with the same period a year ago. The Division has recently increased efforts to grow agent count and middle management. While growth in net sales and earned premium is impacted by agent productivity, growth in the number of average producing agents is what will ultimately be the primary driver of future growth in sales, similar to our other exclusive agencies.
At September 30,
Change
2024 2023 Amount %
Family Heritage
1,362 1,322 40 3

The Liberty National Division represented 14% of all Globe Life health premium income for the nine months ended September 30, 2024. The Liberty National Division markets limited-benefit supplemental health products, consisting primarily of cancer and critical illness insurance. Much of Liberty National's health business is generated through worksite marketing targeting small businesses. Health premium at the Liberty National Division was $143 million for the nine months ended September 30, 2024 up from $141 million for the same period in 2023. Liberty National's first-year collected premium rose 13% to $21 million in the nine months ended September 30, 2024 compared with $19 million for the same period in 2023. Health net sales for the nine months ended September 30, 2024 rose 1% from the comparable period in 2023. For the nine months ended September 30, 2024 and 2023, underwriting margin as a percent of premium was 56%.

While both the American Income Life Division and the Direct to Consumer Division sell life insurance, they also market health products. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division primarily markets Medicare Supplements to employer or union-sponsored groups. On a combined basis, these other channels accounted for 14% of health premium for the nine months ended September 30, 2024 and 2023.


ANNUITIES

Annuities represent an insignificant part of our business. We do not currently market stand-alone fixed or deferred annuity products, favoring instead protection-oriented life and supplemental health insurance products.

INVESTMENTS

We manage our capital resources, including investments and cash flow, through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 12—Business Segments . It is defined as net investment income less the required interest attributable to policy liabilities.

Management also views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company. As excess investment income per diluted common share incorporates all invested assets and insurance liabilities, we view excess investment income per diluted common share as a useful measure to evaluate the investment segment.

74
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Excess Investment Income . The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Analysis of Excess Investment Income
(Dollar amounts in thousands, except for per share data)
Nine Months Ended
September 30,
Change
2024 2023 Amount %
Net investment income $ 853,178 $ 785,275 $ 67,903 9
Interest on policy liabilities (1)
(727,099) (690,717) (36,382) 5
Excess investment income
$ 126,079 $ 94,558 $ 31,521 33
Excess investment income per diluted share
$ 1.38 $ 0.98 $ 0.40 41
Mean invested assets (at amortized cost) $ 21,359,702 $ 20,329,079 $ 1,030,623 5
Average insurance policy liabilities 17,501,496 16,677,765 823,731 5
(1) Interest on policy liabilities, at original rates, is a component of total policyholder benefits, a GAAP measure.

Excess investment income increased $31.5 million, or 33%, compared with the year-ago period. Excess investment income per diluted common share was $1.38 for the nine months ended September 30, 2024, an increase of 41% over the prior-year period. Excess investment income per diluted common share generally increases at a faster pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.

Net investment income for the nine months ended September 30, 2024 was $853 million or 9% greater than the year-ago period. Mean invested assets increased 5% during the first nine months of 2024 over the same period last year. Investment income grew in the current period primarily due to the growth in invested assets and higher interest rates compared to the prior year. The effective annual yield rate earned on the fixed maturity portfolio was 5.26% in the first nine months of 2024, compared with 5.18% a year earlier. In addition to fixed maturities, the Company has also invested in commercial mortgage loans and limited partnerships with debt-like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the Company's commercial mortgage loans for the nine months ended September 30, 2024 was 8.47%. The earned yield on limited partnership investments for the nine months ended September 30, 2024 was 8.64%. See additional information in Note 4—Investments .

Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss from our available for sale debt securities included in accumulated other comprehensive income (loss) as of September 30, 2024, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.

Required interest on insurance policy liabilities reduces excess investment income, as it is the amount of net investment income considered by management necessary to “fund” required interest on insurance policy liabilities. As such, it is reclassified from the insurance segment to the investment segment. As discussed in Note 12—Business Segments , management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the original discount rate assumptions for our insurance policies in force.

The vast majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandate that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business. Each calendar year, we set the original discount rate to be used to calculate the benefit reserve liability for all insurance policies issued that year. The liability reported on the balance sheet is updated in subsequent periods using current discount rates as of the end of the relevant reporting period with a corresponding adjustment to Other Comprehensive Income.

75
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

The discount rate used for policies issued in the current year has no impact on the in-force policies issued in prior years as the rates of all prior issue years are also locked in for purposes of recognizing income. As such, the overall original discount rate for the entire in-force block of 5.5% is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves on the entire block of in force business. Business issued in the current year has little impact on the overall weighted-average original discount rate due to the size of our in-force business.

In comparison to the year-ago period, required interest on insurance policy liabilities increased $36 million, or 5%, to $727 million, consistent with the 5% growth in average interest-bearing insurance policy liabilities.

Realized Gains and Losses. Our life and health insurance companies collect premium income from policyholders for the eventual payment of policyholder benefits, sometimes paid for many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support these obligations. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.

Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. In a bond exchange offer, bondholders may consent to exchange their existing bonds for another class of debt securities. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Condensed Consolidated Statements of Operations .

Realized gains and losses can be significant in relation to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.
The following table summarizes our tax-effected realized gains (losses) by component.

Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands, except for per share data)
Nine Months Ended September 30,
2024 2023
Amount Per Share Amount Per Share
Fixed maturities:
Sales $ (7,693) $ (0.08) $ (61,281) $ (0.64)
Matured or other redemptions (1)
17 (125)
Provision for credit losses (13) (5,924) (0.06)
Fair value option—change in fair value (17,994) (0.20) 6,284 0.06
Mortgages
(2,788) (0.03) (3,886) (0.03)
Other investments
897 0.01 396
Total realized gains (losses)—investments
(27,574) (0.30) (64,536) (0.67)
Other gains (losses) (2)
6,576 0.07 2,156 0.02
Total realized gains (losses)
$ (20,998) $ (0.23) $ (62,380) $ (0.65)
(1) During the nine months ended September 30, 2024 and 2023, the Company recorded $82.2 million and $39.0 million, respectively, of exchanges of fixed maturity securities (noncash transactions) that resulted in no realized gains (losses), net of tax in either period.
(2) Other realized gains (losses) are primarily a result of changes in the fair value for assets held in rabbi trust.

76
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Investment Acquisitions . Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer-term maturities because they more closely match the long-term nature of our life and health policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.

The following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.
Fixed Maturity Acquisitions Selected Information
(Dollar amounts in thousands)
Nine Months Ended
September 30,
2024 2023
Cost of acquisitions:
Investment-grade corporate securities $ 972,998 $ 547,330
Investment-grade municipal securities 11,231 549,528
Other securities
20,436
Total fixed maturity acquisitions (1)
$ 1,004,665 $ 1,096,858
Effective annual yield (one year compounded) (2)
5.96 % 5.93 %
Average life (in years, to next call) 29.9 17.1
Average life (in years, to maturity) 32.7 25.4
Average rating A- A+
(1) Fixed maturity acquisitions included unsettled trades of $4 million in 2024 and $20 million in 2023.
(2) Tax-equivalent basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.

For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls," however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.

Acquisitions in 2023 and 2024 consisted primarily of corporate and municipal bonds with securities spanning a diversified range of issuers, industry sectors, and geographical regions. In the first nine months of 2024, we invested primarily in the industrial, financial, and utility sectors. For the entire portfolio, the taxable equivalent effective yield earned was 5.26%, up approximately 8 basis points from the yield in the first nine months of 2023. The increase in taxable equivalent effective yield was primarily due to new purchases at yields exceeding the yield on dispositions and the average portfolio yield. Our investment in fixed maturity securities was lower this quarter as we also invested in other investment opportunities. For the remainder of 2024, the Company will continue to execute on its existing strategy by seeking to invest in assets that satisfy our quality and other objectives, while maximizing the highest risk-adjusted, capital-adjusted return.

77
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Other Investment Acquisitions
Nine Months Ended September 30,
2024 2023
Limited partnerships
$ 226,448 $ 91,380
Commercial mortgage loans
134,667 91,568
Common stock
17,788 9,598
Convertible notes
2,850 2,650
COLI
200,000
Total $ 581,753 $ 195,196

During the current quarter ended September 30, 2024, the Company acquired a COLI policy in the amount of $200 million.

Since fixed maturities represent such a significant portion of our investment portfolio, the remainder of the discussion of portfolio composition will focus on fixed maturities. See a breakdown of the Company's Other long-term investments in Note 4—Investments .

Selected information concerning the fixed maturity portfolio is as follows:

Fixed Maturity Portfolio Selected Information
At
September 30,
2024
December 31, 2023 September 30,
2023
Average annual effective yield (1)
5.24% 5.23% 5.23%
Average life, in years, to:
Next call (2)
14.9 14.6 14.4
Maturity (2)
19.0 18.6 18.4
Effective duration to:
Next call (2,3)
9.1 9.0 8.4
Maturity (2,3)
10.9 10.7 10.0
(1) Tax-equivalent basis. The yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
(2) Globe Life calculates the average life and duration of the fixed maturity portfolio two ways:
(a) based on the next call date which is the next call date for callable bonds and the maturity date for noncallable bonds, and
(b) based on the maturity date of all bonds, whether callable or not.
(3) Effective duration is a measure of the price sensitivity of a fixed-income security to a 1% change in interest rates.

78
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Credit Risk Sensitivity . The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at September 30, 2024 and December 31, 2023.

Fixed Maturities by Sector
September 30, 2024
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities % of Total Fixed Maturities
Amortized
Cost, net
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Amortized
Cost, net
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 106,736 $ 1 $ (9,729) $ 97,008 $ 2,612,716 $ 97,810 $ (135,645) $ 2,574,881 13 14
Banks 65,764 233 (4,356) 61,641 1,097,327 37,832 (40,168) 1,094,991 6 6
Other financial 74,967 1 (24,050) 50,918 1,304,126 36,120 (124,090) 1,216,156 7 7
Total financial 247,467 235 (38,135) 209,567 5,014,169 171,762 (299,903) 4,886,028 26 27
Industrial
Energy 44,596 (4,541) 40,055 1,372,980 68,775 (50,359) 1,391,396 7 7
Basic materials 1,196,412 52,232 (50,245) 1,198,399 6 7
Consumer, non-cyclical 2,132,998 37,854 (145,263) 2,025,589 11 11
Other industrials 1,086,012 34,228 (65,589) 1,054,651 6 6
Communications 891,588 24,091 (69,391) 846,288 5 5
Transportation 8,403 (213) 8,190 566,520 26,984 (20,755) 572,749 3 3
Consumer. cyclical 131,375 695 (27,573) 104,497 504,368 8,552 (59,499) 453,421 3 2
Technology 50,277 737 51,014 357,825 5,449 (46,988) 316,286 2 2
Total industrial 234,651 1,432 (32,327) 203,756 8,108,703 258,165 (508,089) 7,858,779 43 43
Utilities 29,308 876 (790) 29,394 2,140,610 109,998 (72,371) 2,178,237 11 11
Total corporates
511,426 2,543 (71,252) 442,717 15,263,482 539,925 (880,363) 14,923,044 80 81
States, municipalities, and political divisions:
General obligations 893,380 9,709 (144,841) 758,248 5 4
Revenues 2,360,439 39,700 (280,148) 2,119,991 12 12
Total states, municipalities, and political divisions
3,253,819 49,409 (424,989) 2,878,239 17 16
Other fixed maturities:
Government (U.S. and foreign) 439,763 55 (30,911) 408,907 2 2
Collateralized debt obligations 36,685 5,798 42,483 36,685 5,798 42,483
Other asset-backed securities 7,752 (70) 7,682 83,573 1 (1,677) 81,897 1 1
Total fixed maturities
$ 555,863 $ 8,341 $ (71,322) $ 492,882 $ 19,077,322 $ 595,188 $ (1,337,940) $ 18,334,570 100 100



79
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Sector
December 31, 2023
(Dollar amounts in thousands)
Below Investment Grade Total Fixed Maturities % of Total Fixed Maturities
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
At Amortized Cost, net At Fair Value
Corporates:
Financial
Insurance - life, health, P&C $ 107,010 $ $ (12,472) $ 94,538 $ 2,413,685 $ 61,715 $ (163,455) $ 2,311,945 13 13
Banks 36,906 (4,401) 32,505 1,327,272 25,019 (71,714) 1,280,577 7 7
Other financial 74,965 (25,255) 49,710 1,287,194 25,634 (153,171) 1,159,657 7 7
Total financial 218,881 (42,128) 176,753 5,028,151 112,368 (388,340) 4,752,179 27 27
Industrial
Energy 44,652 (7,481) 37,171 1,446,480 58,637 (62,324) 1,442,793 8 8
Basic materials 1,166,385 39,248 (64,501) 1,141,132 6 6
Consumer, non-cyclical 2,096,651 32,071 (160,828) 1,967,894 11 11
Other industrials 5,185 110 5,295 1,101,059 32,541 (78,817) 1,054,783 6 6
Communications 868,131 21,006 (73,323) 815,814 4 5
Transportation 8,403 (415) 7,988 534,468 21,113 (24,649) 530,932 3 3
Consumer. cyclical 136,343 (25,059) 111,284 515,169 4,941 (57,735) 462,375 3 3
Technology 32,543 625 33,168 280,668 3,521 (44,670) 239,519 1 1
Total industrial 227,126 735 (32,955) 194,906 8,009,011 213,078 (566,847) 7,655,242 42 43
Utilities 34,698 722 (1,523) 33,897 2,017,967 73,925 (94,130) 1,997,762 11 11
Total corporates 480,705 1,457 (76,606) 405,556 15,055,129 399,371 (1,049,317) 14,405,183 80 81
States, municipalities, and political divisions:
General obligations 887,013 8,526 (135,003) 760,536 4 4
Revenues 2,409,292 38,820 (268,326) 2,179,786 13 12
Total states, municipalities, and political divisions
3,296,305 47,346 (403,329) 2,940,322 17 16
Other fixed maturities:
Government (U.S., municipal, and foreign) 442,903 8 (42,654) 400,257 2 2
Collateralized debt obligations 37,110 5,036 42,146 37,110 5,036 42,146
Other asset-backed securities 11,696 (409) 11,287 86,352 3 (4,057) 82,298 1 1
Total fixed maturities $ 529,511 $ 6,493 $ (77,015) $ 458,989 $ 18,917,799 $ 451,764 $ (1,499,357) $ 17,870,206 100 100



80
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the fixed maturity portfolio as of September 30, 2024, representing 80% of amortized cost, net, and 81% of fair value. The remainder of the portfolio is invested primarily in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At September 30, 2024, the total fixed maturity portfolio consisted of 975 issuers.

Fixed maturities had a fair value of $18.3 billion at September 30, 2024, compared with $17.9 billion at December 31, 2023. The net unrealized loss position in the fixed-maturity portfolio decreased from $1.0 billion at December 31, 2023 to $743 million at September 30, 2024 due to an increase in market rates during the period.

For more information about our fixed maturity portfolio by component at September 30, 2024 and December 31, 2023, including a discussion of allowance for credit losses, an analysis of unrealized investment losses, and a schedule of maturities, see Note 4—Investments .

An analysis of the fixed maturity portfolio by composite quality rating at September 30, 2024 and December 31, 2023, is shown in the following tables. The composite rating for each security, other than private-placement securities managed by third parties, is the average of the security’s available ratings as assigned by Moody’s Investor Service, Standard & Poor’s, Fitch Ratings, and Dominion Bond Rating Service, LTD. The ratings assigned by these four nationally recognized statistical rating organizations are evenly weighted when calculating the average. The composite quality rating is created utilizing a methodology developed by Globe Life using ratings from the various rating agencies noted above. The composite quality rating is not a Standard & Poor's credit rating. Standard & Poor's does not sponsor, endorse, or promote the composite quality rating and shall not be liable for any use of the composite quality rating. Included in the following chart are private placement fixed maturity holdings at amortized cost, net of allowance for credit losses, of $409 million ($377 million at fair value) for which the ratings were assigned by the third-party managers.

Fixed Maturities by Rating
At September 30, 2024
(Dollar amounts in thousands)
Amortized Cost, net % of Total Fair
Value
% of Total Average Composite Quality Rating on Amortized Cost, net
Investment grade:
AAA $ 964,999 5 $ 902,425 5
AA 3,259,652 17 2,860,220 16
A 5,614,869 29 5,576,664 30
BBB+ 3,301,623 17 3,266,781 18
BBB 4,312,274 23 4,192,772 23
BBB- 1,068,042 6 1,042,826 5
Total investment grade
18,521,459 97 17,841,688 97 A-
Below investment grade:
BB 507,781 3 439,052 3
B 7,517 7,432
Below B 40,565 46,398
Total below investment grade
555,863 3 492,882 3 BB-
$ 19,077,322 100 $ 18,334,570 100
Weighted average composite quality rating
A-

81
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis


Fixed Maturities by Rating
At December 31, 2023
(Dollar amounts in thousands)
Amortized
Cost, net
% of Total
Fair
Value
% of Total Average Composite Quality Rating on Amortized Cost
Investment grade:
AAA $ 952,822 5 $ 880,729 5
AA 3,179,618 17 2,789,626 15
A 5,118,085 27 4,976,280 28
BBB+ 3,615,102 19 3,495,898 19
BBB 4,278,786 23 4,056,833 23
BBB- 1,243,875 6 1,211,851 7
Total investment grade
18,388,288 97 17,411,217 97 A-
Below investment grade:
BB 450,503 3 376,912 3
B 37,896 35,929
Below B 41,112 46,148
Total below investment grade
529,511 3 458,989 3 BB
$ 18,917,799 100 $ 17,870,206 100
Weighted average composite quality rating
A-

The overall quality rating of the portfolio is A-, the same as of year-end 2023. Fixed maturities rated BBB are 46% of the total portfolio at September 30, 2024, down from 48% at December 31, 2023. While this ratio is high relative to our peers, it is at its lowest level since 2007 and we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of September 30, 2024. Of our fixed maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.

An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:

Below-Investment Grade Fixed Maturities
(Dollar amounts in thousands)
Nine Months Ended
September 30,
2024 2023
Balance at beginning of period
$ 529,511 $ 542,497
Downgrades by rating agencies 35,312 56,217
Upgrades by rating agencies (32,540)
Net Acquisitions (Dispositions)
(12,558) (68,319)
Provision for credit losses (17) (7,500)
Amortization and other 3,615 2,797
Balance at end of period
$ 555,863 $ 493,152

Our investment policy calls for investing primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, the balance of below-investment grade issues is primarily the result of ratings
82
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 8% of our shareholders’ equity excluding accumulated other comprehensive income as of September 30, 2024. Globe Life invests long term and as such, one of our key criterion in our investment process is to select issuers that are anticipated to weather multiple financial cycles.


OPERATING EXPENSES

Operating expenses are included in the "Corporate and Other" segment and are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.

An analysis of operating expenses is shown below.

Operating Expenses Selected Information
(Dollar amounts in thousands)
Nine Months Ended September 30, Increase
2024 2023 (Decrease)
Amount % of
Premium
Amount % of
Premium
Amount %
Insurance administrative expenses:
Salaries $ 95,406 2.7 $ 89,068 2.7 $ 6,338 7
Other employee costs 28,531 0.8 27,850 0.8 681 2
Information technology costs 59,023 1.7 47,106 1.4 11,917 25
Legal costs 19,771 0.6 10,614 0.3 9,157 86
Other administrative costs 48,341 1.4 49,313 1.5 (972) (2)
Total insurance administrative expenses 251,072 7.2 223,951 6.7 27,121 12
Parent company expense 9,166 8,254 912
Stock compensation expense 28,590 22,732 5,858
Legal costs and proceedings 5,764 5,764
Non-operating expenses 2,604 1,137 1,467
$ 297,196 $ 256,074 $ 41,122 16

Total operating expenses for September 30, 2024 increased in comparison with the prior year primarily due to increases in insurance administrative expenses as well as stock compensation and legal costs and proceedings. Insurance administrative expenses increased $27.1 million primarily due to higher information technology costs, legal costs and employee costs, which includes salaries and other. Insurance administrative expenses as a percent of premium were 7.2% for the nine months ended September 30, 2024 compared to 6.7% for the same period in 2023.

83
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

SHARE REPURCHASES

Globe Life has an ongoing share repurchase program that began in 1986. The share repurchase program is reviewed with the Board of Directors by management quarterly, and continues indefinitely unless and until the Board of Directors decides to suspend, terminate or modify the program. Management generally determines the amount of repurchases based on the amount of the excess cash flows and other available sources after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Since implementing our share repurchase program in 1986, we have used $10.3 billion to repurchase Globe Life Inc. common shares after determining that the repurchases provide a greater risk-adjusted after-tax return than other investment alternatives.

Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance subsidiaries less interest expense paid on its debt and other limited operating activities. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises.

The following chart summarizes share repurchases for the nine month periods ended September 30, 2024 and 2023.

Analysis of Share Repurchases
(Amounts in thousands, except per share data)
Nine Months Ended September 30,
2024 2023
Shares Amount Average
Price
Shares Amount Average
Price
Purchases with:
Excess cash flow at the Parent Company (1)
9,748 $ 910,040 $ 93.36 2,708 $ 302,849 $ 111.82
Option exercise proceeds 348 31,454 90.30 526 60,216 114.58
Total 10,096 $ 941,494 $ 93.25 3,234 $ 363,065 $ 112.27
(1) Excludes excise tax on the repurchase of treasury stock of $9.0 million and $2.9 million for the nine months ended September 30, 2024 and 2023, respectively.
The amount of share repurchases in the third quarter were higher as we accelerated repurchases given favorable market conditions and the use of additional capital raised during the quarter. Refer to Note 11—Debt for further details. Throughout the remainder of this discussion, share repurchases will only refer to those made from excess cash flow at the Parent Company.

FINANCIAL CONDITION
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper, and advances from the Federal Home Loan Bank.

Insurance Subsidiary Liquidity . The operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of the excess cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’ operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the leading source of the excess cash is investment income, a significant portion of the excess cash also comes from underwriting income due to our high underwriting margins and effective expense control.
84
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed maturity investment portfolio available to create additional cash flows if required.

Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries with an additional source of liquidity, if needed. Refer to Note 11—Debt for further details.

Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
Nine Months Ended
September 30,
Twelve Months Ended
December 31,
2024 2023 Projected 2024 2023
Liquidity Sources:
Dividends from Subsidiaries $ 451,416 $ 411,661
$480,000—$520,000
$ 459,535
Excess Cash Flows (1)
412,626 387,879
430,000—470,000
416,081
(1) Excess cash flows are reported gross of shareholder dividends. For the nine months ended September 30, 2024 and 2023, shareholder dividends were $65 million and $63 million, respectively. For the twelve months ended December 31, 2024, we project approximately $86 million in shareholder dividends, compared to the $84 million paid in 2023.

Dividends from subsidiaries and excess cash flows are projected to be higher in 2024 than in 2023 primarily due to lower life obligations and the growth in our underwriting margins in 2023, both of which resulted in higher statutory earnings generated by the affiliates. Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany borrowings, debt markets, term loans, and a revolving credit facility.

Short-Term Borrowings. An additional source of Parent Company liquidity is a credit facility with a group of lenders. The facility was amended on March 29, 2024, resulting in an increased capacity of $250 million. The facility allows for unsecured borrowings and stand-by letters of credit up to $1 billion, which could be increased up to $1.25 billion. While the Parent Company may request the increase, it is not guaranteed. The updated five-year credit agreement will mature on March 29, 2029. Up to $250 million in letters of credit can be issued against the facility. The facility serves as a back-up line of credit for a commercial paper program under which commercial paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum, less any letters of credit issued. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. As of September 30, 2024, we had available $458 million of additional borrowing capacity under this facility, compared to $384 million a year earlier. As of September 30, 2024, the Parent Company was in full compliance with all covenants related to the aforementioned debt.

As a part of the credit facility, Globe Life has stand-by letters of credits. These letters of credit are issued on behalf of our insurance subsidiaries.

85
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper
(Dollar amounts in thousands)
At
September 30,
2024
December 31, 2023 September 30,
2023
Balance of commercial paper at end of period (par value) $ 426,908 $ 319,000 $ 251,000
Annualized interest rate 5.56 % 5.71 % 5.65 %
Letters of credit outstanding $ 115,000 $ 115,000 $ 115,000
Remaining amount available under credit line 458,092 316,000 384,000

Credit Facility—Commercial Paper Activity
(Dollar amounts in thousands)
Nine Months Ended September 30,
2024 2023
Average balance of commercial paper outstanding during period (par value) $ 375,851 $ 296,816
Daily-weighted average interest rate (annualized) 5.80 % 5.33 %
Maximum daily amount outstanding during period (par value) $ 633,425 $ 477,700

The Company increased the commercial paper borrowings by $108 million since year-end. The Company was able to issue commercial paper as needed under this facility during the nine months ended September 30, 2024 and 2023.

Globe Life expects to have readily available funds for 2024 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through liquid assets currently available, internally-generated cash flow and the credit facility. In the event that more liquidity is needed, the Parent Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility or term loan, and intercompany borrowing.

Consolidated Liquidity. Consolidated net cash inflows from operations were $1.07 billion in the first nine months of 2024, compared with $1.09 billion in the same period of 2023. The decrease is primarily attributable to fluctuations in the settlement of certain amounts included in other liabilities. In addition to cash inflows from operations, our insurance companies received proceeds from dispositions of fixed maturities available for sale, mortgage loans, and other long-term investments in the amount of $895 million during the first nine months of 2024. The Company sold shorter term securities and reinvested in longer term securities, extending duration and taking advantage of higher current interest rates during the nine months ended September 30, 2024. As previously noted under the caption Short-Term Borrowings , the Parent Company has in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.

Cash and short-term investments were $235 million at September 30, 2024, compared with $185 million at December 31, 2023. In addition to these liquid assets, $18.3 billion (fair value at September 30, 2024) of fixed income securities are available for sale in the event of an unexpected need. Approximately $1.4 billion, at fair value, are pledged for outstanding FHLB advances and reinsurance. Further, approximately 97% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. While our fixed income securities are classified as available for sale, we have the ability and general intent to hold any securities to recovery or maturity. Our strong cash flows from operations, on-going investment maturities, and available liquidity under our credit facility make any need to sell securities for liquidity highly unlikely.

86
GL Q3 2024 FORM 10-Q

Globe Life Inc.
Management's Discussion & Analysis

Capital Resources. The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt) , long-term debt, and shareholders’ equity. It does not include short-term FHLB borrowings, which are obligations of the insurance subsidiaries and typically repaid over the course of the year.

Long-Term Borrowings . The outstanding long-term debt at book value was $2.3 billion at September 30, 2024 and $1.6 billion at December 31, 2023.

Selected Information about Debt Issues
As of September 30, 2024
(Dollar amounts in thousands)
Instrument Issue Date Maturity Date Coupon Rate Interest Payment Dates Par
Value
Book
Value
Fair
Value
Senior notes 09/27/2018 09/15/2028 4.550% semiannual $ 550,000 $ 546,820 $ 550,088
Senior notes 08/21/2020 08/15/2030 2.150% semiannual 400,000 397,017 344,796
Senior notes (1)
05/19/2022 06/15/2032 4.800% semiannual 250,000 246,172 248,443
Senior notes
08/23/2024 09/15/2034 5.850% semiannual 450,000 444,812 464,881
Junior subordinated debentures 11/17/2017 11/17/2057 5.275% semiannual 125,000 123,439 109,657
Junior subordinated debentures 06/14/2021 06/15/2061 4.250% quarterly 325,000 317,367 236,730
Term loan (2)
05/11/2023 08/15/2027 6.593% quarterly 250,000 248,049 248,049
Total long-term debt
2,350,000 2,323,676 2,202,644
FHLB borrowings 17,000 17,000 17,000
Commercial paper 426,908 420,418 420,418
Total short-term debt
443,908 437,418 437,418
Total debt
$ 2,793,908 $ 2,761,094 $ 2,640,062
(1) An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2) Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. The term loan was amended on August 15, 2024 extending the maturity date from November 11, 2024 to August 15, 2027 and increasing the principal amount from $170 million to $250 million.

On August 23, 2024, Globe Life completed the issuance of $450 million principal amount of 5.85% Senior notes due September 15, 2034. Total proceeds received by the Parent from the issuance, net of the underwriters’ discount, were $445 million. The proceeds were used for general corporate purposes, which included open market purchases of shares of its common stock under its share repurchase program.


87
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis

Financing costs for the corporate and other segment consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Condensed Consolidated Statements of Operations .

Analysis of Financing Costs
(Dollar amounts in thousands)
Nine Months Ended
September 30,
Increase
(Decrease)
2024 2023 Amount %
Interest on funded debt $ 53,633 $ 55,732 $ (2,099) (4)
Interest on term loans 9,646 4,605 5,041 109
Interest on short-term debt 28,115 16,284 11,831 73
Other 19 19
Financing costs
$ 91,413 $ 76,640 $ 14,773 19

During the first nine months of 2024, financing costs increased 19% compared with the prior year. The increase in financing costs is primarily due to higher average balances in the current year compared to the prior year. We increased the durations on commercial paper issuances during the quarter ended September 30, 2024 due to market considerations. More information on our debt transactions is disclosed in the Financial Condition section of this report.

Subsidiary Capital : The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of risk-based capital determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC). Companies typically hold a multiple of the Company Action Level RBC depending on their particular business needs and risk profile.

Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2024, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company has concluded that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.

Shareholders' Equity : Shareholders’ equity was $4.6 billion at September 30, 2024. This compares with $4.5 billion at December 31, 2023 and $4.6 billion at September 30, 2023. During the nine months since December 31, 2023, shareholders’ equity increased as a result of net income of $816 million during the first nine months of 2024, but was offset by share repurchases of $910 million and an additional $31 million in share repurchases to offset the dilution from stock option exercises. Additionally, the balance of AOCI increased $288 million primarily due to increased interest rates and discount rates over the period.

On August 8, 2024, the Parent Company announced that it had declared a quarterly dividend of $0.24 per share. This dividend was paid on November 1, 2024.

We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, shareholder dividend payments, investments in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.

Future policy benefits are computed using current discount rates with the impact of changes in discount rates included in accumulated other comprehensive income. Additionally, the liability for future policy benefits is calculated
88
GL Q3 2024 FORM 10-Q

GLOBE LIFE INC.
Management's Discussion & Analysis

using net premiums rather than gross premiums. Given that gross premiums are considerably higher than net premiums for our business, as seen in Note 6—Policy Liabilities , the measurement of the liability is higher than what it would be had it been computed using gross premiums. This is an important consideration when analyzing shareholders' equity.

Globe Life is required under GAAP to revalue its available for sale fixed maturity portfolio to fair market value at the end of each accounting period. These changes, net of their associated impact on income tax, are reflected directly in shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed maturity investments and policy liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit rating agencies, lenders, many industry analysts, and certain other financial statement users prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
89
GL Q3 2024 FORM 10-Q

Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no quantitative or qualitative changes with respect to market risk exposure during the nine months ended September 30, 2024.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures : Globe Life Inc., under the direction of the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
As of the end of the fiscal period completed September 30, 2024, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-Q. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-Q.

Changes in Internal Control over Financial Reporting : During the period ended September 30, 2024, there were no changes to Globe Life Inc.'s internal control over financial reporting or in other factors that could significantly affect the internal control over financial reporting subsequent to the date of their evaluation which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
Part II—Other Information

Item 1. Legal Proceedings

Discussion regarding litigation and unclaimed property audits is provided in Note 5—Commitments and Contingencies .

90
GL Q3 2024 FORM 10-Q

Item 1A. Risk Factors
The following is an update to the material risks previously disclosed in the Company's December 31, 2023 Form 10-K. There are no other material changes to the Company's risk factors.

Our businesses are heavily regulated and changes in regulation or regulatory scrutiny may have a material adverse impact on our business, financial condition or results of operation.

Insurance companies, including our insurance subsidiaries, are subject to extensive supervision and regulation in the states in which they conduct business. The primary purpose of this supervision and regulation is the protection of policyholders, not investors. Regulatory agencies have broad administrative power over numerous aspects of our business, including premium rates for our life, Medicare Supplement and other supplement health products, as well as other terms and conditions included in the insurance policies offered by our insurance subsidiaries, marketing practices, advertising, agent licensing, independent agent practices, policy forms, capital adequacy, solvency, reserves and permitted investments.

Regulatory authorities also have the power to conduct investigations, and to bring administrative or judicial proceedings against us, which could result in suspension or revocation of our licenses, cease and desist orders, fines, civil penalties, disgorgement, criminal penalties or other disciplinary action that could have a material adverse impact on our business, financial condition or results of operation. Press coverage and other public statements that allege wrongdoing, even if untrue, can lead to increased regulatory inquiries or investigations including any that may arise in connection with the subpoenas from U.S. Attorney’s Office for the Western District of Pennsylvania seeking documents related to sales practices by certain of our independent sales agents contracted to sell American Income Life Insurance Company policies. Additionally, any violation or alleged violation of law or regulations could result in significant legal costs or in legal proceedings that may result in monetary and legal remedies being imposed against the Company, which could have a material adverse effect on our business, financial condition or results of operations.

The insurance laws, regulations and policies currently affecting our companies may change at any time, possibly having an adverse effect on our business. Should regulatory changes occur, we may be unable to maintain all required licenses and approvals, or fully comply with the wide variety of applicable laws and regulations or the relevant authority’s interpretation of such laws and regulations. If we do not have the requisite licenses and approvals or do not comply with applicable regulatory requirements, the insurance regulatory authorities could preclude or temporarily suspend some or all of our business activities and/or impose substantial fines.

Actual or alleged misclassification of independent contractors at our insurance subsidiaries could result in adverse legal, tax or financial consequences.

A significant portion of our sales agents are independent contractors. Although we believe we have properly classified such individuals, a risk nevertheless exists that a court, the Internal Revenue Service or other authority will take the position that our sales agents are employees. From time-to-time, we are subject to civil litigation, including class and collective action litigation, alleging that we have improperly classified certain of our sales agents as independent contractors. In September 2024, the EEOC notified us that it had determined that all sales agents affiliated with State General Agent Simon Arias were employees, not independent contractors, of Globe Life Inc. and/or AIL. Such determination is not binding but we expect any potential civil action brought by the EEOC would include such an allegation. A future adverse judgment in connection with any such civil litigation described above could result in substantial damages. Future changes in rules, regulations or interpretations of existing rules and regulations, or significant adverse judgments in litigation, could require us to reclassify all or a portion of our agents as employees and the impact could significantly increase our operating costs and negatively impact our insurance business.

The use of third-party vendors, including independent sales agents, to support the Company's operations makes the Company susceptible to the operational risk of those third parties, which could lower revenues, increase costs, reduce profits, disrupt business, or damage the Company’s reputation.

The Company utilizes third-party vendors, including independent sales agents, to provide certain business services and functions, which exposes the Company to risks outside the control of the Company. The reliance on these third-party vendors creates a number of business risks, such as the risk that the Company may not maintain service
91
GL Q3 2024 FORM 10-Q

quality, control or effective management of the outsourced business operations and that the Company cannot control the information systems, facilities or networks of such third-party vendors. We employ controls and procedures designed to facilitate service quality of our third party vendors; however, such controls and procedures cannot be 100% effective in all cases. The Company may be adversely affected by a third-party vendor who operates in a poorly controlled manner or fails to deliver contracted services, which could lower revenues, increase costs, reduce profits, disrupt business, or damage the Company’s reputation.

Extensive federal and state laws regulate our business, imposing certain requirements that independent sales agents must follow in dealing with clients. Misconduct of our independent sales agents could result in violations of law by, or claims against, us or our subsidiaries. From time to time, we are subject to private litigation as a result of alleged misconduct by independent agents. We employ controls and procedures designed to prevent and detect agent misconduct; however, such controls and procedures cannot be 100% effective in all cases. Instances of misconduct or non-compliance or violations of laws or regulations by our independent sales agents could result in adverse findings in either examinations or litigation and subject us to sanctions, monetary liabilities, restrictions on or loss of the operation of our business or reputational harm, any of which could have a material adverse effect on our business, financial condition or results of operations.

Additionally, the Company is at risk of being unable to meet legal, regulatory, financial or customer obligations if the information systems, facilities or networks of a third-party vendor are disrupted, damaged or fail, whether due to physical disruptions, such as fire, natural disaster, pandemic or power outage, or due to cybersecurity incidents, ransomware or other impacts to vendors, including labor strikes, political unrest and terrorist attacks.

We have become subject to, and may in the future be subject to, short selling strategies driving down the market price of our common stock.

Short selling is the practice of selling securities that the seller does not own but may have borrowed with the intention of buying identical securities back at a later date. A short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. Because it is in the short seller’s best interests for the price of the securities to decline, some short sellers publish, or arrange for the publication of, opinions or characterizations regarding the relevant issuer, its business prospects and similar matters calculated to or which may create negative market momentum, which may permit them to obtain profits for themselves as a result of selling the stock short. Companies, like us, that are subject to unfavorable allegations, even if untrue, may have to expend a significant amount of resources to investigate such allegations and/or defend themselves, including in connection with securityholder litigation against Globe Life Inc. or investigations by regulators related to or prompted by such allegations.

Since April 2024, we have been and continue to be the target of several short sellers who have published reports making allegations about the Company, which resulted in a significant decline in the price of our common stock. In addition, these reports resulted in significant negative publicity against us, damaged our reputation, and exposed us to securities class action litigation. We have already expended significant resources to defend and repair our reputation. We will continue to defend against any unfounded and unsubstantiated claims about our business, our disclosures and the integrity of our financial statements, which may require us to expend significant resources.

We may be subject to additional short seller reports and activity in the future. The publication of any such commentary regarding us may bring about a temporary, or long term, decline in the market price of our common stock. No assurances can be made that similar declines in the market price of our common stock or negative publicity will not occur in the future, in connection with such commentary by short sellers or otherwise.

Damage to the brand and reputation of Globe Life or its subsidiaries could affect our ability to conduct business.

Negative publicity through traditional media, internet, social media, and other public forums, including short seller reports and allegations of independent agent misconduct could damage our brand or reputation, which could adversely impact our ability to recruit and retain agents, our ability to market our products, and the persistency of in-force policies. A reduction in the number of agents selling our products, or the rate of growth of the number of agents selling our products may have an adverse impact on product sales and profit, and such impact may be material.
92
GL Q3 2024 FORM 10-Q


Recent volatility in the trading price of our common stock has and can be expected to result in securities class action litigation.

In April 2024, the trading price of our common stock dropped following the publication of certain short seller reports. As of the date of this Report, one putative securities class action has been filed against Globe Life Inc. and we expect that other putative class action claims may be filed as well. While we intend to defend such actions vigorously, any judgment against us or any future stockholder litigation could have a material adverse effect on our business, financial condition or results of operations.

93
GL Q3 2024 FORM 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Certain Equity Securities by the Issuer and Others for the Third Quarter of 2024
Period
(a) Total Number
of Shares
Purchased
(b) Average
Price Paid
Per Share
(c) Total Number of
Shares Purchased as
Part of Publicly Announced
Plans or Programs
(d) Maximum Number
of Shares (or
Approximate Dollar
Amount) that May
Yet Be Purchased
Under the Plans or
Programs
July 1-31, 2024 227,500 $ 92.62 227,500
August 1-31, 2024 3,261,554 97.39 3,261,554
September 1-30, 2024 2,343,067 105.26 2,343,067


Item 5. Other Information

(c) Trading arrangements

During the nine months ended September 30, 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a Non-Rule 10b5-1 trading arrangement, as each term is defined under Item 408(a) of Regulation S-K.
94
GL Q3 2024 FORM 10-Q

Item 6. Exhibits
Exhibit No. Description
4.1
10.1
31.1
31.2
31.3
32.1
101.INS XBRL Instance Document- the instance document does not appear in the Interactive Data file because the XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).


95
GL Q3 2024 FORM 10-Q

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
GLOBE LIFE INC.
Date: November 6, 2024 /s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
Date: November 6, 2024 /s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
Date: November 6, 2024 /s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

96
GL Q3 2024 FORM 10-Q
TABLE OF CONTENTS